OB/GYN and Women's Health: Recent Episodes
ReachMD
Guest: Sara Horst, MD, MPH, FACG
While inflammatory bowel disease (IBD) does not typically cause significant problems in pregnancy, it’s still essential to discuss potential impacts with patients and monitor them closely. Dr. Sara Horst, a Professor of Medicine at Vanderbilt University Medical Center, joins GI Insights to discuss important considerations for pregnant patients with IBD.
Host: Claire Gill
Guest: Andrea Singer, MD, FACP, CCD
Menopause accelerates bone loss due to declining estrogen levels, increasing the risk of osteoporosis and fractures. To learn how we can best support bone health during this transition, CEO of the Bone Health and Osteoporosis Foundation Claire Gill speaks with Dr. Andrea Singer, Chief Medical Officer of the Bone Health and Osteoporosis Foundation, Professor of Medicine and Obstetrics and Gynecology at MedStar Georgetown University Hospital, and a member of the National Menopause Foundation's Medical Advisory Committee.
Host: Brian Slomovitz, MD
Guest: Robert L. Coleman, MD, FACOG, FACS
In recent years, the treatment landscape for recurrent or metastatic cervical cancer has undergone significant shifts with FDA approvals of first-line pembrolizumab plus platinum-doublet with or without bevacizumab and second-line tisotumab vedotin. The introduction of frontline immune checkpoint blockade also added to the challenges faced by clinicians as they choose optimal regimens for their patients. In this online CME activity, Dr. Coleman and Dr. Slomovitz offer strategies for treatment selection and sequencing with immune checkpoint inhibitors and antibody-drug conjugates for relapsed cervical cancer. Tune in to hear their expert perspectives on biomarker testing, clinical trial evidence, and multidisciplinary management of adverse events associated with these therapies to make sure your patients are getting the most out of these advances.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Hope S. Rugo, MD, FASCO
While endocrine therapy (ET) and CDK4/6 inhibitors are the standard for treating ER+/HER2- metastatic breast cancer, patients can become resistant to ET. To overcome these resistance mechanisms, the ELEVATE study examines whether combining elacestrant with ET could help address this unmet need. Here to share the preliminary findings from ELEVATE with Dr. Charles Turck is lead study investigator Dr. Hope Rugo. She’s also the Winterhof Distinguished Professor of Breast Oncology and the Director of Breast Oncology and Clinical Trials Education at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center.
Host: Jennifer Caudle, DO
Guest: Virginia Kaklamani, MD
Guest: Anne O'Dea, MD
When caring for patients with ER-positive/HER2-negative metastatic breast cancer, there’s uncertainty on the optimal second-line sequencing of treatments after disease progression on first-line CDK4/6 inhibition and endocrine therapy. But the findings from the EMERALD trial, which led to the approval of ORSERDU® (elacestrant) for patients with ER-positive/HER2-negative ESR1-mutated metastatic breast cancer after disease progression on endocrine therapy,1 contribute to our understanding of second-line treatment options. Dive into the results from the EMERALD trial and subgroup analysis with Drs. Virginia Kaklamani and Anne O'Dea. Dr. Kaklamani is a Professor of Medicine in the Division of Hematology and Medical Oncology at the UT Health Sciences Center in San Antonio, and Dr. O'Dea is a breast medical oncologist at the University of Kansas Cancer Center.
Unknown: Arnold Advincula, MD
With over 20 years of experience performing the transabdominal cerclage, Dr. Arnold Advincula, Chief of Gynecologic Specialty Surgery at NewYork-Presbyterian and Columbia, has a deep expertise in helping women with cervical insufficiency achieve successful pregnancies. Through the expanded use of robotics, Dr. Advincula and his team are completing the procedure minimally invasively and with more accuracy and precision. Watch to learn how this advanced technique is transforming gynecologic surgery by reducing recovery time and helping women reach their reproductive goals.
© 2024 NewYork-Presbyterian
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Erika Hamilton, MD
The ELECTRA trial is seeking to evaluate the combination of elacestrant with abemaciclib in patients with ER+/HER2- metastatic breast cancer regardless of metastatic site and ESR1 status to see if this could be an all-oral treatment option before using fulvestrant-based combinations or chemotherapy-based regimens. And now, the preliminary results are here. Joining Dr. Charles Turck to share what we’ve learned so far from the ELECTRA trial is study investigator Dr. Erika Hamilton.
Guest: Jennifer L. Payne, MD
Guest: Melissa Simon, MD
Since postpartum depression is a serious medical condition that can negatively impact mothers, infants, and partners, it is important to identify symptoms in a timely manner.1-4 Dr. Jennifer Payne and Dr. Melissa Simon are here to share their clinical experiences screening patients for postpartum depression, explore strategies to overcome common challenges in screening, and identify best practices for collaborating in the care of perinatal women.
Dr. Payne is a Professor of Psychiatry and Neurobehavioral Sciences as well as Obstetrics and Gynecology at the University of Virginia, and Dr. Simon is a Professor of Obstetrics and Gynecology at the Northwestern University Feinberg School of Medicine.
References
- American Psychiatric Association. Depressive disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™. 5th ed. American Psychiatric Publishing; 2013:155-188.
- Campbell SB, Cohn JF, Meyers T. Depression in First-Time Mothers: Mother-Infant Interaction and Depression Chronicity. Dev Psychol. 1995;31:349-357.
- Moore Simas TA, Huang MY, Patton C, et al. The humanistic burden of postpartum depression: a systematic literature review. Curr Med Res Opin. 2019;35(3):383-393.
- Thompson KS, Fox JE. Post-partum depression: a comprehensive approach to evaluation and treatment. Ment Health Fam Med. 2010;7(4):249-257.
Sage Therapeutics and the Sage Therapeutics logo …
Host: Matt Birnholz, MD
Guest: Jennifer L. Payne, MD
Guest: Melissa Simon, MD
Postpartum depression is a serious medical condition that is among the most common complications during and after pregnancy; however, it is often underdiagnosed.1-4 To learn more about screening patients for postpartum depression, Dr. Matt Birnholz speaks with Dr. Jennifer Payne and Dr. Melissa Simon about screening strategies, the impact of health inequities, and the latest medical guidelines regarding the importance of early screening for postpartum depression.
Dr. Payne is a Professor of Psychiatry and Neurobehavioral Sciences as well as Obstetrics and Gynecology at the University of Virginia, and Dr. Simon is a Professor of Obstetrics and Gynecology at the Northwestern University Feinberg School of Medicine.
References
- American Psychiatric Association. Depressive disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™. 5th ed. American Psychiatric Publishing; 2013:155-188.
- Bauman BL, Ko JY, Cox S, et al. Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression - United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(19):575-581.
- Cox EQ, Sowa NA, Meltzer-Brody SE, Gaynes BN. The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes. J Clin Psychiatry. 2016;77(9):1189-1200.
- Thompson KS, Fox JE. Post-partum depression: a comprehensive approach to evaluation and treatment. Ment Health Fam Med. 2010;7(4):249-257. …
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Linda Bradley, MD
Guest: Melissa Simon, MD
The use of validated patient questionnaires, notably the SF-36 and EHP-30 scales, can greatly hasten the suspicion for an endometriosis diagnosis. Coupled with shared decision-making, or SDM, this patient-centered process can help ensure therapeutic adherence. Join Drs. Lee Shulman, Melissa Simon, and Linda Bradley as they discuss how to utilize the SF-36 and EHP-30 questionnaires in clinical practice and explore strategies to facilitate patient-healthcare provider discussions to improve overall short- and long-term patient outcomes.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Guest: Sawsan As-Sanie, MD
GnRH antagonists have emerged as a viable first-line (or subsequent-line) medical therapy for the management of endometriosis. They have proven to be effective and safe, and their use avoids the flare response observed with GnRH agonists. Join Drs. Lee Shulman, Ayman Al-Hendy, and Sawsan As-Sanie as they discuss the estrogen threshold hypothesis from the perspective of GnRH antagonists and delve into clinical data supporting the use of GnRH antagonists in the medical management of endometriosis.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Linda Bradley, MD
Guest: Melissa Simon, MD
Both provider- and patient-related healthcare disparities exist in the diagnosis and management of endometriosis. Many disparities derive from incorrect historical biases, while others are associated with social determinants of health, or SDOH. Join Drs. Lee Shulman, Linda Bradley, and Melissa Simon as they address these issues to help facilitate a patient-centered practice environment for all patients.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Leigh Anne Cantrell, MD, MSPH
The updated ASCCP guidelines now address the use of dual-stain technology for cervical cancer management. CINtec PLUS Cytology is a test for the co-expression of p16 and Ki67 and confirms the presence of a transforming HPV infection and defines patients with high-risk cervical disease. To learn more about these guidelines and how to apply them in practice, join Dr. Leigh Cantrell, Medical Physician and Fellow in the American College of Obstetrics and Gynecology.
COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 07/24
Host: Matt Birnholz, MD
Guest: Kay Matthews, LCHW
Ms. Kay Matthews has lived experience with postpartum depression and now advocates for others as the Executive Director and Founder of Shades of Blue, which is dedicated to breaking cultural barriers in maternal mental health. Tune in to hear her speak with Dr. Matt Birnholz about her journey with postpartum depression, barriers that can prevent or delay patients from seeking care, and strategies for combatting stigma and ensuring a timely diagnosis.
Sage Therapeutics and the Sage Therapeutics logo are registered trademarks of Sage Therapeutics, Inc.
Sage Therapeutics, Inc. All rights reserved.
Sage Therapeutics ©2024 MRC-PPD-00792 06/2024
Host: Jennifer Caudle, DO
Guest: Joyce O'Shaughnessy, MD
The results from the phase III EMERALD trial led to the approval of ORSERDU® (elacestrant) as the first oral selective estrogen receptor degrader for ER-positive/HER2-negative metastatic breast cancer patients with ESR1 mutations after disease progression following at least one line of endocrine therapy.1 But given the results from prior analyses, clinicians wanted to better understand the data for elacestrant in subgroups of patients with key clinical or biomarker characteristics, and so a post hoc analysis of elacestrant in these subgroups who typically have a poorer prognosis was conducted. Explore the EMERALD trial and the key outcomes from this subgroup analysis with Dr. Jennifer Caudle and medical oncologist Dr. Joyce O'Shaughnessy.
Host: Warner K. Huh, MD
Guest: Kimberly Levinson, MD, MPH
More effective triage tests are essential to improving cervical cancer risk-stratification and thus reducing the potential for unnecessary colposcopies. Enduring consensus cervical cancer screening recommendations, published in 2024, describe specific-use algorithms for p16/Ki-67 dual-staining cytology as an effective triage test, and also offer insight on how this test can best fit into clinical practice. Join Drs. Warner Huh and Kimberly Levinson as they first establish the rationale for using p16/Ki-67 dual-staining cytology and then break down the most salient algorithms for its use as offered in the recent recommendations.
Host: Jennifer Caudle, DO
Guest: Tamera A. Paczos, MD, FACOG, FACP
The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories.
COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 02/23
Host: Michael Lewiecki, MD, FACP, FACE
Although step therapy is the approach that many health plans and organizations are fond of, individualizing treatment decisions for patients with osteoporosis is essential, especially those who are at risk of fractures. To learn how you can create personalized treatment plans for patients with osteoporosis, tune in to hear Dr. Michael Lewiecki give us a recap of the session he presented at the 2024 Congress of Clinical Rheumatology.
Host: Michael Lewiecki, MD, FACP, FACE
Here to talk about current concepts in the management of osteoporosis like insurance coverage, therapy sequencing, and comparative effectiveness is Dr. Michael Lewiecki, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.
Guest: Dena Goffman, MD
Dr. Dena Goffman believes that better maternal care requires a proactive, system-wide approach and is making her vision a reality at NewYork-Presbyterian. She focuses on implementing guidelines that standardize care across all of NewYork-Presbyterian’s hospitals. Dr. Goffman has also aided in FDA approval and adoption of a new, ingenious hemorrhage tool and embraced simulations to train and improve the skills of healthcare professionals throughout the labor and delivery process. Join health and science journalist Catherine Price as she speaks with Dr. Dena Goffman, Vice Chair for Quality and Patient Safety and the Associate Chief and Quality Officer for Obstetrics for NewYork-Presbyterian, about how her work has helped establish goals and quality standards for safer labor and delivery.
© 2024 NewYork-Presbyterian
Guest: Dena Goffman, MD
Dr. Dena Goffman believes that better maternal care requires a proactive, system-wide approach and is making her vision a reality at NewYork-Presbyterian. She focuses on implementing guidelines that standardize care across all of NewYork-Presbyterian’s hospitals. Dr. Goffman has also aided in FDA approval and adoption of a new, ingenious hemorrhage tool and embraced simulations to train and improve the skills of healthcare professionals throughout the labor and delivery process. Join health and science journalist Catherine Price as she speaks with Dr. Dena Goffman, Vice Chair for Quality and Patient Safety and the Associate Chief and Quality Officer for Obstetrics for NewYork-Presbyterian, about how her work has helped establish goals and quality standards for safer labor and delivery.
© 2024 NewYork-Presbyterian
Host: John Buse, MD, PhD
Guest: Kim Boggess, MD
The most common forms of diabetes encountered in pregnant patients include gestational diabetes and preexisting type 2 diabetes. So how does adding metformin to insulin treatment help these patients? Join Dr. John Buse as he talks about the MOMPOD Trial with lead author, Dr. Kim Boggess, Professor of Maternal Fetal Medicine at the University of North Carolina at Chapel Hill.
Host: Eliza C. Miller, MD
Stroke is one of the leading causes of death in pregnancy in the United States, underscoring the importance of knowing the causes, risks, and treatment of stroke in pregnancy and postpartum. That’s why Dr. Eliza Miller is here to share key insights from her session at the 2024 AAN Annual Meeting that focused on this exact topic. Dr. Miller is an Associate Professor of Neurology in the Division of Stroke and Cerebrovascular Disease at Columbia University.
Host: Eliza C. Miller, MD
Stroke is one of the leading causes of death in pregnancy in the United States, underscoring the importance of knowing the causes, risks, and treatment of stroke in pregnancy and postpartum. That’s why Dr. Eliza Miller is here to share key insights from her session at the 2024 AAN Annual Meeting that focused on this exact topic. Dr. Miller is an Associate Professor of Neurology in the Division of Stroke and Cerebrovascular Disease at Columbia University.
Host: John Buse, MD, PhD
Guest: Kim Boggess, MD
The most common forms of diabetes encountered in pregnant patients include gestational diabetes and preexisting type 2 diabetes. So how does adding metformin to insulin treatment help these patients? Join Dr. John Buse as he talks about the MOMPOD Trial with lead author, Dr. Kim Boggess, Professor of Maternal Fetal Medicine at the University of North Carolina at Chapel Hill.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Derrick Barnes, MD
“Whatever dream you have of what you want your practice to look like, you can do.” That’s what OB-GYN Dr. Derrick Barnes believes when it comes to beginning a career in locum tenens. Tune in to hear Dr. Barnes share his experience with locum tenens work and how it offered him variety and flexibility in his career.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Derrick Barnes, MD
“Whatever dream you have of what you want your practice to look like, you can do.” That’s what OB-GYN Dr. Derrick Barnes believes when it comes to beginning a career in locum tenens. Tune in to hear Dr. Barnes share his experience with locum tenens work and how it offered him variety and flexibility in his career.
Host: Javed Butler, MD, MBA, MPH
Guest: Michael J. LaMonte, PhD, MPH
The American Heart Association recommends physical activity to help lower the risk of heart failure, but how much exercise is needed, especially for older women, to lower that risk? According to a recent study, even just low-intensity exercise for 30 minutes is associated with a 25 percent lower risk of overall heart failure. Dive further into the findings with Dr. Javed Bulter and Dr. Michael LaMonte, a Research Professor of Epidemiology and Environmental Health at the University of Buffalo.
Host: Javed Butler, MD, MBA, MPH
Guest: Michael J. LaMonte, PhD, MPH
The American Heart Association recommends physical activity to help lower the risk of heart failure, but how much exercise is needed, especially for older women, to lower that risk? According to a recent study, even just low-intensity exercise for 30 minutes is associated with a 25 percent lower risk of overall heart failure. Dive further into the findings with Dr. Javed Bulter and Dr. Michael LaMonte, a Research Professor of Epidemiology and Environmental Health at the University of Buffalo.
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Victoria Leavitt, PhD
Disease-modifying therapies (DMTs) are an effective option for patients with multiple sclerosis (MS). In fact, a recent study presented at the 2023 joint ECTRIMS-ACTRIMS meeting in Italy found that MS patients being treated with a DMT had better cognitive function than those who were not. However, the same study also found that women are less likely than men to receive DMT treatment. Dive further into the findings with Dr. Andrew Wilner and Dr. Victoria Leavitt, Assistant Professor of Neuropsychology at Columbia University.
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Victoria Leavitt, PhD
Disease-modifying therapies (DMTs) are an effective option for patients with multiple sclerosis (MS). In fact, a recent study presented at the 2023 joint ECTRIMS-ACTRIMS meeting in Italy found that MS patients being treated with a DMT had better cognitive function than those who were not. However, the same study also found that women are less likely than men to receive DMT treatment. Dive further into the findings with Dr. Andrew Wilner and Dr. Victoria Leavitt, Assistant Professor of Neuropsychology at Columbia University.
Host: Ashley Baker, MSN, PMHNP
Guest: Anna Shah, MD
The prevalence of multiple sclerosis seems to be increasing in patients, and the majority of those patients are diagnosed with MS around the peak family planning age. So family planning should be an integral part of comprehensive patient-centered MS care. Learn more with Psychiatric Nurse Practitioner Ashey Baker as she speaks with Dr. Anna Shah, Assistant Professor of Neurology and the Director of Neurology Outpatient Patient Safety & Experience at the University of Colorado Anschutz School of Medicine.
Host: Ashley Baker, MSN, PMHNP
Guest: Anna Shah, MD
The prevalence of multiple sclerosis seems to be increasing in patients, and the majority of those patients are diagnosed with MS around the peak family planning age. So family planning should be an integral part of comprehensive patient-centered MS care. Learn more with Psychiatric Nurse Practitioner Ashey Baker as she speaks with Dr. Anna Shah, Assistant Professor of Neurology and the Director of Neurology Outpatient Patient Safety & Experience at the University of Colorado Anschutz School of Medicine.
Host: Kathleen Moore, MD, MS
Guest: Susana Banerjee, MBBS, MA, FRCP, PhD
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Host: Kathleen Moore, MD, MS
Guest: Brad McGregor, MD
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Susana Banerjee, MBBS, MA, FRCP, PhD
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Brad McGregor, MD
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Host: Kathleen Moore, MD, MS
Guest: Susana Banerjee, MBBS, MA, FRCP, PhD
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Susana Banerjee, MBBS, MA, FRCP, PhD
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Host: Kathleen Moore, MD, MS
Guest: Brad McGregor, MD
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Kathleen Moore, MD, MS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Guest: Brad McGregor, MD
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.
On April 5, 2024, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. . To learn more about this approval, please visit: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
Host: Lee Shulman MD, FACOG, FACMG
Guest: Kristina Deligiannidis, MD
The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD). These agents have a quick onset and function as GABAA positive allosteric modulators. Join Drs. Shulman and Deligiannidis as they address the burdens and impacts of PPD on mothers, babies, and partners, and deep dive into the pathophysiologic role and clinical findings associated with the use of neuroactive steroids in the management of PPD.
Host: Lee Shulman MD, FACOG, FACMG
Guest: Kristina Deligiannidis, MD
The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD). These agents have a quick onset and function as GABAA positive allosteric modulators. Join Drs. Shulman and Deligiannidis as they address the burdens and impacts of PPD on mothers, babies, and partners, and deep dive into the pathophysiologic role and clinical findings associated with the use of neuroactive steroids in the management of PPD.
Host: Jessica Ailani, MD
Guest: Dawn C. Buse, PhD
Upwards of 47 million people in the U.S. suffer from migraines, often accompanied by widespread personal, professional, and social disabilities. Though a similar prevalence is initially observed between men and women, by mid-adulthood the prevalence of migraine is 3-fold greater in women than men. Newer agents, both injectable and oral and focused on modulating the calcitonin gene-related peptide pathway, have emerged and have proven highly effective in managing both acute and chronic migraine. Join Drs. Jessica Ailani and Dawn Buse as they provide an overview of the changing landscape of migraine therapy, especially as it impacts women across different life-stages.
Host: Jessica Ailani, MD
Guest: Dawn C. Buse, PhD
Upwards of 47 million people in the U.S. suffer from migraines, often accompanied by widespread personal, professional, and social disabilities. Though a similar prevalence is initially observed between men and women, by mid-adulthood the prevalence of migraine is 3-fold greater in women than men. Newer agents, both injectable and oral and focused on modulating the calcitonin gene-related peptide pathway, have emerged and have proven highly effective in managing both acute and chronic migraine. Join Drs. Jessica Ailani and Dawn Buse as they provide an overview of the changing landscape of migraine therapy, especially as it impacts women across different life-stages.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Pavani Chalasani, MD, MPH
Acquired ESR1 mutations cannot be detected on archival tissue and require liquid biopsy. Fortunately, this approach circumvents the challenges of acquiring serial tissue while allowing for the real-time monitoring of ESR1 status in patients with metastatic breast cancer. Learn more about the rationale behind liquid biopsies and best practices for utilizing them in clinical practice with Dr. Charles Turck and Dr. Pavani Chalasani, Division Director of Hematology-Oncology at the GW Cancer Center in Washington, DC.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Pavani Chalasani, MD, MPH
Acquired ESR1 mutations cannot be detected on archival tissue and require liquid biopsy. Fortunately, this approach circumvents the challenges of acquiring serial tissue while allowing for the real-time monitoring of ESR1 status in patients with metastatic breast cancer. Learn more about the rationale behind liquid biopsies and best practices for utilizing them in clinical practice with Dr. Charles Turck and Dr. Pavani Chalasani, Division Director of Hematology-Oncology at the GW Cancer Center in Washington, DC.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Stephanie Graff, MD
Guest: Pavani Chalasani, MD, MPH
When treating patients with metastatic breast cancer, it’s important to repeatedly conduct liquid biopsies to look for acquired ESR1 mutations when patients progress after endocrine therapy, even if initial testing was done. That’s why Dr. Charles Turck is breaking down best practices for utilizing liquid biopsies to detect ESR1 mutations with Drs. Stephanie Graff and Pavani Chalasani. Dr. Graff is the Director of Breast Oncology at the Lifespan Cancer Institute in Providence, Rhode Island, and Dr. Chalasani is the Division Director of Hematology-Oncology at the GW Cancer Center in Washington, DC.
Guest: Mariya Rozenblit, MD
ESR1 mutations are frequently acquired during aromatase inhibitor treatment for HR+/HER2- metastatic breast cancer, making liquid biopsy monitoring vital to identify endocrine resistance. Learn more about this acquired mutation and how it can impact treatment with Dr. Mariya Rozenblit, Assistant Professor of Medicine in the Section of Medical Oncology at the Yale School of Medicine.
Host: Pavani Chalasani, MD, MPH
Guest: Marcela Mazo Canola, MD
Recent studies have examined the implications of ESR1 mutations in metastatic breast cancer and found that ESR1 mutations predict poor response to subsequent endocrine therapy. These acquired mutations also correlate with aggressive disease and, by extension, worse prognosis. Dive further into these findings from various studies and how they might impact the way we treat patients with metastatic breast cancer with Dr. Pavani Chalasani and Dr. Marcela Mazo Canola, Assistant Professor at UT Health San Antonio’s Mays Cancer Center.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Stephanie Graff, MD
Guest: Pavani Chalasani, MD, MPH
When treating patients with metastatic breast cancer, it’s important to repeatedly conduct liquid biopsies to look for acquired ESR1 mutations when patients progress after endocrine therapy, even if initial testing was done. That’s why Dr. Charles Turck is breaking down best practices for utilizing liquid biopsies to detect ESR1 mutations with Drs. Stephanie Graff and Pavani Chalasani. Dr. Graff is the Director of Breast Oncology at the Lifespan Cancer Institute in Providence, Rhode Island, and Dr. Chalasani is the Division Director of Hematology-Oncology at the GW Cancer Center in Washington, DC.
Host: Pavani Chalasani, MD, MPH
Guest: Marcela Mazo Canola, MD
Recent studies have examined the implications of ESR1 mutations in metastatic breast cancer and found that ESR1 mutations predict poor response to subsequent endocrine therapy. These acquired mutations also correlate with aggressive disease and, by extension, worse prognosis. Dive further into these findings from various studies and how they might impact the way we treat patients with metastatic breast cancer with Dr. Pavani Chalasani and Dr. Marcela Mazo Canola, Assistant Professor at UT Health San Antonio’s Mays Cancer Center.
Guest: Mariya Rozenblit, MD
ESR1 mutations are frequently acquired during aromatase inhibitor treatment for HR+/HER2- metastatic breast cancer, making liquid biopsy monitoring vital to identify endocrine resistance. Learn more about this acquired mutation and how it can impact treatment with Dr. Mariya Rozenblit, Assistant Professor of Medicine in the Section of Medical Oncology at the Yale School of Medicine.
Guest: Cara Dolin, MD
Guest: Jennifer Simpson
Guest: Diana Girnita, MD ,PhD
Explore this video roundtable featuring an interdisciplinary panel of experts discussing a woman’s journey with mycophenolate therapy and strategies to approach risk mitigation. Learn more about how to provide critical education on the risks of mycophenolate, the importance of effective contraception, and navigating family planning.
Guest: Cara Dolin, MD
Guest: Jennifer Simpson
Guest: Diana Girnita, MD ,PhD
Explore this video roundtable featuring an interdisciplinary panel of experts discussing a woman’s journey with mycophenolate therapy and strategies to approach risk mitigation. Learn more about how to provide critical education on the risks of mycophenolate, the importance of effective contraception, and navigating family planning.
Guest: Megan Kruse, MD
While intrinsic mutations, like PIK3CA, are present at the outset and can be identified upfront in patients with HR+/HER2- metastatic breast cancer, acquired mutations, like ESR1, cannot be detected on baseline tumor profiling. That’s why longitudinal monitoring with liquid biopsies over the course of treatment is required. Learn more about these key differences in testing for acquired versus intrinsic mutations with Dr. Megan Kruse, a breast medical oncologist at the Cleveland Clinic.
Guest: Megan Kruse, MD
While intrinsic mutations, like PIK3CA, are present at the outset and can be identified upfront in patients with HR+/HER2- metastatic breast cancer, acquired mutations, like ESR1, cannot be detected on baseline tumor profiling. That’s why longitudinal monitoring with liquid biopsies over the course of treatment is required. Learn more about these key differences in testing for acquired versus intrinsic mutations with Dr. Megan Kruse, a breast medical oncologist at the Cleveland Clinic.
Host: John Buse, MD, PhD
Guest: Helen Murphy, PhD
There are many challenges associated with managing type 1 diabetes (T1D) in pregnant patients, which is why a recent study examined the use of an automated insulin delivery system in this patient population. Using this method, insulin doses were adjusted every 8 to 10 minutes according to a patient’s real-time glucose levels taken from her continuous glucose monitor. As a result, women experienced a higher percentage time in the pregnancy glucose target range, less hyperglycemia, and less gestational weight gain. Learn more about how these findings may impact the management of T1D both during and after pregnancy with Dr. John Buse and Dr. Helen Murphy, a Professor of Medicine in Diabetes and Antenatal Care at the University of East Anglia in the United Kingdom.
Host: Blake Zwerling, MD
The Society of Family Planning and the Society of Maternal Fetal Medicine have released updated guidelines for medication abortion. Tune in as Dr. Blake Zwerling, Assistant Clinical Professor of Complex Family Planning, reviews these updates and shares how they can be used in clinical practice.
Host: Blake Zwerling, MD
The Society of Family Planning and the Society of Maternal Fetal Medicine have released updated guidelines for medication abortion. Tune in as Dr. Blake Zwerling, Assistant Clinical Professor of Complex Family Planning, reviews these updates and shares how they can be used in clinical practice.
Host: John Buse, MD, PhD
Guest: Helen Murphy, PhD
There are many challenges associated with managing type 1 diabetes (T1D) in pregnant patients, which is why a recent study examined the use of an automated insulin delivery system in this patient population. Using this method, insulin doses were adjusted every 8 to 10 minutes according to a patient’s real-time glucose levels taken from her continuous glucose monitor. As a result, women experienced a higher percentage time in the pregnancy glucose target range, less hyperglycemia, and less gestational weight gain. Learn more about how these findings may impact the management of T1D both during and after pregnancy with Dr. John Buse and Dr. Helen Murphy, a Professor of Medicine in Diabetes and Antenatal Care at the University of East Anglia in the United Kingdom.
Guest: Christena Raines, NP
Perinatal mood disorders are among the most common complications during pregnancy and immediately following delivery. So front line providers need to be able to initiate treatment. Perinatal Psychiatric Nurse Practitioner and Adjunct Professor of Psychiatry at UNC Chapel Hill, Christena Raines, discusses her session at the 26th Annual Nurse Practitioners in Women’s Healthcare Conference and the importance of recognizing and treating perinatal mood disorders in our female patients.
Guest: Christena Raines, NP
Perinatal mood disorders are among the most common complications during pregnancy and immediately following delivery. So front line providers need to be able to initiate treatment. Perinatal Psychiatric Nurse Practitioner and Adjunct Professor of Psychiatry at UNC Chapel Hill, Christena Raines, discusses her session at the 26th Annual Nurse Practitioners in Women’s Healthcare Conference and the importance of recognizing and treating perinatal mood disorders in our female patients.
Host: Pavani Chalasani, MD, MPH
Guest: Jose Pablo Leone, MD
Breast cancer is the second most common cause of brain metastases. Given this prevalence, how can we identify the early signs and symptoms and treat patients with metastatic breast cancer accordingly? Here to dive further into this topic with Dr. Pavani Chalasani is Dr. Jose Pablo Leone, Director of the Program for Breast Cancer in Men at Dana-Farber.
Guest: Dawn Kimberly Hopkins, PhD, WHNP-BC
Understanding the manifestations of polycystic ovary syndrome (PCOS) can help to identify this condition in women better. And though it’s a common condition, some providers are unaware of how to diagnose it. Dig into the pathophysiology of PCOS with Dr. Dawn Kimberly Hopkins, Research Associate at the Henry Jackson Foundation in Bethesda, Maryland.
Host: Pavani Chalasani, MD, MPH
Guest: Jose Pablo Leone, MD
Breast cancer is the second most common cause of brain metastases. Given this prevalence, how can we identify the early signs and symptoms and treat patients with metastatic breast cancer accordingly? Here to dive further into this topic with Dr. Pavani Chalasani is Dr. Jose Pablo Leone, Director of the Program for Breast Cancer in Men at Dana-Farber.
Guest: Dawn Kimberly Hopkins, PhD, WHNP-BC
Understanding the manifestations of polycystic ovary syndrome (PCOS) can help to identify this condition in women better. And though it’s a common condition, some providers are unaware of how to diagnose it. Dig into the pathophysiology of PCOS with Dr. Dawn Kimberly Hopkins, Research Associate at the Henry Jackson Foundation in Bethesda, Maryland.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: William R. Short, MD, MPH, AAHIVS
As of January 2023, the breastfeeding guidelines for HIV patients were updated, and they now recommend supporting the parent’s choice through shared decision-making. Joining Dr. Charles Turck to share what these new guidelines look like in practice and key counseling strategies for HIV patients is Dr. William Short. Dr. Short is an Associate Professor of Medicine and Infectious Disease at the University of Pennsylvania in Philadelphia, and he also spoke about this exact topic at the 2023 ANAC conference in his session, titled “New Recommendations for Infant Feeding for Persons with HIV in the United States.”
Guest: Genevieve Hofmann, NP
Menopause can impact everyday life, and many women go untreated for their menopausal symptoms. To learn more about some of the complex issues surrounding menopause management, join Dr. Genevieve Hofmann, Women’s Health Nurse Practitioner, Certified Menopause Clinician, and Assistant Professor of OB/GYN Health at the University of Colorado School of Medicine, who will be discussing these strategies at the 2023 Annual NPWH Women’s Healthcare Conference.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: William R. Short, MD, MPH, AAHIVS
As of January 2023, the breastfeeding guidelines for HIV patients were updated, and they now recommend supporting the parent’s choice through shared decision-making. Joining Dr. Charles Turck to share what these new guidelines look like in practice and key counseling strategies for HIV patients is Dr. William Short. Dr. Short is an Associate Professor of Medicine and Infectious Disease at the University of Pennsylvania in Philadelphia, and he also spoke about this exact topic at the 2023 ANAC conference in his session, titled “New Recommendations for Infant Feeding for Persons with HIV in the United States.”
Guest: Genevieve Hofmann, NP
Menopause can impact everyday life, and many women go untreated for their menopausal symptoms. To learn more about some of the complex issues surrounding menopause management, join Dr. Genevieve Hofmann, Women’s Health Nurse Practitioner, Certified Menopause Clinician, and Assistant Professor of OB/GYN Health at the University of Colorado School of Medicine, who will be discussing these strategies at the 2023 Annual NPWH Women’s Healthcare Conference.
Guest: Sadia Haider, MD, PhD
After a historic year of legislation for abortion and contraception, there are still many questions surrounding patient care. Tune in as Dr. Sadia Haider, Interim Chair of OB-GYN at RUSH University and President Elect of the Society of Family Planning, discusses the research presented at the 2023 Society of Family Planning Annual Meeting.
Guest: Sadia Haider, MD, PhD
After a historic year of legislation for abortion and contraception, there are still many questions surrounding patient care. Tune in as Dr. Sadia Haider, Interim Chair of OB-GYN at RUSH University and President Elect of the Society of Family Planning, discusses the research presented at the 2023 Society of Family Planning Annual Meeting.
Host: John Buse, MD, PhD
Guest: David Simmons, MD
Gestational hypertension is more common in preeclampsia, and there’s more chance of the baby ending up in the neonatal intensive care unit. So what can we learn from the randomized trials of women patients with gestational diabetes? Learn more with Dr. John Buse as he speaks with Dr. David Simmons, Distinguished Professor of Medicine at the Western Sydney University Macarthur Clinical School in Australia.
Host: John Buse, MD, PhD
Guest: David Simmons, MD
Gestational hypertension is more common in preeclampsia, and there’s more chance of the baby ending up in the neonatal intensive care unit. So what can we learn from the randomized trials of women patients with gestational diabetes? Learn more with Dr. John Buse as he speaks with Dr. David Simmons, Distinguished Professor of Medicine at the Western Sydney University Macarthur Clinical School in Australia.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Craig Chepke, MD, FAPA
From a women's mental health pre-conference to new mechanisms of action coming into psychiatry for the first time in decades, there’s a lot to look forward to at this year’s meeting. Join Dr. Mary Katherine Cheeley as she gets more highlights from Dr. Craig Chepke, Medical Director of Excel Psychiatric Associates and Psych Congress 2023 Scientific Advisor.
Host: Pavani Chalasani MD, MPH
Guest: Nick McAndrew, MD, MSCE
How can ribociclib plus endocrine therapy help reduce recurrence in early breast cancer? That’s the exact question the NATALEE trial sought to answer, and here to discuss the results with Dr. Pavani Chalasani is Dr. Nicholas McAndrew, Assistant Professor in the Division of Hematology and Oncology at the UCLA David Geffen School of Medicine.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: John J. Russell, MD
Guest: Darvin Scott Smith, MD
Hospitals and health systems face several economic and logistical challenges due to low rates of flu vaccination. Fortunately, there are policies, programs, and initiatives that can be implemented in health system environments and at the community level to increase flu vaccination rates. Learn more with Drs. Darvin Scott Smith and John Russell. Dr. Smith is an Infectious Disease Consultant of Public Health Works, LLC in Northern California, and Dr. Russell is a family medicine physician at Jefferson Health System in Abington, Pennsylvania.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Vaccines are essential in reducing death and disability related to influenza, but unfortunately, not all patients have equal access to these life-saving resources. In fact, many barriers exist, like misinformation and lack of public awareness and education. That’s why Dr. Charles Turck speaks with Dr. Keith Ferdinand about ways we can break down barriers and improve vaccination rates among members of racial and ethnic minority communities.
Guest: Candace T. Westgate, DO, MPH, FACOG
Guest: Ethan D. Schram, MD, FACP
Early detection of cancer is essential to reducing the significant burdens associated with it. When cancer is detected at earlier stages, treatments can be initiated sooner, resulting in improved outcomes, reduced morbidity and mortality, and better quality of life. While the implementation of current screening guidelines has resulted in an overall reduction in cancer deaths, only 25 percent of cancers are diagnosed using traditional screening modalities, leaving much room for improvement. Blood-based multi-cancer early detection, or MCED, tests that can screen from four to greater than 50 types of cancers have been developed to complement the population-based screening of asymptomatic individuals. At the spring 2023 American Association for Cancer Research, also known as AACR, American Society of Clinical Oncology, or ASCO, and National Comprehensive Cancer Network, orNCCN, annual conferences, a multitude of data was presented on MCEDs, including real-world data, clinical trial data, novel MCEDs in development, MCED accuracy, and the inherent health equity challenges that their implementation will face. This educational activity has two parts. Dr. Candace Westgate delivers an MCED Primer designed to build primary care clinicians’ knowledge about the science of MCEDs and how to implement their use in primary care practice, followed by chapterized discussions between …
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Sarah Bauerle Bass, PhD, MPH, FSBM
Although the rate of new HIV diagnoses in the United States is steadily declining, people in prisons are still disproportionately living with the virus, which is why researchers at Temple University are now developing an app aimed at improving HIV prevention and substance use treatment access for incarcerated women in Philadelphia. To learn more about this research, Dr. Mary Katherine Cheeley is joined by Dr. Sarah Bauerle Bass, Associate Professor of Social and Behavioral Sciences and the Director of Risk Communication Laboratory at Temple University.
Host: Jennifer Caudle, DO
Guest: Ravi Jhaveri, MD
Influenza vaccines have prevented between 39,000 and 105,000 hospitalizations and between 3,700 and 9,800 deaths each year over the last 10 years in the United States alone.1 But many challenges still exist in the traditional egg-based influenza vaccine manufacturing process. To explore how cell-based vaccines, an option that uses an alternative manufacturing approach, could help address those challenges and the overall influenza burden, Dr. Jennifer Caudle speaks with Dr. Ravi Jhaveri, Division Head of Pediatric Infectious Diseases at the Ann & Robert H. Lurie Children's Hospital of Chicago.
References:1. Centers for Disease Control and Prevention. Past seasons estimated influenza disease burden averted by vaccination. https://www.cdc.gov/flu/vaccines-work/past-burden-averted-est.html. Accessed April 8, 2022.
USA-QIVc-23-0038 06/23
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Richard T. Penson, MD, MRCP
Uterine cancer is the most common type of gynecologic malignancy in the United States, and disease mortality is on the rise. What do we need to know from recent studies to diagnose patients earlier? Take a deep dive with Dr. Charles Turck as he is joined by Dr. Richard Penson, Medical Oncologist specializing in Gynecologic Oncology at Massachusetts General Hospital in Boston.
Guest: Emily MacDuffie, MD
A recent survey conducted by physicians at Penn Medicine found that one-third of female oncologists reported experiencing infertility. Join Dr. Emily Macduffie, Radiation Oncology Resident Physician at Penn Medicine, as she speaks about potential solutions related to infertility for women in medicine based on her 2023 ASCO presentation.
Guest: Alison Wakoff Loren, MD, MSCE
Cancer occurs in approximately 1 in every 1,000 pregnant patients and requires complex solutions from a multidisciplinary team. Learn more about the expanding management options for these patients with Dr. Alison Loren, Chief of the Division of Hematology and Oncology at the University of Pennsylvania Perelman School of Medicine.
Guest: Oluwatosin Goje, MD
Better diagnostic techniques with rapid turnover and therapies for the treatment of both acute and chronic vulvovaginitis can help address the long-term burden facing reproductive-aged women. Learn more with Dr. Tosin Goje, Associate Professor of Obstetrics/Gynecology and Reproductive Biology at the Cleveland Clinic's Lerner College of Medicine at Case Western Reserve University.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Oluwatosin Goje, MD
A delay in diagnosis and treatment of vulvovaginitis can have big impacts on a patient’s quality of life and their overall health. Explore how screening modalities like molecular tests and treatment guidelines from the CDC can help optimize the management of patients with vulvovaginitis with Dr. Charles Turck and Dr. Tosin Goje, Associate Professor of Obstetrics and Gynecology and Reproductive Biology at the Cleveland Clinic’s Lerner College of Medicine at Case Western Reserve University.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily M. Godfrey, MD, MPH
A recent study presented at the 2023 ACOG Annual Clinical and Scientific Meeting examined patient perspectives on clinician communication regarding medication abortion during telemedicine versus in-clinic visits and found that patients prefer to receive abortion care via telemedicine. Learn more about the study’s design and results with Dr. Charles Turck and Dr. Emily Godfrey, Professor of Family Medicine and Obstetrics and Gynecology at the University of Washington.
Guest: Mitchell D. Creinin, MD
Dive into the research presented at the 2023 ACOG Annual Scientific and Clinical Meeting that found that the use of levonorgestrel 52-mg intrauterine device (IUD) in patients with heavy menstrual bleeding reduced blood loss by more than 90 percent over six months with Dr. Mitch Creinin, Professor in the Department of Obstetrics and Gynecology as well as the Director of the Complex Family Planning Fellowship at the University of California Davis Health.
Guest: Mitchell D. Creinin, MD
While the use of levonorgestrel 52-mg intrauterine device (IUD) has been shown to reduce blood loss in patients with heavy menstrual bleeding, these same patients are at an increased likelihood of expelling the IUD. That’s why it’s important to set realistic expectations with patients, as Dr. Mitch Creinin from the University of California Davis Health explains.
Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG
According to a poster that was featured at the 2023 ACOG Annual Clinical and Scientific Meeting, only 75 percent of patients at UMass Chan Medical School were screened for perinatal mental health conditions, and of those screened, white patients were more likely to be connected with appropriate care and treatment than black or Hispanic patients. Dive deeper into the findings that underscore the importance of addressing disparities and inequities in perinatal depression care with Dr. Tiffany Moore Simas, Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School.
Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG
Host: Charles Turck, PharmD, BCPS, BCCCP
New guidelines regarding the screening, diagnosis, and pharmacological treatment of perinatal mental health conditions as well as resources like in-depth toolkits and implementation guides are now available to help optimize the management of patients with perinatal mental health conditions. Find out how these tools can help you better address one of the most common complications of pregnancy with Dr. Charles Turck and Dr. Tiffany Moore Simas, the Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School who presented a few sessions focusing on this exact topic at the 2023 ACOG Annual Clinical and Scientific Meeting.
Host: Warner K. Huh, MD
Guest: Sarah E. Dilley, MD, MPH, FACOG
Effective triage tests are needed to lessen diagnostic uncertainty when assessing cervical cancer risk and selecting which patients will move on to colposcopy. An FDA-approved dual-staining cytology test is available that can help in decision-making for a wide range of patients. Join Drs. Warner Huh and Sarah Dilley as they address current 2019 ASCCP guidelines and anticipate potential updates to ASCCP’s guidance in 2023.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Megan Kruse, MD
From disease-related factors to the latest clinical trial data, there’s a lot to consider when selecting a therapy for patients with ER+/HER2- metastatic breast cancer. Here with Dr. Charles Turck to break down the key factors that can guide our treatment selections is breast medical oncologist Dr. Megan Kruse from the Cleveland Clinic in Ohio.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Michael K. Georgieff, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Arjeme Denise Cavens, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Arjeme Denise Cavens, MD
Guest: Lee Shulman MD, FACOG, FACMG
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Michael Auerbach, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Michael Auerbach, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Arjeme Denise Cavens, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Michael Auerbach, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Michael Auerbach, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Malcolm G. Munro MD, FRCS(c), FACOG
Guest: Arjeme Denise Cavens, MD
This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Host: Jennifer Caudle, DO
Guest: Tamera A. Paczos, MD, FACOG, FACP
The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories.
COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 02/23
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Hope S. Rugo, MD, FASCO
The treatment landscape for metastatic breast cancer is rapidly evolving. With all of these new advancements and research, it can be helpful to review the available treatment options and best practices for selecting an approach after treatment with a CDK4/6 inhibitor has failed. That’s why Dr. Charles Turck discusses how we can treat patients with metastatic breast cancer in the second- and third-line setting with Dr. Hope Rugo, who’s a Professor of Medicine in the Division of Hematology and Oncology at the University of California San Francisco Hellen Diller Family Comprehensive Cancer Center.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Derrick Barnes, MD
Locum tenens offers physicians the opportunity to work in a variety of environments with a diverse range of patient populations. Dr. Charles Turck sits down with Dr. Derrick Barnes, who has affiliations with the Community Hospital of the Monterey Peninsula and the California Pacific Medical Center Van Ness Campus with Sutter Health, to share his experience with locum tenens.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Jason Goldman, MD
Misconceptions continue to spread about the influenza vaccine during pregnancy. What are some ways we can address them? To answer this question, Dr. Paul Doghramji and Dr. Jason M. Goldman from the American College of Physicians explore the CDC’s recommendations and share strategies to challenge these assumptions.
Host: Warner K. Huh, MD
Guest: Leigh Anne Cantrell, MD, MSPH
Explore the case of a young patient to see the ACS and ASCCP cervical cancer screening guidelines in action. Who needs to be screened, how is it best to screen, and what's the best test? Leading experts, Drs. Leigh Cantrell and Warner Huh, review the benefits of primary screening as they explore shifts in current guidelines. Find out how you can improve outcomes for patients, not only through appropriate primary HPV testing in lieu of cytology as the screening modality, but also by reinforcing how a “negative” HPV test actually sends a powerful “positive” message. As a bonus, you might just change a young patient’s life.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Alexandra Benachi, MD, PhD
Guest: Julien Zuber, MD, PhD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and Gynecology
There exists a long-standing controversy about drawing parallels between transplant and pregnancy immunology. Listen in as Drs. Alexandra Benachi, Julien Zuber, and Lee Shulman discuss why these considerations are so important for you and your colleagues, patients, and their families to understand. Discover how links between kidney transplantation and maternal anti-fetal rejection may impact your practice and spark new pathways in medicine.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Eric Klein, MD
While the state of cancer screening hasn’t seen too many changes over the years, the results from the PATHFINDER study may offer clinicians a new screening tool. Dr. Eric Klein from the Glickman Urological and Kidney Institute dives into this clinical data and how it might impact cancer screening protocols.
Host: Jennifer Caudle, DO
Guest: Diane M. Harper, MD, MPH, MS
There are several testing methods available for cervical cancer screening, such as co-testing and primary HPV testing. So what are some of the most prominent benefits and limitations of these and other testing approaches? Joining Dr. Jennifer Caudle to break down the latest advancements in cervical cancer screening is Dr. Diane Harper, a Professor in the Departments of Family Medicine and Obstetrics and Gynecology at the University of Michigan.
For patients with ER+/HER2- advanced breast cancer, current treatment guidelines recommend the use of endocrine therapy plus a CDK 4/6 inhibitor as a first-line treatment. And while the guidelines recommend sequential endocrine therapy for disease progressions, this progression can lead to ESR1 mutations and resistance to endocrine therapy. Could a novel oral selective estrogen receptor have more efficacy in preventing ESR1 mutations associated with endocrine resistance? That’s the exact question the EMERALD trial sought to answer, and what this study found in its subgroup analyses is the focus of this Audio Abstract.
Host: Jennifer Caudle, DO
Guest: Stephanie Graff, MD
Endocrine resistance and toxicities are just a few of the many challenges facing clinicians who treat patients with ER+/HER2- advanced breast cancer. So what strategies can we use to better address these challenges and unmet needs? Joining Dr. Jennifer Caudle to share her approach is Dr. Stephanie Graff, Director of the Breast Oncology Program at Lifespan Cancer Institute in Providence, Rhode Island.
Host: Jennifer Caudle, DO
Guest: Nan Chen, MD
Selective estrogen receptor degraders (SERDs) are a novel class of drugs for the treatment of ER+/HER2- advanced breast cancer. So how exactly do they work to treat this type of advanced breast cancer, and what are the findings from recent trials investigating the clinical utility of SERDs? Get the answers to these and other key questions with Dr. Jennifer Caudle and Dr. Nan Chen, Assistant Professor of Medicine at the University of Chicago School of Medicine.
Endocrine therapy is the recommended treatment for ER+/HER2- advanced breast cancer, but progression to advanced disease can lead to ESR1 mutations, which can then lead to endocrine therapy resistance. But could treatment with an oral selective estrogen receptor degrader (SERD) improve outcomes for our patients? Join us as we take a deep dive into the EMERALD trial, which explored that exact question, in this Audio Abstract.
Host: Jennifer Caudle, DO
Guest: Stephanie Graff, MD
Guest: Pavani Chalasani MD, MPH
Given the challenges and unmet needs associated with the current treatment options for ER+/HER2- advanced breast cancer, what strategies can we use to optimize our approach? Here with Dr. Jennifer Caudle to share their perspectives are Dr. Stephania Graff from Lifespan Cancer Institute and Dr. Pavani Chalasani from the University of Arizona Cancer Center.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Paul Hunter, MD
It’s important to recognize that older adults are more susceptible to influenza infection—as well as increased severity of infection—than younger, healthier populations.1 Fortunately, there are vaccines available that can help prevent influenza in this aging population. But do the relative benefits and harms of higher-dose and adjuvanted vaccines, compared with one another and with other influenza vaccines, favor the use of any one or more of these vaccines over other age-appropriate options for people 65 and older?2 That's the exact question the CDC’s Advisory Committee on Immunization Practices (ACIP) sought to answer and what Dr. Charles Turck discusses with Dr. Paul Hunter, Associate Professor in the Department of Family Medicine and Community Health at the University of Wisconsin School of Medicine and Public Health.
References:
1. Centers for Disease Control and Prevention. Fly & People 65 Years and Older. Accessed August 16, 2022. https://www.cdc.gov/flu/highrisk/65over.htm.
2. National Center for Immunization & Respiratory Diseases. Advisory Committee on Influenza Practices. Influenza Vaccines for Older Adults: GRADE Summary. Accessed August 16, 2022.
USA-FLUD-22-0056 December 2022
Host: Warner K. Huh, MD
Guest: Leigh Anne Cantrell, MD, MSPH
Guest: Mark H. Stoler, MD
Experts discuss the ACS and ASCCP CCV screening guidelines and review the benefits of primary screening and the latest data driven testing options. Is Pap cytology a thing of the past? Find out more about harmonization of guidelines from leading experts, Drs. Cantrell, Stoler and Huh. You might just transform your clinical practice.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Masja de Haas, MD, PhD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and Gynecology
Neonatal alloimmune neutropenia (NAIN or NIN) is a neutrophil blood group antagonism similar to HDFN and FNAIT. Its presentation varies clinically and ranges from asymptomatic to severe manifestations such as sepsis and meningitis. Listen in as Drs. Masja de Haas and Lee Shulman discuss clinical clues that should catch your eye. Discover novel yet simple ways to be vigilant and make the right clinical calls.
Host: Andrea Singer, MD, FACP, CCD
Guest: Susan V. Bukata, MD, FAOA, FAAOS
Life-altering secondary fractures are a harsh reality, but Medicare studies show, and orthopedic surgeons agree, that knowledge has not translated into prevention. Why is there clinical inertia in providing preventative interventions related to secondary fragility fractures? Join Drs. Andrea Singer and Susan Bukata as they provide a cogent medical approach to preventing these fractures and a roadmap for when and how to use available therapies based on their mechanisms of action.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Eugenia Shmidt, MD
The pregnancy inflammatory bowel disease and neonatal outcomes (PIANO) registry is the largest US-based study that examines pregnant women who have inflammatory bowel disease (IBD). So how can clinicians use the takeaways from this study in their practice? Join Dr. Peter Buch as he discusses IBD in pregnant women with Dr. Eugenia Shmidt, Assistant Professor in the Division of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota.
HPV testing plays an important role in cervical cancer screening, but not every patient whose HPV-positive will develop cervical cancer. One option that can help us identify which HPV-positive patients are truly at risk is CINtec PLUS Cytology, an immunohistochemistry test that simultaneously detects p16 and Ki67 biomarker proteins. Learn more about how this dual staining technique works in this video.
Host: Jacob Sands, MD
Guest: Tomasz Beer, MD, FACP
Multi-cancer early detection tests are designed to detect multiple cancers from a single blood test. Could these tests help address some of the most common limitations associated with current cancer screening methods, like a lack of adherence and access? Joining Dr. Jacob Sands to discuss how multi-cancer early detection tests work and their potential impact on cancer screening is Dr. Tom Beer, Adjunct Professor of Medicine at the OHSU Knight Cancer Institute and the Chief Medical Officer for Multi-Cancer Early Detection at Exact Sciences Corporation.
Host: Lee Shulman MD, FACOG, FACMG
Guest: Andrea S. Lukes, MD, MHSc, FACOG
Are you currently considering GnRH antagonists as first-line therapy, or are you waiting for patients to fail other endometriosis treatment approaches first? Drs. Andrea Lukes and Lee Shulman discuss how the advent of effective GnRH antagonists is evolving the care of endometriosis. Are you ready to provide patients with the clinical outcomes they seek while balancing the benefits of medical and surgical approaches?
Host: David L. Eisenberg, MD, MPH, FACOG
Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARCs), are the most effective reversible contraceptive methods. The major advantage of LARCs compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term, effective use. In addition, after the device is removed, the return of fertility is rapid. Join Dr. David Eisenberg has he discusses when LARCs should be recommended as a first-line contraceptive choice and when they should not. He further details how to approach a shared decision-making discussion with patients about their contraceptive options.
Host: Andrew M. Kaunitz, MD, FACOG
By the age of 50, ultrasound imaging demonstrates that 70%-80% of women have fibroids. Uterine fibroids are associated with disability similar to other chronic diseases. They can even lead to lower vitality and social function than are experienced by women with breast cancer. Fibroid-related hysterectomies account for 45% of all US hysterectomies, but a surgical approach is no longer one size fits many. Join Dr. Andrew Kaunitz as he describes the clinical presentations of fibroids and how newly emergent medical options greatly improve fibroid-related symptoms, provide time to consider other alternatives, and can be used to bridge the transition to menopause.
Host: Michael Krychman, MD
For affected women, acute vulvovaginal candidiasis (VVC) brings with it a significant health burden, and the substantial morbidity and poor quality of life associated with recurrent disease (RVVC) requires improved diagnosis, management, and quality of care. Join Dr. Michael Krychman as he dissects the barriers to managing VVC and RVVC and provides insights on diagnosis and management based on guidelines, plus an overview of innovative therapeutic agents. The unique qualities of the current and emerging therapeutic interventions may well represent a significant step forward in how you manage these challenging infections.
Host: Anita H. Clayton, MD
Guest: Jennifer L. Payne, MD
This animated Women’s Health 2022 lecture features a discussion between Drs. Jennifer Payne and Anita Clayton who clearly highlight the importance of screening for perinatal and postpartum depression (PPD). Our experts delve into the critical importance of proactively diagnosing and treating women during the various stages of pregnancy and review the latest therapies that specifically target PPD. Find out how these therapies compare to traditional antidepressants and how PPD treatment can improve the health and quality of life for patients and their families. What changes can you implement into your clinical practice to improve maternal and infant health?
Host: Hugh S. Taylor, MD
Endometriosis is challenging to diagnose, with approximately 6 to 11 years from symptom onset to definitive diagnosis and treatment. Many medical providers are not adequately familiar with the disease, and this, coupled with historically limited medical options, has resulted in surgical approaches often being considered as the first treatment option. Join us as Dr. Hugh Taylor discusses how this landscape is changing to one in which safe and effective medical options can now offer improved outcomes for our patients with endometriosis.
Host: Jennifer L. Payne, MD
Optimizing the management of comorbid depression and menopause is a significant clinical challenge. When the darkness begins to set in, are you able to hear your patients’ needs and deliver life-changing treatment?
Join Dr. Jennifer Payne as she provides concrete tips and explores the latest guidelines and research on therapies that improve vasomotor symptoms, mood, and perimenopausal depression. Get ready to offer new hope to your patients as you help them cool off and begin to see the dawn of a new day.
Host: Kara B. Markham, MD
What are the essential steps in managing hemolytic disease of the fetus and newborn (HDFN)? How soon after “the cord has been cut” does newborn care transfer from the maternal-fetal medicine specialist and ob-gyn to the pediatric team? At a recent satellite symposium of the American Academy of Pediatrics, Dr. James Bussel, Dr. Kara Markham, and Bethany Weathersby presented the latest data regarding current and emerging practice patterns and highlighted the critical need for improved understanding and multidisciplinary collaboration in the area of HDFN. Tune in to hear Dr. Markham summarize how diagnosis, care, and treatment have evolved—plus insights on how these might change the way you practice.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Natalia Castillo Almeida, MD
Patients in urban communities often face challenges when accessing influenza vaccines. But there are ways we can help address those geographic and socioeconomic barriers. Joining Dr. Charles Turck to share key strategies for improving influenza vaccination rates in urban communities is Dr. Natalia Castillo, Assistant Professor in the Division of Infectious Diseases at University of Nebraska Medical Center.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: James B. Bussel, MD
Program Chairman:
As the platelet equivalent of hemolytic disease of the fetus and newborn, fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an uncommon yet complex and life-threatening bleeding disorder that results from incompatibility between mother and baby for platelet-specific antigens. Despite relatively normal platelet function, in the setting of severe thrombocytopenia, intracranial hemorrhage is a consequence. Drs. Shulman and Bussel discuss advances in management strategies and concrete steps you can take to lower the risk and stop the progression of this disorder in your patients.
Host: Lee Shulman MD, FACOG, FACMG
Guest: Ayman Al-Hendy, MD
GnRH antagonists are revolutionizing the medical management of uterine fibroids. Drs. Al-Hendy and Shulman discuss how medical myomectomy with GnRH antagonists is revolutionizing care by bridging gaps during 3 different stages of patients’ lives.
Host: Kevin Cleveland, PharmD, ANP
Older adults face a variety of unique challenges that increase their risk of serious influenza infections. But fortunately, vaccinations can help address these challenges. Learn more with Dr. Kevin Cleveland, Associate Professor at the Idaho State University College of Pharmacy.
Host: Christina Madison, BS, PharmD, BCACP, AAHIVP
In the midst of a potential tridemic between COVID-19, RSV, and influenza, it’s now more critical than ever to raise awareness among patients about the importance of flu vaccines. Here to provide counseling strategies for educating patients about flu vaccines is Dr. Christina Madison, Associate Professor of Pharmacy Practice at Roseman University of Health Sciences.
Host: Jennifer Caudle, DO
Guest: Carolyn Bridges, MD
We all know that influenza vaccinations can help prevent serious infections and save lives. But how often do you consider the underrecognized benefits of these vaccines—like how influenza vaccinations can be a cost-effective solution for both patients and the entire healthcare system? Joining Dr. Jennifer Caudle to discuss these underrecognized benefits and how we can educate patients about the benefits of influenza vaccination is Dr. Carolyn Bridges, Director of Adult Immunizations at Immunize.org.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Kimberly McKeirnan, Pharm.D., BCACP
Vaccination rates are much lower in rural communities compared to other regions, which has a big impact on patients and the larger healthcare system as a whole. So what are some of the factors contributing to this disparity, and what strategies can we use to address them? Joining Dr. Charles Turck to discuss how we can increase vaccination rates in rural communities is Dr. Kimberly McKeirnan, Director of the Center for Pharmacy Practice Research at Washington State University.
Host: Lee Shulman MD, FACOG, FACMG
Guest: Elizabeth Stewart, MD
Fertility preservation is a significant clinical concern for all women of reproductive age diagnosed with endometriosis or uterine fibroids (UF). Drs. Elizabeth Stewart and Lee Shulman discuss how the advent of GnRH antagonists is affecting how we approach these 2 conditions. Management trends are evolving beyond reflexive, prophylactic surgery, so are you ready to change with the times?
Host: Pavani Chalasani MD, MPH
Guest: Hope S. Rugo, MD
Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Kenneth J. Moise Jr., MD
Program Chairman:
How well do you understand the biology of hemolytic disease of the fetus and newborn (HDFN)? What about its connection to the FcRn receptor pathway and IgG? Drs. Lee Shulman and Ken Moise go beyond the basics taught in medical school immunology and look more closely at FcRn’s role in protecting IgG. With an improved understanding of these mechanisms, we can expand therapeutic targets beyond the fetus and newborn and finally put the needles away.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Linda Bradley, MD
Join Drs. Linda Bradley and Lee Shulman as they discuss factors contributing to disparities in care for patients with endometriosis and/or uterine fibroids. They offer practical tips to overcome the disproportionate disease burden that especially impacts women of color. Cut through the noise to clearly hear each patient’s voice. Your clinical impact may be profound.
Host: Torie Comeaux Plowden, MD, MPH, FACOG
Guest: Sateria Venable
Do you want to be part of the solution? Pain and pelvic pressure, heavy menstrual bleeding, and dysmenorrhea should not be considered “normal” in a woman’s history. Diagnosing uterine fibroids or endometriosis early can help women improve their quality of life, preserve their uterus, and preserve their future fertility. Medical management can achieve this, but too often a hysterectomy is the only intervention offered. Tune in to hear from Dr. Torie Comeaux Plowden and Sateria Venable talk about the need for widespread educational efforts to address proper diagnosis and appropriate treatment, that can minimize the physical, mental, and socioeconomic effects of endometriosis and uterine fibroids.
Host: Matt Birnholz, MD
Guest: David Canaday, MD
As we age, our immune system becomes weaker and is therefore unable to ward off infection as easily as in our younger years.1 This is particularly troublesome during flu season. In fact, the CDC’s Advisory Committee on Immunization Practices (ACIP) recently looked at flu vaccine data for adults aged 65 years and older, and they now recommend that this age group preferentially receive higher dose or adjuvanted vaccines over standard dose unadjuvanted vaccines when available.2 So what was the data that led to these updated recommendations? Joining Dr. Matt Birnholz to share those key findings and the role of adjuvanted vaccines like FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) in preventing influenza in older adults is Dr. David Canaday, Professor in the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University in Cleveland.
Avoid use in patients who have experienced any severe allergic reactions to any component of the vaccine. For more risk information please see below or consult the Full US Prescribing Information for FLUAD® QUADRIVALENT here.
References:
1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2(11):659-666.
2. Centers for Disease Control and Prevention. Past seasons estimated influenza disease …
Host: Matt Birnholz, MD
Guest: David Canaday, MD
As we age, our immune system becomes weaker and is therefore unable to ward off infection as easily as in our younger years.1 This is particularly troublesome during flu season. In fact, the CDC’s Advisory Committee on Immunization Practices (ACIP) recently looked at flu vaccine data for adults aged 65 years and older, and they now recommend that this age group preferentially receive higher dose or adjuvanted vaccines over standard dose unadjuvanted vaccines when available.2 So what was the data that led to these updated recommendations? Joining Dr. Matt Birnholz to share those key findings and the role of adjuvanted vaccines like FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) in preventing influenza in older adults is Dr. David Canaday, Professor in the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University in Cleveland.
Avoid use in patients who have experienced any severe allergic reactions to any component of the vaccine. For more risk information please see below or consult the Full US Prescribing Information for FLUAD® QUADRIVALENT here.
References:
1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2(11):659-666.
2. Centers for Disease Control and Prevention. Past seasons estimated influenza disease …
Host: Robert L. Coleman, MD, FACOG, FACS
Guest: Kathleen Moore, MD, MS
The global burden of cervical cancer is immense, especially for patients who have failed first-line therapy. Second-line interventions have historically had low response rates of short duration. But the landscape is changing with new and emerging agents in late-stage clinical trials, including antibody-drug conjugates, immunotherapy regimens, and tumor-infiltrating lymphocyte therapies. Join Drs. Robert Coleman and Kathleen Moore as they discuss and distill the “need to know” findings about these more effective therapies—therapies destined to improve outcomes for patients whose cervical cancer has failed first-line therapy.
Guest: Rishi D. Naik, MD, MSCI
Colorectal cancer may be more prevalent than you think, underscoring the importance of colorectal cancer screening. Join us as we explore the latest screening recommendations and available modalities with Dr. Rishi Naik, Assistant Professor of Medicine in the Department of Gastroenterology, Hepatology, and Nutrition at Vanderbilt University Medical Center in Nashville, Tennessee.
Host: Hector O. Chapa, MD, FACOG
Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous research has shown its link to cardiovascular (CV) risk factors later in life, a new study has revealed that PCOS can increase the risk of heart complications during delivery. So what do these findings mean when it comes to caring for pregnant patients with PCOS? Find out with Dr. Hector Chapa as he’s joined by lead author of the study Dr. Erin Michos, who's the Director of Women’s Cardiovascular Health and an Associate Professor of Medicine at Johns Hopkins School of Medicine.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Nick Kusnezov, MD
Can you balance locum tenens with a full-time career? To answer that question, Dr. Charles Turck is joined by board-certified orthopedic surgeon, Dr. Nicholas Kusnezov, to walk us through his journey from joining the military to locum tenens.
Host: Jennifer Caudle, DO
Guest: Roni Devlin, MD
As rates of burnout continue to rise in the healthcare community, how can help our female physicians combat it? Dr. Jennifer Caudle joins Infectious Disease Specialist, Dr. Roni Devlin, to discuss how we can prevent burnout for female physicians.
Host: Jennifer Caudle, DO
Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
Guest: Gary Marshall, MD
It's well understood that annual vaccination is the best way to help reduce the high burden associated with influenza. And while most influenza vaccines available in the United States are produced in eggs, this presents some inherent challenges, which can lead to reduced vaccine effectiveness. Fortunately, alternative production processes can help us overcome those challenges, and to learn more, Dr. Jennifer Caudle speaks with Dr. Wendy Wright and Dr. Gary Marshall.
USA-CRP-22-0018 May 2022
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Nanette F. Santoro, MD
Tune out the noise and get to the heart of managing menopause and associated vasomotor symptoms. This program provides highlights from the 2022 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting. Join Drs. Nanette Santoro and Lee Shulman as they dive into the latest research, which could alter your current practice patterns and help your patients cool off.
Host: Ayman Al-Hendy, MD
Despite its profound impact, endometriosis remains critically undermanaged. This program provides highlights from a live symposium at the annual meeting for obstetrics and gynecology professionals and is based on patient & provider surveys. Join Dr. Ayman Al-Hendy to explore management gaps, the role of GnRH antagonists in addressing deficits, and the latest research, which he presented with Drs. Andrea Lukes and Lee Shulman—you might just alter your current practice patterns.
Host: Mitchell D. Creinin, MD
In-office delivery of sexual and reproductive healthcare (SRH) services was markedly restricted for 2 years during the COVID-19 pandemic. Now, in-office access to these services has begun to improve. What have we learned since 2020 that can prepare us for future periods of reduced access? Join Dr. Mitchell Creinin as he discusses SRH service strategies initiated during the pandemic that remain useful even in times of full in-office access.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Asma Khapra, MD
Over the last few years, we've only started to gain an understanding of how gender affects our approach to GI illnesses. And since a greater awareness of these differences will help us become better clinicians, Dr. Peter Buch speaks with Dr. Asma Khapra about how we can optimize our approach to managing common GI illnesses in our female patients.
Host: Jacob Sands, MD
Guest: Marie Wood, MD
Can our breast cancer patients benefit from chemoprevention? Joining Dr. Jacob Sands to share treatment options for chemoprevention and which patients may benefit the most is Dr. Marie Wood, the Director of Breast Medical Oncology and Director of the Cancer Clinical Trials Office at the University of Colorado Anschutz Medical Center.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: Jeffery D. Dunn, PharmD, MBA
Guest: Gary M. Owens, MD
Guest: Anita L. Nelson, MD
Are you ready to see what is on the horizon to more effectively navigate vasomotor symptoms (VMS)? Join Drs. Dunn, Owens, and Nelson as they discuss highlights from a symposium held at AMCP 2022 featuring the latest data on the impact of menopause and evolving treatments options. They provide guidance, context, and recommendations for the medical management of VMS beyond estrogen. The nonhormonal treatment options that are currently being studied represent a new horizon for both patients and payers.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Samantha Conroy, MD
Locum tenens can improve quality of care around the globe—especially in remote and underserved communities. To share how, Dr. Paul Doghramji joins Dr. Samantha Conroy, a family practice obstetrician to share her experiences working as a locum tenens obstetrician in underserved communities.
Host: Jennifer Caudle, DO
Guest: Maurice G. Sholas, MD, PhD
After years of serving the New Orleans community, one physician decided to pursue locum tenens work. Dr. Jennifer Caudle joins Dr. Maurice Sholas, a pediatric physical rehabilitation physician, to share his experiences with locum tenens and in New Orleans.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Stephanie Martin, DO
How ready are you to go beyond simply ordering CBCs and recognizing anemia? Join Drs. Martin and Shulman as they discuss the latest developments in oral and IV iron therapies. Learn how you may take a more active role in managing iron deficiency anemia, focusing on abnormal uterine bleeding.
Participating in this activity will ensure that you are prepared to address the goals with your patients by improving access and adherence to efficacious and convenient therapies.
Host: Hector O. Chapa, MD, FACOG
Guest: Naomi Whittaker, MD
The challenges that come with conception can be strenuous and emotionally draining. But with emerging tools and technology, there are many ways we can help our patients conceive naturally. Dr. Naomi Whittaker, an OB/GYN physician, joins Host Dr. Hector Chapa to share these strategies.
Guest: Kenneth J. Moise Jr., MD
Host: Charles Turck, PharmD, BCPS, BCCCP
Hemolytic disease of the fetus/newborn (HDFN) may be rare, but it is important to recognize and diagnose the disease and ensure appropriate patient management since the consequences in cases that go undiagnosed or are poorly managed can be devastating. To help us gain a better understanding of maternal alloimmunization and the risk for HDFN in pregnancy, Dr. Charles Turck speaks with Dr. Kenneth Moise, Director of the Comprehensive Fetal Care Center in Texas.
© Janssen Pharmaceuticals, Inc. 2022 12/21 cp-272563v1
Guest: Kenneth J. Moise Jr., MD
Host: Charles Turck, PharmD, BCPS, BCCCP
Hemolytic disease of the fetus/newborn (HDFN) may be rare, but it is important to recognize and diagnose the disease and ensure appropriate patient management since the consequences in cases that go undiagnosed or are poorly managed can be devastating. To help us gain a better understanding of maternal alloimmunization and the risk for HDFN in pregnancy, Dr. Charles Turck speaks with Dr. Kenneth Moise, Director of the Comprehensive Fetal Care Center in Texas.
© Janssen Pharmaceuticals, Inc. 2022 12/21 cp-272563v1
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Janos L. Tanyi, MD, PhD
Recently the FDA approved a “Glowing Tumor” imaging drug to help oncologists better identify ovarian cancer cells using an approach pioneered by surgeons at Penn Medicine. Joining Dr. Charles Turck to discuss this recent approval and fluorescence-guided, intraoperative imaging is Dr. Janos Tanyi, Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania.
Host: Patty Cason, RN, MS, FNP-BC
Guest: Joely Pritzker, RN, MS, FNP-C
Are you ready to apply the latest counseling techniques to address the contraceptive revolution?
Join nurse practitioners Patty Cason and Joely Pritzker as they briefly review the history of contraceptive counseling and then use case vignettes to illustrate how shared decision-making techniques will support the appropriate use of nonhormonal contraceptive options, such as the vaginal pH modulator (VPM).
Participating in this activity will ensure that you are ready to effectively counsel patients on their many options so that each patient’s reproductive and sexual health goals can be met.
Host: Hector O. Chapa, MD, FACOG
Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Guest: Anum Minhas, MD, MHS
Cardiovascular disease is currently the leading cause of death for pregnant and postpartum women in the United States, and from a global perspective, hypertensive complications during pregnancy result in 50,000 maternal deaths each and every year. This, along with the increasing rates of peripartum cardiomyopathy diagnoses, is why a new subspeciality of cardiology is needed. So what exactly is cardio-obstetrics? To learn more about how this emerging subspecialty is helping to provide better care for our pregnant and postpartum patients, Dr. Hector Chapa speaks with Drs. Erin Michos and Anum Minhas.
Host: John J. Russell, MD
Guest: Joseph E. Bavaria, MD
Featuring a wide range of disciplines and a new approach to comprehensive care, what do we need to know about the Aorta Center at Penn Medicine? Dr. John Russell is joined by Dr. Joseph E. Bavaria to dive into this aortic program and discuss a new approach to comprehensive care.
Host: Hector O. Chapa, MD, FACOG
Guest: Dani Dumitriu, MD, PhD
The COVID-19 pandemic has taken a toll on all patients, especially pregnant women. Here to walk us through her research on the pandemic's impact on the psychosocial health of mothers and the neurodevelopment of their fetuses is Dr. Dani Dumitriu, a pediatrician, neuroscientist, and pediatric environmental health scientist at Columbia University in New York.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Maryam Lustberg, MD, MPH
Amid the evolving treatment landscape for HER2-low breast cancer, many therapeutic challenges and limitations remain, resulting in unmet needs for our patients. Fortunately, developments in the therapeutic landscape can help address those unmet needs, and joining Dr. Charles Turck to share what’s on the horizon is Dr. Maryam Lustberg.
Host: David J. Portman, MD
Guest: Patty Cason, RN, MS, FNP-BC
Guest: David L. Eisenberg, MD, MPH, FACOG
Are you ready for the contraceptive revolution? Are you applying the latest information on contraceptive efficacy, recent clinical trial data, and sexual satisfaction when counseling your patients on contraceptive options? Join Dr. David Portman, Dr. David Eisenberg, and Ms. Patty Cason as they discuss the novel mechanisms of action of cutting-edge, non-hormonal contraceptive options, such as the vaginal pH modulator (VPM). Participating in this activity will ensure that you are prepared to discuss sexual and reproductive goals with your patients and confirm that your patients’ goals are being met.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Ayman Al-Hendy, MD
Surgery has long been the default choice when managing uterine fibroids and endometriosis. However, over the past few years, reliable and durable medical interventions have emerged, notably GnRH antagonist therapy. Clinical trial data for GnRH antagonists highlight both their safety and efficacy for a broad demographic of patients. Join Drs. Lee Shulman and Ayman Al-Hendy as they discuss the “how” and the “why” of a paradigm shift that is occurring, changing our focus from surgery to first-line medical intervention for uterine fibroids and endometriosis.
Host: Jacob Sands, MD
Guest: Kathleen Fenn, MD
Guest: Oudai Hassan, MD
How do the 2018 ASCO/CAP guidelines redefine our approach to caring for patients with HER2-mutated breast cancer? Find out as Dr. Jacob Sands speaks with Dr. Kathleen Fenn and Dr. Oudai Hassan about HER2 scoring criteria and how the data drives collaborative care between the medical oncology and pathology teams.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Diane M. Harper, M.D., M.P.H., M.S.
While HPV 16 causes nearly 60 percent of the cervical cancers, it’s only associated with about 20 percent of the NILM, ASCUS, and LSIL cytology diagnoses. This means that 80 percent of early screening abnormalities associated with types other than 16 are missed. So how can we better detect types beyond HPV types 16 and 18? Joining Dr. Charles Turck to discuss same-genotype persistence for high-risk HPV is Dr. Diane Harper.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Donald Middleton, MD
Influenza causes considerable morbidity and mortality in children. In fact, the CDC estimates that from the 2010-2011 season to the 2019-2020 season, seasonal flu-related hospitalizations among children younger than 5 years old have ranged from 7,000 to as high as 26,000 every year.1 This is a sobering reminder of the pivotal role vaccination plays in preventing influenza disease, and now, recent safety and immunogenicity data has led to the expanded age indication for the cell-based vaccine FLUCELVAX QUADRIVALENT. Explore that data and what this approval means for patients 6 months of age and older with Drs. Charles Turck and Donald Middleton.
- Centers for Disease Control and Prevention. Flu and young children. https://www.cdc.gov/flu/highrisk/children.htm. Accessed December 22, 2021
USA-QIVc-21-0169 December 2021
Guest: Pavani Chalasani MD, MPH
What were the key findings from the EMERALD, Destiny-03, and PADA 1 trials that were featured at the 2021 San Antonio Breast Cancer Symposium? Explore the data on emerging breast cancer therapies with Dr. Pavani Chalasani, Associate Professor of Medicine and Program Director of the Hematology and Oncology Fellowship at the University of Arizona Cancer Center.
Host: Jacob Sands, MD
Guest: Yasmin Jayasinghe, FRANZCOG, PhD
Pediatric and adolescent oncofertility patients are cared for differently than adult patients. That’s why Dr. Yasmin Jayasinghe, Director of the Oncofertility Program at the Royal Children’s Hospital, is here to give us an overview of the available procedures for pediatric patients and the key considerations that go along with them.
Host: Jacob Sands, MD
Guest: Yasmin Jayasinghe, FRANZCOG, PhD
Cancer treatment can impact fertility outcomes for individuals throughout the U.S. as well as around the globe, which is why the emerging field of oncofertility is here to help male and female patients navigate their fertility options before and after their cancer treatments. So what can we learn from oncofertility services and efforts from other countries around the world? Joining Dr. Jacob Sands to share her global viewpoints on the field of oncofertility is Dr. Yasmin Jayasinghe, Director of the Oncofertility Program at the Royal Children’s Hospital.
Guest: Terry P. Mamounas, MD
What do we need to know about the management of the axilla for patients with early-stage breast cancer? Dr. Terry Mamounas shares highlights from his presentation at the 2021 San Antonio Breast Cancer Symposium titled, “Refining Axillary Management After Neoadjuvant Chemotherapy - What Does the Evidence Support?”
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Kathryn Gallagher, MS, RN, BSN
Guest: Kate Newcomb-DeSanto, MSN, RN, MSW
What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care.
Guest: Steven J. Chmura, MD, PhD
What do we need to know about the ablation of oligometastatic disease? Dr. Steven J. Chmura shares his vantage point on this topic and others from the 2021 San Antonio Breast Cancer Symposium.
Host: Hector O. Chapa, MD, FACOG
Guest: Linda Ahn, MD, FACOG
Amid growing evidence that infection with high-risk HPV can increase the risk of cervical cancer, the American College of Obstetricians and Gynecologists, the American Society for Colposcopy and Cervical Pathology, and the American Cancer Society have all updated their guidelines to help identify patients at risk while reducing unnecessary invasive procedures and over-testing. Joining Dr. Hector Chapa to walk us through these guidelines is board-certified obstetrician/gynecologist Dr. Linda Ahn.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sandy Marks
Guest: Kim Horvath, JD
Guest: Kyle Thomson, JD
With telehealth services expanding during the COVID-19 pandemic, has our access to them changed? To better understand this, Dr. Charles Turck meets with Sandy Marks, Kim Horvath, and Kyle Thomson from the AMA to explore what’s been done to provide Medicare coverage during a public health emergency and what’s on the horizon for telehealth access.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW
The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Andrea S. Lukes, MD, MHSc, FACOG
By 50 years of age, 70% to 80% of women are affected by uterine fibroids, and nearly 10% of women are affected by endometriosis. Clinical trial data demonstrate that GnRH antagonist therapy can dramatically impact pain and bleeding and improve results across all EHP-30 domains. Join Drs. Lee Shulman and Andrea Lukes as they dive into these data and offer strategies to help you better incorporate patient-centric medical management for uterine fibroids and endometriosis into your clinical practice.
Host: Jacob Sands, MD
Guest: Suneeta Senapati, MD, MSCE
Guest: Mindy Christianson, MD
Patients undergoing treatments such as chemotherapy may be at significant risk of impairment or inability to have children later in life. This risk impacts both men and women equally, but fortunately, the field of oncofertility can help guide patients as they navigate their fertility options prior to cancer treatment. Here to share their insights on this emerging field with Dr. Jacob Sands are Dr. Mindy Christianson and Dr. Suneeta Senapati.
Host: Jennifer Caudle, DO
Guest: Sarah Ali, MD
From working in a big city to taking on an assignment in a small mountain village, Dr. Sarah Ali from the Ventura County Medical Center joins Dr. Jennifer Caudle to talk about her adventures abroad with locum tenens and share key lessons she learned along the way.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Maryam Lustberg, MD, MPH
Can cardiac rehabilitation programs play a role in the management of breast cancer survivors? Dr. Maryam Lustberg, Chief of Breast Medical Oncology and the Director of The Breast Cancer Center at Smilow Yale Cancer Center, shares the common risk factors between cardiovascular disease and cancer and why these types of programs are beneficial to patient care.
Guest: Peter Goadsby, MD, PhD, DSc
Guest: Kathleen B. Mullin, MD
Women with migraine have unique needs that often remain undermanaged. Have you taken a critical look at the standard of care and how current treatment strategies have recently shifted? Groundbreaking research on the calcitonin gene-related peptide (CGRP) pathway has led to the development of new medications that act on the specific cascade of inflammatory response associated with migraine. Also called gepants, the CGRP receptor antagonists confer clinical benefit to patients who seek better control of their migraines.
Tune in to this Women’s Health 2021 program to hear our experts, Drs. Peter Goadsby and Kathleen Mullin, discuss the diagnosis of migraine with a focus on the recent evolution of acute and preventive treatment strategies and the role of gepants. Are you doing all you can to ensure that your patients’ needs are optimally addressed?
Host: Jennifer Caudle, DO
Guest: Erik Munson, Ph.D
Mycoplasma genitalium (M. gen) is an STI that shares similar health consequences to chlamydia and gonorrhea. Further complicating this health threat is the fact that there’s been little guidance on how to manage this new pathogen until recently when the 2021 STI Treatment Guidelines were released. Joining Dr. Jennifer Caudle to talk about M. gen and why the guidelines recommend the use of nucleic acid amplification tests for the diagnosis of this pathogen is Dr. Erik Munson, an Assistant Professor of Clinical Laboratory Science at Marquette University.
Host: Hector O. Chapa, MD, FACOG
Guest: Alexander W. Pastuszak, MD, PhD
Despite the fact that there’s no evidence showing any correlation between COVID-19 vaccines and fertility risks, many patients are still concerned. So how did this myth become so prominent, and how can we talk to our patients about it? Join Dr. Hector Chapa and Dr. Alex Pastuszak as they dive deep into this myth.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Erica E. Marsh MD, MSCI, FACOG
Hear from Dr. Erica Marsh and Dr. Lee Shulman as they discuss the burden, prevalence, and treatment of uterine fibroids and endometriosis and the disproportionate impact these conditions have on vulnerable populations. Learn how to prioritize early diagnosis and treatment to improve outcomes for your patients; as well as evaluating barriers to proper diagnosis and treatment
Our experts offer strategies to guide discussions beyond surgical treatment approaches to include pharmacotherapeutic options such as GnRH agonists and new oral GnRH antagonists. Open communication with patients allows them to carefully consider symptom severity, risks, and fertility preferences to optimize treatment outcomes and patient satisfaction. Tune in to make sure that you’re really doing all you can for your patients.
Host: John J. Russell, MD
Guest: Randy C. Miles, MD, MPH
Are enlarged lymph nodes caught on CT scans following mRNA vaccination cause for concern? Or is it just a case of incidentaloma? Joining Dr. John Russell to answer those and other key questions regarding the link between COVID-19 vaccines and abnormal mammogram findings is Dr. Randy C. Miles.
Guest: Banu Arun, MD
Here to give highlights from the “Finetuning Risk Assessment and Risk Reduction” session at the 2021 San Antonio Breast Cancer Symposium (SABCS) is Dr. Banu Arun, Professor of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center and Executive Director of Cancer Genetics for the MD Anderson Cancer Networks.
Host: Anita L. Nelson, MD
How confident are you in determining which of your patients with endometriosis are suitable candidates for medical intervention? Do you ask about each patient’s goals and preferences? Have you heard about the paradigm shift occurring in the medical management of endometriosis?
While medical management of endometriosis is often a secondary consideration to surgery, it should often be the first line of treatment. Join Dr. Anita Nelson as she discusses long-standing and novel medical strategies for managing endometriosis. Find out how you can use shared decision-making strategies to help you provide more options to your patients. Join us and take an important first step that can improve outcomes and quality of life for your patients while enabling them to make educated decisions about their immediate and long-term treatment.
Host: Anita L. Nelson, MD
In this Women’s Health 2021 lecture, Dr. Anita Nelson discusses why uterine fibroids are such a high priority for both women and their clinicians. Listen in as she shares strategies to engage patients in discussions about their fibroid symptoms and their preferences for treatment. Dr. Nelson also evaluates the latest evidence on the mechanisms of action, safety, and efficacy of the newer class of therapies that are now available and can improve the quality of life for women with fibroids.
Host: Anita H. Clayton, MD
Guest: Nancy Byatt, DO
Guest: Jennifer L. Payne, MD
In this panel discussion, Drs. Anita Clayton, Jennifer Payne, and Nancy Byatt walk us through two clinical cases of postpartum depression. Listen in as they discuss optimal strategies to screen, diagnosis, and treat patients, as well as go over the newer class of medications specifically targeted at treating PPD.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Rachael Consoli, MD, MPH, FACOG
With years of missionary work under her belt, one OB-GYN is fighting to reduce maternal mortality in underserved communities around the world. Dr. Charles Turck is joined by Dr. Rachel Consoli, an OB-GYN surgeon and Hospitalist based at North Shore Medical Center, to share stories from her time serving medical missions around the globe.
Host: Anita H. Clayton, MD
Listen in as Dr. Anita Clayton takes us through the importance of screening for postpartum depression (PPD) and reaching an early diagnosis in the perinatal and postnatal stages of pregnancy. This Women’s Health 2021 lecture also covers the exciting new agents that are targeted specifically for PPD. Find out how they compare to the traditional antidepressants and how they can improve the quality of life for your patients with PPD.
Host: Jennifer Caudle, DO
Guest: Drew Weissman, MD, PhD
mRNA vaccines are one of the latest developments in medicine, but researchers have been evaluating mRNA technology for years. One of those researchers, Dr. Dr. Drew Weissman, Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, joins Dr. Jennifer Caudle to talk about his role in the research and development of mRNA vaccines as well as what’s on the horizon for them.
Guest: Cynthia Leifer, PhD
With variants continuing to emerge, how are the COVID-19 vaccines faring. Here to share how these vaccines are holding up—and what that means for future variants—is Dr. Cynthia Leifer, Professor of Immunology at Cornell University.
Guest: Cynthia Leifer, PhD
In the midst of a global pandemic, where do vaccine ethics come into play? Dr. Cynthia Leifer, a Professor of Immunology at Cornell University, reviews diversity in clinical trial, the impact of vaccine mandates, and more.
Guest: Jeniffer Hernandez, PhD
mRNA vaccines are far from the only emerging technology out there. Dr. Jeniffer Hernandez, Associate Professor of Biopharmaceutical Sciences at the Keck Graduate Institute, reflects on where vaccine technology is headed.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Onyema Ogbuagu MBBCh, FACP, FIDSA
With so many questions and confusion points surrounding booster shots, what do we need to know? Dr. Charles Turck is joined by Dr. Onyema Ogbuagu, Associate Professor in the section of Infectious Diseases at Yale University School of Medicine, to answer common questions regarding the COVID-19 vaccine booster shots.
Host: Andrea Singer, MD, FACP, CCD
Guest: Paul A. Anderson, MD
Guest: Susan V. Bukata, MD, FAOA, FAAOS
While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jill Foster, MD
From mRNA vaccines to egg-based vaccines, what do we need to know about the different types of vaccines? Dr. Jill Foster, Director of the Division of Pediatric Infectious Diseases and Immunology at the University of Minnesota, joins Dr. Charles Turck to explore what we need to know about the various types of vaccines available.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: René F. Najera, DrPH
Misinformation regarding the COVID-19 vaccines have prevented patients from getting vaccinated. How should we talk to our patients about these misconceptions? Dr. Charles Turck joins epidemiologist, Dr. René Najera, to review leading myths surrounding the COVID-19 vaccines and how we can counsel our patients.
Guest: Muthiah Vaduganathan, MD, MPH
What do we currently know about the cardiac consequences of the COVID-19 vaccines? Dr. Muthiah Vaduganathan, cardiologist and investigator at Brigham Women's Hospital at Harvard Medical School, addresses the cardiac concerns surrounding the vaccines and how we can talk to patients about them.
Host: John J. Russell, MD
The global pandemic incited the expedited development of COVID-19 vaccines. But how did that change the development process? ReachMD host and Family Medicine Physician, Dr. John Russell, tells us how the rollout of the COVID-19 vaccine differs from other vaccines and what it could mean for the medical field.
Host: Jennifer Caudle, DO
Guest: Charles P. Vega, MD
The development of mRNA vaccines marked a turning point in the battle against the COVID-19 pandemic, but what do we need to know about this emerging vaccine technology? Dr. Jennifer Caudle and Dr. Charles Vega, a Clinical Professor in the Department of Family Medicine at the University of California Irvine, discuss some of the benefits and common concerns.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Mojgan Saber, MD
Can Locum Tenens be an option for healthcare professionals just completing their residency? Dr. Paul Doghramji is joined by Dr. Mojgan Saber to share her own experience as well as tips and tricks for residents looking at Locum Tenens right after residency.
Guest: Gregory Pokrywka MD, FACP, FNLA, FASPC, NCMP
Guest: Karol Watson, MD, PhD
Join us to discover optimal ways to identify women at risk or with atherosclerotic cardiovascular disease (ASCVD). In this Women’s Health 2021 lecture, our experts, Dr. Gregory Pokrywka and Dr. Karol Watson, dive deeper into evidence-based approaches to assess and manage ASCVD in women. They discuss topics from lifestyle modifications to recent clinical trial data on the use of omega-3 fatty acids for ASCVD event reduction.
Host: David L. Eisenberg, MD, MPH, FACOG
Many women prefer to use a nonhormonal contraceptive. They also want the freedom to self-administer on demand and want assurances that the contraceptive is safe, effective, and has received FDA approval. One such contraceptive is a self-administered, hormone-free gel that functions as a vaginal pH modulator. Join Dr. David Eisenberg as he describes the evolution of this vaginal pH modulator and the clinical trials leading to FDA approval. Even more significant is patient acceptance, which was remarkably high for this contraceptive. In fact, approximately 9 out of 10 women participating in the clinical trials indicated they would continue using the vaginal pH modulator and also recommend this novel method to their friends.
Host: Charles P. Vega, MD
Guest: Candice Taylor Lucas, MD, MPH, FAAP
What is cultural humility, and how can it be incorporated into clinical practice? How does your patient's culture impact their health behaviors, and why does your culture matter?
Listen in as two leading experts navigate concerns surrounding cultural humility and emphasize the importance of empathy, awareness, and advocacy. Discover ways to integrate small but important changes into your clinical practice to help bridge communication gaps and enable your patients to thrive.
Host: Paul Nyirjesy, MD
The global burden of acute vulvovaginal candidiasis (VVC) and the substantial morbidity and poor quality of life associated with recurrent disease (RVVC) requires improved solutions and quality of care for affected women. Join Dr. Paul Nyirjesy as he dissects the barriers to managing VVC and RVVC in your clinical practice and provides both diagnostic and therapeutic guidance inclusive of newly emerging and novel agents. These agents have unique qualities that may well represent a significant step forward in how you manage this challenging infection.
Host: Matt Birnholz, MD
Guest: Mark H. Stoler, MD
Now that vaccinated women have entered the screening population, we are seeing HPV 16 and 18 decreasing. These changes in HPV genotype prevalence may have a significant impact on the clinical management of cervical cancer, and an HPV test with extended genotyping may change the way we screen for cervical cancer as well. Joining Dr. Matt Birnholz to discuss the role of HPV extended genotyping in cervical cancer screening and the importance of identifying HPV 31 is Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System.
Host: Charles P. Vega, MD
Guest: Robert O. Roswell, MD, FACC, FACP
Diversifying our physician workforce so that it is more racially, ethnically, and geographically balanced can ultimately have a positive impact on community health. Join us as two experts discuss how pipeline programs reaching children as early as elementary school can help ensure workplace diversity. Also find out how clinicians can be advocates for their patients by helping to disentangle them from structural inequities and working towards policy changes. There’s a lot than can be done to provide more balanced care, but we need to look beyond simple fixes to the root causes of the issues. So find your bandwidth – that’s what you can do today – and discover why it’s so important to move upstream to solve the problems manifesting downstream.
Host: Charles P. Vega, MD
Guest: Sateria Venable
Regional healthcare disparities are biases that are based on where people live. Are your patients’ treatment options being impacted and limited by their geographical location? Join us as our two experts discuss how to support broader policy issues and highlight the importance of diagnostic algorithms that have been developed with diverse input. These steps may be of value in your clinical practice to ensure all patients have equal access to care regardless of their epidemiologic, socioeconomic, or insurance circumstances.
Host: Brooke M. Faught, DNP, WHNP-BC,NCMP, IF
Our patients express a number of misperceptions about combined hormonal non-LARC contraceptives such as the contraceptive patch, vaginal rings, and oral contraceptive pills. How well do you explain the advantages and disadvantages of these different options to your patients? How often have you prescribed what appeared to be a good contraceptive method for your patients only to have them be dissatisfied and become nonadherent?
Join Dr. Brooke Faught in this Women’s Health 2021 lecture as she tackles these issues and offers insights into how to discuss the full range of combined hormonal non-LARC contraceptive options with your patients using shared decision-making strategies. Remember, each patient’s needs, goals, and cultural background are important factors in a patient-centric approach to the choice of contraception.
Host: Charles P. Vega, MD
Guest: Lionel Phillips, MBA
Learn why diversity in clinical trials is so important to community health. Two experts discuss the key role that trusted messengers play in enrollment, why it is critical to break the cycle of medical mistrust, and the downstream effect of a lack of diversity in clinical trials.
Host: Jennifer Caudle, DO
Host: John J. Russell, MD
“What makes the Delta variant different?” “I keep hearing about breakthrough infections, so are the COVID-19 vaccines effective?”
These are just some of the questions patients now have amid the surge of the Delta variant, and many patients are turning to physicians for answers. That’s why ReachMD hosts and primary care physicians Drs. Jennifer Caudle and John Russell sit down to share their approach to answering these FAQs regarding the Delta variant, the COVID-19 vaccines, and more.
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Emily Louise Johnson, MD
According to recent estimates, between 150,000 and 450,000 transgender patients have epilepsy. And as that number is only expected to grow, Assistant Professor of Neurology at Johns Hopkins School of Medicine Dr. Emily Johnson shares key considerations for treating transgender patients with epilepsy.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Michelle Y. Owens, MD
OB-GYN clinicians can improve how they communicate with their patients about hemolytic disease of the fetus and newborn or HDFN. Strategies include encouraging patients to talk about their feelings when learning about this condition and communicating with them in terms that are not overly complex. In this program, Drs. Lee Shulman and Michelle Owens discuss how to break things down for the patient in front of you and explain how to use a read-back approach. This tactic ensures that your patient has absorbed what was discussed and also allows you to identify gaps in her understanding that can be addressed with further counseling.
Host: Hector O. Chapa, MD, FACOG
Guest: Susan Crowe, MD
Both UNICEF and WHO recommend exclusive breastfeeding for the first six months of life, starting within the very first hour of birth. But are we adhering to that recommendation? Joining Dr. Hector Chapa to discuss the importance of breastfeeding shortly after delivery and how we can help our patients and their newborns reap the benefits of this golden hour is Dr. Susan Crowe, Director of Outpatient Breastfeeding Medicine Consultative Services at Stanford Children's Health who recently spoke about this topic at the 2021 ACOG Annual Clinical and Scientific Meeting.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Yvonne Michael, ScD, SM
Dr. Yvonne Michael, an Associate Professor at the Dornsife School of Public Health at Drexel University, discusses risk factors that we should take into consideration when examining postmenopausal patients with coronary heart disease.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Kenneth J. Moise, Jr., MD
Guest: Christopher Robinson, MD
Hemolytic disease of the fetus and newborn (HDFN) is a rare disease that occurs due to the incompatibility between fetal and maternal red cell antigens. HDFN can lead to both short- and long-term consequences, including potentially fatal outcomes. In order to better prevent these associated issues, the timely evaluation, recognition, and treatment of HDFN are critical.
Listen in as three leading experts, Drs. Lee Shulman, Kenneth Moise, and Christopher Robinson, join together to discuss new epidemiologic evidence, the underlying pathophysiology of HDFN, health equity, and evolving management strategies you can implement to improve your clinical practice.
Host: Ana Maria Rosario
Guest: Patricia M. Boatwright, MD
As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn’t always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.
Guest: Patricia M. Boatwright, MD
Ob-gyn Dr. Patricia Boatwright once cared for a patient who told her the following philosophy: "If it doesn't bother you, don't bother it." Sadly, this is far from the only isolated event in which healthcare professionals hear this or a similar mantra from their patients. To help us better manage this all-too-common occurrence, Dr. Boatwright walks us through this particular patient case and how she encourages her patients to listen to their bodies rather than their peers.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Anna-Barbara Moscicki, MD
Updated cervical cancer screening guidelines were published by both the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American Cancer Society (ACS). Dr. Lee Shulman leads a discussion with Dr. Anna-Barbara Moscicki on the recent guidelines, the range of cervical cancer screening tests, and the impact on risk stratification and patient management.
Host: Ana Maria Rosario
Guest: Patricia M. Boatwright, MD
When a patient comes to an appointment saying, “I want” or “I need,” it can be difficult to challenge them. But as ob-gyn Dr. Patricia Boatwright explains, doing so is absolutely critical to ensuring they receive the best and most appropriate care. Tune in to hear Ana Maria Rosario and Dr. Boatwright discuss a patient case and how we can do right by our patients, even if it means challenging their—or even a colleague's—opinion.
Guest: Maryam Lustberg, MD, MPH
In the field of breast cancer, how far have targeted therapies come? Dr. Maryam Lustberg, Assistant Professor of Internal Medicine in the Division of Medical Oncology at Ohio State University, shares some insight into the latest developments in the treatment of early-stage HER2-positive breast cancer.
Host: Samilia Obeng-Gyasi, MD, MPH
How do surgical delays play a role in breast cancer outcomes? Dr. Samilia Obeng-Gyasi, an Assistant Professor of Surgery at Ohio State University, shares insight from her presentation at the 2021 American Society of Clinical Oncology Annual Meeting.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Paul Nyirjesy, MD
Guest: Christina Muzny, MD
Diagnosing vaginal infections early and accurately is key, but are current testing methods for vaginal infections facilitating early diagnosis? Joining Dr. Charles Turck to help answer this question are Drs. Christina Muzny and Paul Nirjesky, who share their multidisciplinary viewpoints on vaginal infections and diagnostic practices in women’s health.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Lincoln Nadauld, MD, PhD
Current cancer screening methods like mammograms, colonoscopies, and CT scans are all effective in detecting cancers, but they don’t always detect cancers as early as we’d like them to, resulting in missed and delayed diagnoses. Could new technology like multicancer early detection (MCED) be the answer to addressing current unmet needs in cancer screening? Find out with Dr. Charles Turck and Dr. Lincoln Nadauld, an oncologist and the Vice President and Chief of Precision Health and Academics at Intermountain Healthcare.
Guest: Barbara Van Der Pol, PhD, MPH
Dr. Barbara Van Der Pol, a Professor of Medicine in Infectious Diseases at The University of Alabama at Birmingham and Scientist at the Center for Women’s Reproductive Health briefly discusses how rapid testing could impact the treatment landscape for sexually transmitted infections.
Guest: Yvonne Michael, ScD, SM
Dr. Yvonne Michael, an Associate Professor at the Dornsife School of Public Health at Drexel University, shares her findings and discusses preventative measures we can share with postmenopausal patients to help them combat risk factors for coronary heart disease.
Guest: Nanette K. Wenger, MD, MACC, MACP, FAHA
What do we need to know about cardiovascular complications during pregnancy? Dr. Nanette Wenger, a Professor of Medicine in the division of cardiology at the Emory University School of Medicine, reviews what cardiologists know about pregnancy complications and the risk of coronary artery disease.
Host: Jerome Lisk, MD
Guest: Merle Diamond, MD
With migraine as a major global health problem that affects over 10% of the population, approximately 1 billion globally, and about 12% in the US, now more than ever it’s vital that healthcare professionals have a deep understanding of the role of the calcitonin gene-related peptide (CGRP) and its receptor in migraine pathophysiology1,2,3. That’s why Dr. Merle Lea Diamond joins Dr. Jerome Lisk to review that and more.
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2018;392:1789-1858.
- Lipton RB, et al. Neurology. 2007;68:343-349.
- Lassen LH, et al. Cephalalgia. 2002;22:54-61.
USA-334-84583
Guest: Maheen Mausoof Adamson, PhD
Tune in to hear Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, discuss her study on mental health in women and how we can take a more targeted treatment approach.
Host: David L. Eisenberg, MD, MPH, FACOG
Guest: David J. Portman, MD
A new form of contraception based on vaginal pH modulation is available. In this activity, Dr. Eisenberg reviews the risks and benefits of the hormone-free, user-controlled gel, and Dr. Portman provides his perspective on clinical trial results within the context of the “creeping Pearl Index.”
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Maheen Mausoof Adamson, PhD
Traumatic brain injury, or TBI, manifests differently in men and women. Here to explore these differences is Dr. Maheen Mausoof Adamson, a Clinical Associate Professor of Neurosurgery at Stanford School of Medicine, meets with Dr. Andrew Wilner to discuss traumatic brain injuries in female patients.
Guest: Nanette K. Wenger, MD, MACC, MACP, FAHA
Is there a relationship between pregnancy complications and subsequent coronary disease? Dr. Nanette Wenger, a Professor of Medicine in the division of cardiology at the Emory University School of Medicine, discusses a recent study exploring this correlation in Black women and shares what cardiologists need to know about pregnancy complications.
Host: Hector O. Chapa, MD, FACOG
Guest: Mikaela Rush, MD FACOG
The use of social media has become a way of life around the world. Many use social media tools to stay in touch with friends or share life experiences. Others may use these platforms for more professional reasons, including medical education. But in the digital age where online posts have the potential to spread like wildfire, even some well-intentioned professional posts—like the one Dr. Mikaela Rush, a board-certified ob-gyn physician in Cedar Park, Texas, shared about a contraceptive device—may have some unexpected consequences. Now, Dr. Rush joins Dr. Hector Chapa to share her story and to explain why she views social media as an ally and not an adversary.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE
How much do we understand the non-traditional risk factors of atherosclerotic cardiovascular disease, or ASCVD, in women? Dr. Erin Michos, an Associate Professor of Medicine and Director of the Women's Cardiovascular Health Center at Johns Hopkins School of Medicine, meets with Dr. Alan Brown to review ASCVD risk factors in women.
Guest: Chandrajit P. Raut, MD, MSc
Dr. Chandrajit P. Raut, Chief of the Division of Oncology at Brigham and Women’s Hospital, gives us a sneak preview of his presentation on the surgical management of breast angiosarcoma at the upcoming 2021 American Society of Clinical Oncology Annual Meeting.
Guest: Kevin Kalinsky MD, MS
In anticipation of the upcoming American Society of Clinical Oncology Annual Meeting, Dr. Kevin Kalinsky shares clinical trials and presentations that he’s looking forward to seeing.
Guest: Kelly Hunt, Md
Here to give us a brief overview of her session at the 2021 American Society of Clinical Oncology Annual Meeting titled, “From Desmoid and Phyllodes to UPS: A One-Size-Does-Not-Fit-All Approach to Surgery,” is Dr. Kelly Hunt, Professor and Chair of the Department of Breast Surgical Oncology in the Division of Surgery at the University of Texas MD Anderson Cancer Center.
Host: Linda Bradley, MD
In this activity, Dr. Linda Bradley reviews risk factors for uterine fibroids, the use of TVS,
Host: Nanette F. Santoro, MD
In this activity, Dr. Nanette F. Santoro explains risk factors for vasomotor symptoms, reviews current medical options for this bothersome problem, and describes the mechanism of action of a new class of nonhormonal agents: selective neurokinin-3 receptor antagonists.
Host: Lola Fayanju, MD, MA, MPHS
In light of the upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Lola Fayanju, an Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine, shares with us some of the updates in breast cancer care amid the COVID-19 pandemic that she’s most excited to learn more about at the conference.
Guest: Michael R. Shafique, MD
Here to give us a look at the unique genetic characteristics and prognostic implications for male and female patients with non-small cell lung cancer who harbor the RET fusion gene is Dr. Michael Shafique, Assistant Professor of Thoracic Oncology at the Moffitt Cancer Center in Tampa, Florida.
Host: Matthew J. Ellis, MD
What do we need to know about the Microscaled Proteogenomic Analysis method and the potential impacts of providing detailed tissue analyses from single-core needle biopsies? Here to talk about this new diagnostic tool for breast cancer is Dr. Matthew Ellis, Director of the Lester and Sue Smith Breast Center at Baylor College of Medicine.
Host: Hector O. Chapa, MD, FACOG
ACOG's Annual Clinical and Scientific Meeting will be held virtually this year, but that doesn't mean the content is any less collaborative and impactful. Listen in to hear what ReachMD's host and practicing OB-GYN, Dr. Hector Chapa, is looking forward to at this year's meeting.
Guest: Manisha Bahl, MD
What’s recent research saying about the use of tomosynthesis versus conventional 2D digital mammography to screen for breast cancer? Find out with Dr. Manisha Bahl, a breast imaging radiologist and Assistant Professor of Radiology at Harvard Medical Center.
Host: Floor J. Backes, MD
Guest: Robert L. Coleman, MD, FACOG, FACS
Does immunotherapy play a role in improving quality of life and survival for patients with ovarian cancer? Learn how experts are determining immunotherapy’s place in the treatment plan during the PARP era and what’s on the horizon.
Guest: Lajos Pusztai, MD
What are the current rationales for the use of adjuvant therapies in the management of early-stage breast cancer patients? Here to share some insights is Dr. Lajos Pusztai, Director of Breast Cancer Translational Research at the Yale Cancer Center.
Guest: Randy C. Miles, MD, MPH
There’s been a sharp decrease in breast cancer diagnoses since the beginning of the COVID-19 pandemic. But that doesn’t necessarily mean there are any fewer cases out there. Here to share how the COVID-19 pandemic has impacted breast cancer screening and how we can increase access to this essential proactive measure is Dr. Randy Miles, Clinical Service Chief in the Division of Breast Imaging at the Department of Radiology at the Massachusetts General Hospital.
Guest: Rachel Jimenez, MD
The NCCN Clinical Practice Guidelines in Oncology provide a wealth of information in the therapeutic management of early breast cancer. But how do those guidelines vary based on tumor biology? Here to give us a brief overview is Dr. Rachel Jimenez, Associate Program Director at the Harvard Radiation Oncology Residency Program in Boston.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Andrew M. Kaunitz, MD, FACOG
The estrogen component of combined oral contraceptives in part helps to suppress FSH and folliculogenesis, stabilizes the endometrium, minimizes unscheduled bleeding, and supports progestin activity. Nonetheless, there are downsides to estrogen, including an increased risk for cardiovascular and thromboembolic adverse events such as pulmonary embolism and deep vein thrombosis.
Join Drs. Lee Shulman and Andrew Kaunitz as they envision a better oral contraceptive—one formulated with a high NEST activity estrogen that has less potential to increase the risk of thromboembolic events while maintaining good cycle control.
Host: John J. Russell, MD
Guest: Rose George
Dr. John Russell is joined by Rose George, the author of the book “Nine Pints," to take an in-depth look into everything we know about blood.
Host: Jerome Lisk, MD
Guest: Anthony L. Fine, M.D
Recent advancements in the field of fetal neurology have equipped clinicians to detect neurological diseases before the child is even born. Dr. Jerome Lisk joins Dr. Anthony Fine, a pediatric neurologist and epileptologist at Mayo Clinic in Rochester, to discuss some of these advancements.
Host: Hector O. Chapa, MD, FACOG
Guest: Meredith Williamson, MD
One of the most common medical complications during pregnancy and the postpartum period, perinatal depression affects many women and often goes undetected. What steps can we take to improve the detection and care for women suffering from this condition? Dr. Meredith Williamson, a licensed psychologist at Texas A&M Health Family joins Dr. Hector Chapa to discuss the concerns of mental health in perinatal women.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Lee P. Shulman, MD, FACMG, FACOG
Cervical cancer is the fourth most common cancer in women worldwide, which makes it essential for us to keep ahead of advances in cervical cancer prevention—advances like a biomarker-based cytology test. Here to discuss this and other recent advancements in cervical cancer screening is Dr. Lee Shulman, the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University.
Guest: Ann L. Steiner, MD
COVID-19 has encouraged many people to adopt new habits, but some of them can take a toll on a woman’s breast health. Tune in to hear Dr. Ann Steiner, Clinical Professor of Obstetrics and Gynecology at Penn Medicine, share what two of those risky habits are and how women can lower their risk of breast cancer while they’re sheltering at home.
Published September 23, 2020
Guest: Ann L. Steiner, MD
Access to breast cancer screening and treatment can be difficult for women during the COVID-19 pandemic. Fortunately, healthcare professionals are finding ways to overcome these barriers. Dr. Ann Steiner, Clinical Professor of Obstetrics and Gynecology at Penn Medicine, compares her practice to before COVID-19 and explains how testing for breast cancer patients has changed.
*Published September 23, 2020*
Guest: Ann L. Steiner, MD
When it’s not safe for a patient to come into the office, what can we do to help patients manage their breast pain at home? Dr. Ann Steiner, Clinical Professor of Obstetrics and Gynecology at Penn Medicine, explains how COVID-19 has influenced lifestyle and dietary habits and how simple changes can go a long way in managing breast pain.
Published September 23, 2020
Host: Jennifer Caudle, DO
Guest: Kathleen E. O'Neill, MD, MTR
Guest: Nawar Abdul Latif, MD, MPH, MSCE
Patients with uterine factor infertility, or UFI, only had two options if they wanted to achieve parenthood: using a gestational carrier or adoption. Until now.
Joining Dr. Jennifer Caudle to talk about the opportunities of uterine transplants and key information about the UNTIL trial are lead investigators Drs. Kathleen O’Neill and Nawar Latif from Penn Medicine.
Host: Paul Doghramji, MD
Guest: Megan Arnot
Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.
Host: Jenn Simmons, MD
Guest: Susan Domchek, MD
Tune in as Dr. Jen Simmons is joined by Dr. Susan Domcheck, who debunks the common misconception that men don’t have to worry about the BRCA mutation and dives into the explorations of the BFOR Study.
Host: Jennifer Caudle, DO
Guest: Stanley Green, MD
Fresh out of residency and hesitant to sign a long-term contract, Dr. Stanley Green was exploring other options for his career. That’s when he discovered locum tenens work, which might just hold the key to achieving his inspiring lifelong goal.
Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC
With less and less primary care physicians partnering with physical therapists, it’s time we ask: are we doing ourselves—and our patients—a disservice by not taking advantage of this option? To find out, Dr. Jennifer Caudle sits down with physical therapist Catherine Apicella to discuss the often-overlooked benefits of physical therapy and how primary care physicians and physical therapists can work together to benefit their patients.
Host: Jennifer Caudle, DO
Guest: Theresa Rand, PA
Burnout is unfortunately experienced by many professionals in the healthcare space today, and its effects cannot be underestimated. Take Theresa Rand, for instance. After over 20 years as a physician assistant, Theresa kept finding herself unhappy and exhausted, no matter the people or practice. But in the pursuit of change, she turned to locum tenens…and has never looked back.
Host: Brian P. McDonough, MD, FAAFP
Guest: Teresa Gil, PhD
Since about 21 million mothers in America experienced sexual abuse in their childhood, there’s a good chance that some of these women are our patients. So as their physicians, how can we provide them with the best possible care as they continue to cope with the lifelong effects of sexual abuse? That’s what Dr. Brian McDonough explores with Dr. Teresa Gil, author of Women Who Were Sexually Abused as Children: Mothering, Resilience, and Protecting the Next Generation.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Kara Rood, MD
A recent study following 346 pregnant patients found that 63 percent of the women were admitted into the hospital for uncertain diagnosis or delivery—all because preeclampsia has many of the same symptoms of other diseases. The good news, however, is that there’s a new test currently underway that could make the diagnosis and treatment of preeclampsia easier in order to prevent potentially dangerous outcomes for the mother and baby, as OB/GYN Dr. Kara Rood explains.
Host: Kimberly Kearns, NP
Guest: Betty White, ARNP, MN
Recapping the “Optimal IBD Outcomes: What Advanced Practice Providers Need to Know” session they moderated at the second annual Crohn’s & Colitis Congress in Las Vegas, adult nurse practitioner-board certified Kimberly Kearns and advanced practice nurse Betty White talk about the top 10 takeaways, including which patients are right for clinical trials and managing IBD in pregnant patients.
Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC
Frustrating multiple sclerosis (MS) symptoms like urinary frequency and incontinence can be detrimental to a patient’s quality of life, but there are resources available to help. To explore the benefits of pelvic floor physical therapy for MS, Dr. Jennifer Caudle sits down with two special guests: physical therapist Catherine Apicella from CORE 3 Physical Therapy and her patient—and ReachMD’s very own employee—Crystal Gouldey.
Guest: David J. Portman, MD
Providing the best care to your patients goes hand in hand with being aware of all the updates surrounding sexual health disorders, but unfortunately, this is often easier said than done. To help you make the most out of your limited time with patients, Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman shares tips on how you can stay current on sexual health topics.
Guest: David J. Portman, MD
For the one in eight women who will develop breast cancer in their lifetime and for the three million breast cancer survivors, what’s the best way to manage genitourinary syndrome of menopause (GSM)? Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman explains the rationale behind his approach.
Host: Matt Birnholz, MD
Guest: David J. Portman, MD
Recorded live during ReachMD's Innovation Theater in Chicago, Illinois, Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman joins Dr. Matt Birnholz to share his tips for getting past the taboo and providing sexual health counseling and treatment to your patients.
Host: Jennifer Caudle, DO
Guest: Thomas C. Wright, Jr., MD
The Cervical Cancer Screening practice environment continues to change for both physicians and patients. Physicians are constantly tasked with evaluating analyses of new data on how best to approach cervical cancer screening for a particular patient demographic; and patients remain confused and unsure if the “new” approaches are better, or even less safe, than the “Pap” that has served as the bedrock for so many years.
This activity previously aired as a ReachMD Live Broadcast, where Dr. Thomas Wright, Jr., addressed these wide-ranging issues in a real-time, question and answer forum.
THIS ACTIVITY IS NO LONGER AVAILABLE FOR CME CREDIT.
Host: Brian P. McDonough, MD, FAAFP
Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people contracting HPV at some point in their lives.
Host Dr. Brian McDonough is joined by Samantha Gottlieb, medical anthropologist and author of Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. They explore the history of Gardasil, a vaccine developed for HPV but marketed primarily as a cervical cancer vaccine, which became embroiled in sociopolitical debates about adolescent sexuality and pediatric vaccinations.
The two discuss these precedents alongside current controversies, such as whether vaccinating both males and females will induce herd immunity, and if the benefits outweigh the risks.
Guest: Sandro Esteves, MD, PhD
Recent studies have highlighted limitations of the existing definitions of poor ovarian response.
In this video, Dr. Sandro Esteves will review these limitations, explain the new POSEIDON criteria, discuss its new marker of success in Assisted Reproductive Technology, and provide innovative alternatives for clinical management.
Host: Andrea J. Singer, MD, FACP, CCD
Guest: Lisa Larkin, MD, FACP, NCMP, IF
Direct Primary Care, or DPC, is a new healthcare model that focuses on affordability, accessibility and personalization. Health insurance is an obstacle that many patients face and one of DCP's goals is to create an affordable way for patients to get the healthcare they need at a reasonable price with a physician who has the time to see them.
Joining Dr. Andrea Singer in this emerging discussion of Direct Primary Care is Dr. Lisa Larkin, President and CEO of Lisa Larkin M.D. & Associates, Internal Medicine and Women's Health Group Practice, Medical Director of Women's Health Services for TriHealth Corporate Health, and Founder of the Cinncinati Sexual Health Consortium in Cinncinati, Ohio. The two discuss both the benefits and challenges of Direct Primary Care as well as the similiarities and differences between DCP and traditional primary care.
Host: Thomas C. Wright, Jr., MD
Guest: Andrew M. Kaunitz, MD, FACOG
Recorded live at a recent Women’s Health Annual Visit symposium, host Dr. Thomas Wright Jr. welcomed Dr Andrew Kaunitz to discuss the misconceptions of hormonal therapy of menopausal patients, current guidelines and recommendations, and patient safety.
Dr. Andrew Kaunitz is Professor and Associate Chair of Obstetrics and Gynecology at the University of Florida College of Medicine. He also serves as Director of Menopause and Gynecologic Ultrasound Services at Southside Women's Health.
Host: Matt Rosenberg, MD
Guest: Zil Garner Golstein, FNP-BC
The medical knowledge needed to treat trangender patients is not as equipped as it should be, which leads to trouble in finding adequate doctors to meet their specifc needs. This conversation includes tips on how to offer transgender patients adequate healthcare and how medical practioners can make their offices more welcoming.
Joining Dr. Matt Rosenberg in this discussion is Ms. Zil Gardner Goldstein, Family Nurse Practioner, Assistant Professor of Medical Education at the Icahn School of Medicine, and Program Director at the Center for Transgender Medicine and Surgery at Mount Sinai.
Host: Andrea J. Singer, MD, FACP, CCD
Guest: Stephen M. Cohen, MD, FACOG
Over 6 million women in the United States are impacted by infertility. Luckily, there are many treatment options available for couples dealing with infertility, and there are many things physicians can do to help infertile couples in their office.
At a recent live event in Pasadena, CA, program moderator, Dr. Andrea Singer, was joined by Dr. Stephen M. Cohen, Faculty at SUNY Upstate Medical School in Syracuse, New York to discuss infertility testing and treatments.
Host: Matt Rosenberg, MD
Guest: Aiden Harrington, ANP, CNM
Current CDC Treatment Guidelines include transgender men and women as special populations. These guidelines recommend risk assessment based on current anatomy and sexual behaviors and screening for asymptomatic STIs based on the patient's history and sexual practices.
At a recent live event recorded in Chicago, moderator Dr. Matt T. Rosenberg welcomes Aiden Harrington, ANP, CNM from Howard Brown Health in Chicago, Illinois. Topics covered include health risks in the LGBTQ community, STI screening and treatment, and how to discuss sexuality with your patients.
Host: Matheus Roque, M.D.
Dr. Matheus Roque will review current studies and papers exploring the rationale and effectiveness of a freeze-all policy, as well as discuss how to identify the proper patient population to benefit from this technique.
Guest: Sheryl A. Kingsberg, PhD
Dr. Sheryl Kingsberg demonstrates counseling strategies clinicians can use with their patient when discussing dyspareunia in post-menopausal women.
Dr. Sheryl Kingsberg is Chief of the Division of Behavioral Medicine in the Department of OB/GYN at University Hospitals Cleveland Medical Center and Professor of Reproductive Biology and Psychiatry at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Guest: David J. Portman, MD
Dr. David J. Portman demonstrates how clinicians can begin the conversation of dyspareunia with patients, as well as how to discuss the available treatment options for managing this condition in post-menopausal women.
Dr. Portman is Director Emeritus at Columbus Center for Women’s Health Research; and, Adjunct Instructor of Obstetrics and Gynecology at The Ohio State University, Columbus, OH.
Host: Maurice Pickard, MD
Guest: Bonnie Rochman
With the ever-expanding array of prenatal and postnatal tests, from carrier screening to genome sequencing, parents’ access to this previously unknown information is altering perceptions of disability, redefining the question of what sort of life is worth living, and who draws the line. Is this technology a triumph of modern medicine or a Pandora’s box of possibilities?
Host Dr. Maurice Pickard chats with Bonnie Rochman, author of the book The Gene Machine: How Genetic Technologies are Changing the Way We Have Kids - and the Kids We Have, about the new frontier of gene technology and how it is transforming medicine, bioethics, health care, and the factors that shape a family.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Heidi Faith
Doulas have become an integral part of the obstetrics field. In recent years, a new, specialized type of doula, called the bereavement doula, has emerged. But what roles and duties are performed by this care provider?
Host Dr. Renee Allen speaks with Heidi Faith, Founder, President and CEO of StillBirthDay, a highly specialized doula program. The two talk about the unique care roles a bereavement doula can play in the labor and delivery of stillborn babies.
Host: Brian P. McDonough, MD, FAAFP
It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, specifically, and how can we leverage these understandings into better primary care?
Dr. Brian McDonough is joined by Dr. Maureen Murphy, research scientist at the Wistar Institute at the University of Pennsylvania. Dr. Murphy has spent the past twenty years studying how genes affect breast cancer risk in women, particularly for African American populations. She discusses her findings on the discovery of p53 protein variants and how this advances the role for precision medicine in treating breast cancer.
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
Released May 18, 2017
Host: Brian P. McDonough, MD, FAAFP
Polycystic Ovary Syndrom (PCOS) afflicts 10 to 15% of women worldwide, yet physicians often don't recognize the symptoms associated with this disease.
Host Dr. Brian McDonough chats with Dr. Fiona McCulloch, a Toronto-based naturopath and author of the book 8 Steps to Reverse Your PCOS, about different approaches to managing PCOS and how dietary changes can make huge impacts for women dealing with PCOS.
This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Martha Luna Rojas, MD.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Marcos Horton, MD.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Marcos Horton, MD.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Sandro Esteves, MD, PhD.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Guest: Andrea J. Singer, MD, FACP, CCD
This interview with Andrea J. Singer, MD, FACP, CCD, explores strategies for your patients on how to maintain a healthy sexual relationship during ART treatments.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Host: Prathima Setty, MD
A couple of extra minutes attached to the umbilical cord at birth may translate into a significant boost in neurodevelopment several years later, research suggests.
Dr. Prathima Setty is joined by Dr. Kecia Gaither, a perinatal consultant at St. Lukes Hospital in Kansas City, MO as they talk about how delaying cutting the umbilical cord can be beneficial.
Host: John J. Russell, MD
Guest: Amy Mackey, MD
Hosts Dr. John Russell and Dr. Amy Mackey sit down to reflect on their individual and shared experiences participating in medical missions from their respective vantage points of family medicine and obstetrics & gynecology.
Host: Matt Birnholz, MD
Guest: Robert H. Debbs, DO
Joining Dr. Matt Birnholz to discuss counseling methods for patients who are trying to conceive is Dr. Robert Debbs, Director of the Pennsylvania Hospital Maternal Fetal Medicine Network in New Jersey and Clinical Professor of Obstetrics and Gynecology at Penn Medicine. Dr. Debbs will discuss pre-conceptual counseling on a range of topics such as obesity, congenital heart disease, depression, and conceiving after a miscarriage.
Host: Matt Birnholz, MD
Guest: Ari Brooks, MD
Guest: Brian Englander, MD
Host Dr. Matt Birnholz is joined by Dr. Ari Brooks, Director of Endocrine and Oncology Surgery and Director of the Integrated Breast Center at Pennsylvania Hospital, and Dr. Brian Englander, Clinical Assistant Professor and Chair of the Department of Radiology at Pennsylvania Hospital. Drs. Brooks and Englander discuss the hot topics within breast cancer innovations. They touch upon the increase in involvement of genetics and genomic research that is impacting breast cancer treatment options, new breast imaging modalities, and continuity of care.
Host: Matt Birnholz, MD
Guest: Paris D. Butler, MD, MPH
Host Dr. Matt Birnholz welcomes Dr. Paris D. Butler, who will be discussing breast reduction surgery for women who suffer from chronic back pain and breast cancer patients undergoing reconstructive surgery following a diagnosis. Dr. Butler will go into detail about the pros and cons of taking an immediate versus a delayed reconstruction approach and the various techniques associated.
Host: Brian P. McDonough, MD, FAAFP
How can primary care clinicians best help women facing a diagnosis of breast cancer, and what counseling methods will guide them to optimal treatment plans?
Host Brian McDonough talks with Dr. Richard Bleicher, Director of the Breast Fellowship Training Program at Fox Chase Cancer Center, about strategies health care providers should take to help breast cancer patients deal with their diagnosis and prepare for the next steps in therapy.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Carmen Brown, MD
What does it take to pick up your practice and move to a foreign country? And what can be gained and lost in translation?
Host Dr. Renee Allen chats with Dr. Carmen Brown,a board-certified OB/GYN practicing in New Zealand, about her experiences and perspectives transitioning a clinical practice and family home to another continent.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Rob Olson, MD
The OB/GYN hospitalist model is one potential approach to enhancing the quality and safety of hospital’s obstetric–gynecologic services and reducing the incidence of adverse events
Host Dr. Renee Allen sits down with Dr. Rob Olson, an OB/GYN hospitalist program consultant with over 7 years experience practicing in this role. Dr. Olson is founding President of the newly formed Society of OB/GYN Hospitalists, and he speaks nationally on the many benefits of OB/GYN Hospitalist models of care.
Host: Ana Maria Rosario
Guest: Martin R. Chavez, MD, FACOG
From the Women's Health Annual Visit in Chicago, host Ana Maria Rosario talks with Dr. Martin Chavez, the Director of Maternal Fetal Medicine and Fetal Surgery Program at Winthrop University Hospital, about the maternal-fetal effects of the Zika virus outbreak.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Reports indicate that there is a national upsurge in the number of women with opioid addiction. The problem is multigenerational, with consumption habits that begin as early as the mid-teenage years and extend well into the elderly population.
Additionally, opioid addiction disproportionately affects women, who are more likely to become dependent and overdose unintentionally on painkillers compared to men.
Host Dr. Patrice Basanta-Henry talks with Dr. Regan Theiler, Director of the Division of General OB/GYN at Dartmouth-Hitchcock Medical Center about treatment approaches for opioid-addicted pregnant women and women of childbearing age.
Host: Brian P. McDonough, MD, FAAFP
50% or women who suffer from Polycystic Ovary Syndrome (PCOS) are unaware that they have it.
Dr. Brian McDonough talks with naturopathic doctor Fiona McCulloch about that the signs of PCOS and various approaches women can utilize in dealing with it.
Host: Jennifer Caudle, DO
Joining Dr. Jennifer Caudle to share insights about fibroid treatment updates and counseling methods is Dr. Jessica Shepherd, Assistant Professor of OB/GYN and Director of Minimally Invasive Gynecology at the University of Illinois in Chicago. Dr. Shepherd is the founder of HerViewpoint.com, an online forum for women designed to discuss all those women's health topics that are difficult to raise in doctors' offices.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Many menopausal and perimenopausal women are faced with the decision of whether synthetic or bioidentical hormone therapy is the best option for them. There are many pros and cons for each, but questions surface from patients and clinicians alike on comparative safety and efficacy profiles.
Host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, a board-certified practicing OB/GYN at Heras Healthcare for Women. They talk about the differences between bioidentical and synthetic hormones, and whether bioidentical hormone therapy is a safe option for women.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Advances in technology have resulted in increased information being available for pregnant woman. With this increased information has come a rise in the number of requests for termination of pregnancy for fetal indications. However, termination of pregnancy remains a controversial issue in the area of women’s health. Women requesting second trimester terminations may face significant legal barriers as well as poor access to providers and/or facilities that are able to provide the procedure.
Host Dr. Patrice Basanta-Henry chats with Dr. Reagan Theiler, Division Director for General Obstetrics and Gynecology and Director of Ryan Residency Training Program at the Dartmouth Hitchcock Center and the controversy surrounding second trimester termination.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
According to the American Congress of Obstetricians and Gynecologists, between 14% and 23% of women will struggle with some symptoms of depression during their pregnancy. This condition often goes unrecognized and untreated in part because of safety concerns in using medications or other therapeutic methods during pregnancy.
Host Dr. Patrice Basanta-Henry talks with Dr. Nzinga Harrison, a board-certified physician in addiction medicine and psychiatry and Chief Medical Officer for Anka Behavioral Health, Inc about the current recommendations for depression screenings in the pregnant patient.
Host: Ana Maria Rosario
Guest: David Gandell, MD
Genital Herpes Simplex Virus (HSV) infection is a major public health problem. A dramatic upsurge in genital HSV infections have been documented from several prominent studies, making recognition, treatment, and patient counseling strategies more important than ever.
Joining host, Ana Rosario at the Women's Health Annual Visit in Deerborn, MI, is Dr. David Gandell, Clinical Professor of Obstetrics and Gynecology at the University of Rochester and attending phsyician at Strong Memorial Hospital.
Host: Ana Maria Rosario
Guest: Anita L. Nelson, MD
Joining host Ana Maria Rosario at the Women's Health Annual Visit in Deerborn, MI, is Dr. Anita Nelson, professor emeritus at UCLA and professor and chair of OB/GYN at Western University in California. The two discuss patient barriers to accessing IUDs and implants in a rapidly growing contraceptive market.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Approximately just 0.5% of all births occur before the third trimester of pregnancy, yet these very early deliveries result in the majority of neonatal deaths and more than 40% of infant deaths. Care for infants born at the threshold of viability, less than 24 weeks of gestation and with body weights less than 1000 grams, poses many difficult clinical, social, and ethical questions among clinicians and families.
Host Dr. Patrice Basanta-Henry speaks with guest Dr. Fyama Wenner, a maternal-fetal medicine specialist at Atlanta Maternal Fetal Medicine, about special care considerations for extremely preterm infants, as well as effective counseling strategies for families.
Host: Brian P. McDonough, MD, FAAFP
Egg freezing, also known as oocyte cryopreservation, has gained rapid popularity as patient populations have broadened. Once intended almost exclusively for cancer patients undergoing aggressive chemotherapy treatments, more and more healthy women are choosing this resource to expand their reproductive options later in life.
Dr. Lisa Ashe, internist and medical director for Be Well Medical Group in Alexandria, VA, speaks with Dr. Brian McDonough about her personal experience with egg freezing from three simultaneous vantage points: physician, patient, and minister.
Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions. Cuzick J, Ho L, Terry G, Kleeman M, Giddings M, Austin J, Cadman L, Ashdown-Barr L, Costa MJ, Szarewski A. J Clin Virol. 2014 May;60(1):44-9. doi: 10.1016/j.jcv.2014.02.002. Epub 2014 Feb 14.
Abstract BACKGROUND:
HR HPV genotypes when assayed collectively, achieve high sensitivity but low specificity for the prediction of CIN2+. Knowledge of the specific genotypes in an infection may facilitate the use of HR HPV detection in routine clinical practice.
OBJECTIVES:
To compare the rate of HR HPV detection and the accuracy of CIN2+ prediction between PapType test (Genera Biosystems) and other commercially available HR HPV assays, and to examine the value of full HPV genotyping.
STUDY DESIGN:
PreservCyt samples from 1099 women referred for abnormal cervical cytology were used. CIN2+ was chosen as the primary end-point but CIN3+ was also evaluated. A hierarchy of HR HPV genotypes was created using PPV and this was used to create 3 groups of genotypes with potentially different …
Host: Thomas C. Wright, Jr., MD
A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N. Gynecol Oncol. 2015 Sep;138(3):573-8. doi: 10.1016/j.ygyno.2015.06.040. Epub 2015 Jul 4.
Abstract BACKGROUND:
In US cervical screening, immediate colposcopy is recommended for women with HPV-positive ASC-US(equivocal) cytology. We evaluated whether partial typing by Onclarity™ (BD) might identify HPV-positive women with low enough CIN3+ risk to permit 1-year follow-up instead.
METHODS:
The NCI-Kaiser Permanente Northern California Persistence and Progression cohort includes a subset of 13,890 women aged 21+ with HC2 (Qiagen)-positive ASC-US at enrollment; current median …
Host: Maurice Pickard, MD
STDs are widespread in all walks of life, regardless of gender, race, social status, or education. Seduced into complacency by the notion that "it can't happen to me" many sexually active teens and young adults are stunned when they are diagnosed with an STD.
In Seductive Delusions: How Everyday People Catch STDs, author and physician Dr. Jill Grimes reveals the truths about sexually transmitted diseases through narrated accounts of young men and women, their exam room conversations with doctors, and both the physical symptoms and the emotional reactions that can accompany infection.
Host: Matt Birnholz, MD
The American Congress of Obstetricians and Gynecologists have made several recommendations regarding the practice of umbilical cord blood banking.
Host Dr. Matt Birnholz speaks with Dr. Jordan Perlow, Associate Director of Maternal-Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, about the newest guidelines set forth from ACOG.
Host: Michael Krychman, MD
Feminine hygiene, though an important part of daily life, is rarely discussed openly,not even in clinical settings.
Host Dr. Michael Krychman sits down with Dr Alyssa Dweck, practicing gynecologist in New York and Assistant Clinical Professor at Mt. Sinai School of Medicine. They give essential tips for clinicians on how to talk to patients about feminine hygiene.
Host: Michael Krychman, MD
The primary purpose of contraception is to separate sex from procreation. However, sexual function is rarely addressed or considered in the context of making contraceptive choices.
Dr. Michael Krychman speaks with Dr. Rachel Perry, Assistant Professor of OB/GYN at the University of California-Irvine, about the various complex sexual health impacts of oral contraceptives, IUDs, condoms, and permanent sterilization procedures.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Hypertensive disorders of pregnancy, including preeclampsia and HELLP Syndrome, complicate up to 10% of pregnancies worldwide. Hypertension is the leading medical problem encountered in pregnancy and, despite major advances in medicine, remains one of the greatest causes of maternal and perinatal morbidity and mortality worldwide.
Host Dr. Patrice Basanta-Henry speaks with guest Dr. Fyama Wenner, a maternal-fetal medicine specialist at Atlanta Maternal Fetal Medicine, about updated recommendations for the management of hypertensive disease in pregnancy.
Host: Jennifer Caudle, DO
There are many widely circulated myths regarding breast cancer, such as:
- Beliefs that this disease affects women only.
- Fears that mammograms can cause cancers to spread.
- Assumptions that most patients with breast cancer have family histories positive for this disease.
Host Jennifer Caudle talks with guest Dr. Monique Gary, a fellowship-trained breast surgical oncologist at Grand View Health in Sellersville, Pennsylvania. Together, they dispel myths about breast cancer and talk about what patients can expect during a surgical oncologist appointment.
Host: Michael Krychman, MD
Flibanserin was one of the first FDA-approved medications for treatment of Hypoactive Sexual Desire Disorder in pre-menopausal women. But the drug's effectiveness has frequently been called into question, and the known side effects such as fainting, dizziness, and low blood pressure, many of which were found to be exacerbated by alcohol and hormonal contraception, created concerns for clinicians and patients alike.
Host Dr. Michael Krychman talks with guest Dr. Lisa Larkin, women’s health internist and Director of the Women's Health Center at the University of Cincinnati College of Medicine, about the “Pink Viagra" pill, concerns around its safety and effectiveness, and the diagnosis and treatment of HDSS.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Robert Wild, MD, MPH, D.Phil.
Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to discuss types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception. The two discuss ways for clinicians to trace the source of dyslipidemia in these women, from primary to secondary causes, and how this knowledge can guide future contraception choices.
Dr. Robert Wild is Professor of OB/GYN and Adjunct Professor in Biostatistics and Epidemiology at the University of Oklahoma. He is also Adjunct Professor in Epidemiology at the University of Pittsburgh, and Adjunct Professor of Nutrition at Oklahoma State University.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Obstetrical emergency care units offer pregnant women highly-specialized emergency care as a better alternative to the traditional emergency room visit. These units have been proven to increase patient satisfaction and improve emergency room wait time lengths. Where are they being utilized, and what are the barriers to implementing them nationwide?
Host Renee Allen talks with guests Dr. Brian Gilpin, National Clinical Director of Operations for OB Hospitalists at Mednax National Medical Group, and Dr. Christopher Swain, Founder and Chief Medical Officer for Ob Hospitalist Group (OBHG). They discuss the benefits and challenges of obstretical emergency care units.
Host: Michael Krychman, MD
Ovarian cancer is among the most highly prevalent and deadly cancers in existence, and in the struggle to care for patients and protect their quality of life, clinical standards in diagnostic screening and treatment protocols must change frequently.
Joining host Dr. Michael Krychman to discuss advances in treatment and prevention of ovarian cancer, with special focus on sexual health priorities, is guest Dr. Leslie Randall. Dr. Randall is Associate Professor of Obstetrics and Gynecology at the University of California-Irvine, and also Director of UC’s gynecologic oncology fellowship program.
Host: Michael Krychman, MD
Clinicians play an important role in helping patients understand and navigate issues around the use of sexual accessories to help improve sexual health for both men and women. With expertise in underlying issues such as vaginal dryness and discomfort with sex, health experts can better advise patients on which products to seek versus avoid.
Host Dr. Michael Krychman joins guest Dr. Barb DePree, gynecologist and Director of Midlife Woman’s Health at Holland Hospital, to discuss ways physicians can talk about accessories to advance sexual health for patients.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Babies born before 37 weeks gestation face many challenges in their first weeks of life. For premature babies to thrive in the NICU, the American Academy of Pediatrics recommends all preterm babies weighing less than 1500 grams be fed human milk. However, this recommendation creates a dilemma for mothers who are unable to supply their own breast milk and must therefore turn to donation programs to feed their babies.
Dr. Renee Allen chats with Scott Elster, CEO of Prolacta Bioscience, about the goals of breast milk donor programs to improve health outcomes for critically ill preemies, while also reducing NICU costs.
Host: Matt Birnholz, MD
Guest: Ronald J. Wapner, MD
Innovations in medical genetics are changing the practice of obstetrics and gynecology. With advancing knowledge of underlying genetic predispositions, doctors can provide more precisioned care plans for patients in women's health centers.
Dr. Matt Birnholz talks with Dr. Ronald J Wapner, Professor of Obstetrics and Gynecology and Director of Reproductive Genetics at Columbia University, about how the ever-changing field of medical genetics is revolutionizing OB/GYN treatment options and patient care.
Host: Michael Krychman, MD
Women who experience low libido often feel embarrassed, lonely, and unsure where to turn or with whom to confide. Left unaddressed, this issue can have devastating effects on relationships.
Dr. Michael Krychman sits down with Amanda Parrish, nationally recognized patient advocate for women's sexual health, to talk about hypoactive sexual desire disorder (HSDD) and the need for clinicians to foster open conversations with patients about low libido.
[Read the Article]
An estimated 15 million Americans do some kind of rotating shift work, including overnights, evenings and early morning shifts. But can this type of shift work increase the risk of coronary heart disease? A new study examined the link between rotating night shift work and heart disease in a group of female nurses.
Researchers at Brigham and Women's Hospital used data from the Nurses' Health Studies (1 and 2), which followed participants for a twenty-four year period. They specifically looked at 189,000 women who reported their lifetime exposure to rotating night shift work. Over the course of the study period, more than 10,000 new cases of coronary heart disease were reported.
The results suggested that rotating night shift work was associated with modest risk of coronary heart disease, but further research is needed to help determine whether the association is related to specific work hours and/or individual characteristics.
[Watch more videos of The JAMA Report]
Host: Barnett Mennen, MD
Guest: Angela DeMichele, MD, MSCE
Penn Medicine’s Breast Cancer Translational Center of Excellence (TCE), known as the 2-PREVENT TCE is led by Drs. Lewis Chodosh and Angela DeMichele. 2-PREVENT TCE aims to address one of the greatest challenges in breast cancer treatment: the high rate of relapse and late treatment effects among breast cancer survivors.
Host Dr. Barry Mennen welcomes Dr. Angela DeMichele, the Alan and Jill Miller Endowed Chair in Breast Cancer Excellence, Professor of Medicine and Epidemiology, and Co-Leader of the Breast Cancer Research Program at the Abramson Cancer Center of the University of Pennsylvania School Of Medicine.
Host: Jennifer Caudle, DO
Joining Dr. Jennifer Caudle to discuss top tips in breast cancer risk, screening, and detection is Dr. Monique Gary, breast surgical oncologist at Grand View Health in Sellersville, PA. Dr. Gary earned her medical degree from Philadelphia College of Osteopathic Medicine. She completed her internship and residency at University of Massachusetts Hospital and went on to complete her fellowship at Georgetown University Hospital.
Host: Brian P. McDonough, MD, FAAFP
Guidelines in testing intervals and recommended methods for cervical cancer screening have been changing rapidly. What's the bottom line on helping primary care clinicians best protect their patients from this disease development? Joining Dr. Brian McDonough on the floors of Omnia Education's Women's Health Annual Visit in New York to discuss updated strategies drive down cervical cancer risk is Dr. Edward Mayeaux, Professor and Chairman of the Department of Family and Preventive Medicine at the University of South Carolina School of Medicine.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Guest: LaToya Stephens, MD
Vaginal atrophy is a painful and emotionally distressing condition affecting many women, yet many suffer in silence. For those who find traditional treatment options to be ineffective, a vaginoplasty procedure already in use for cosmetic applications has been demonstrated to help counter the most severe symptoms. Join host Dr. Patrice Basanta Henry and Dr. Benita Stephens, Board Certified Ob-Gyn and founder of Ciao Bella Medical Center & Spa in Atlanta, GA, as they discuss the benefits and risks of "vaginal rejuvenation" procedures for symptomatic vaginal atrophy.
Host: Michael Krychman, MD
Dr. Michael Krychman interviews Dr. Brett Worly, Assistant Professor of Obstetrics and Gynecology at the Ohio State University School of Medicine. Dr. Worly talks about successful integrations of sexual medicine into evaluative, diagnostic, and treatment protocols in women's health practice, and how this progression led to the formation of a novel women's sexual health clinic at OSU.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
From the American Cancer Society, ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. A woman's risk of getting ovarian cancer during her lifetime is about 1 in 75. Her lifetime chance of dying from ovarian cancer is about 1 in 100. Host Dr. Renee Allen is joined by Dr. Evelyn Reynolds to discuss critical updates in ovarian cancer, specifically dispelling the myth about ovarian cancer being a "silent killer." Dr. Reynolds an Associate Professor and Division Director of Gynecologic Oncology at the Morehouse School of Medicine. She is board-certified in General Obstetrics and Gynecology and also Gynecologic Oncology.
Host: Thomas C. Wright, Jr., MD
How should clinicians educate patients on recommended timing intervals for receiving pap smears based on updated guidelines? And for those patients who receive a positive HPV test, what counseling strategies and treatment pathways would be most helpful?
Joining Dr. Thomas Wright from Omnia Education's Women's Health Annual Visit in Boston, MA is Dr. Dana Gossett, Division Chief of General Obstetrics and Gynecology at Northwestern Medical Faculty Foundation and Associate Professor at Northwestern University Feinberg School of Medicine.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Recent guidelines have been released on the recommended frequency of conducting pap smears, which has caused considerable debate between health care providers. How should non-gynecologists interpret these guidelines, as well as opposing views from specialists, for best performance of pap smears? And why in the age of DNA testing is this still an important exam? ReachMD host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, practicing obstetrician & gynecologist in private practice at Heras Healthcare for Women, to address these and other questions. Dr. Slaughter-Moore is an attending physician at Clearview Regional Medical Center and Eastside Medical Center in Georgia.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Guest: Kenan R. Omurtag, MD
It is estimated that 3 to 5% of all couples desiring pregnancy will suffer recurrent pregnancy loss (RPL). What are our current understandings of this unfortunate condition, and how can patients be treated to support successful future pregnancies? Host Dr. Patrice Basanta-Henry discusses the many facets of this clinical issue with Dr Kenan Omurtag, Assistant Professor of the Division of Reproductive Endocrinology and Infertility at Washington University School of Medicine in St Louis, Missouri.
[Read the Article]
Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testing, barriers to testing, and how the test results affected treatment decisions.
In 2006, the rates of BRCA testing were in the seventy percent range and by 2012 that proportion rose to ninety-five percent. While the majority of women reported being tested for BRCA 1 and 2, many were not, and a small minority reported that no one had discussed genetic risk or testing options. The study authors note that the overall goal of genetic testing is to help women make informed treatment decisions. Assessment of a young woman's genetic risk after a breast cancer diagnosis can affect treatment decisions and the results can also have health implications for her relatives.
[Watch more videos of The JAMA Report]
Host: Michael Krychman, MD
Host Dr. Michael Krychman welcomes Dr. Risa Kagan to discuss the intimacy and sexuality issues that patients face when they are dealing with fragility fractures. Dr. Kagan is Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. Since October 2005, she has been practicing gynecology with the East Bay Physicians Medical Group. Dr. Kagan is also a medical consultant at the Foundation for Osteoporosis Research and Education (FORE), and principal investigator on several clinical research trials involving women’s health. She is a North American Menopause Society (NAMS) certified Menopause Practitioner and is certified by the International Society of Clinical Densitometry.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
What is the role and importance of the Ob-Gyn Oncologist, especially for women diagnosed with pelvic cancers? What are some barriers patients face in seeing an Ob-Gyn Oncoloogist? And how can clinicians better partner with this group of specialists? In this episode, host Dr. Renee Allen explores answers to these questions with guest expert Dr. Evelyn Reynolds, board certified physician in both General Obstetrics & Gynecology and Gynecologic Oncology. She is also an Associate Professor and Division Director of Gynecologic Oncology at the Morehouse School of Medicine.
Host: Brian P. McDonough, MD, FAAFP
Reporting from the Caribbean island of Bonaire, Dr. Brian McDonough provides an update on local public sentiments and concerns around the continuing spread of Zika virus infections across the world.
Host: Stephen M. Cohen, MD, FACOG
Standards in cervical cancer detection methods have come a long way in the past 30 years, from cervical cytology to HPV co-testing and HPV primary screening. How did the OB/GYN community get here, and is the direction of current practice standards in sync with clinical preferences nationwide?
Joining Dr. Stephen Cohen to discuss these and other questions at the Women's Health Annual Visit in Houston, TX is Dr. Thomas Cox, former Director of Gynecology and Colposcopy at the University of California-Santa Barbara Health Services Center and Past-President of the American Society of Colposcopy and Cervical Pathology.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
When should you discuss the transition into menopause? How do you best counsel patients during this perimenopausual period? Dr. Renee Allen discusses these and other important clinical questions with guest Dr. Jocelyn Slaughter-Moore, practicing obstetrician & gynecologist in private practice at Heras Healthcare for Women. Dr. Slaughter-Moore is an attending physician at Clearview Regional Medical Center and Eastside Medical Center in Georgia.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Egg freezing, or oocyte cryopreservation, can be a major relief for women who wish to preserve their fertility, allowing patients to wait for the “right time.” What are the latest advances in technology and protocol for this procedure, and who are the right patients? Host Dr. Patrice Basanta Henry welcomes guest expert Dr Kenan Omurtag to address these and other questions. Dr. Omurtag is Assistant Professor of the Division of Reproductive Endocrinology and Infertility at Washington University School of Medicine in St Louis, Missouri.
[Read the Article]
Women facing infertility often turn to in vitro fertilization (IVF). Although IVF technology has improved, there is still a widely held belief that if a woman doesn't experience a successful live birth after three or four IVF cycles, her chances of a successful live birth are very low. A new study looked at IVF success rates after repeated treatment cycles well beyond the third or fourth attempts.
Researchers from the University of Bristol, in England reviewed the medical records of almost 160,000 women in the United Kingdom who underwent nearly 260,000 full IVF cycles between 2003 and 2010. They examined live birth rates among these women thru 2012.
They found that women under the age of forty who used their own eggs had a 33 percent success rate within the first cycle. This rate remained at above 20 percent up to and including the fourth cycle. By the sixth cycle, women had a cumulative live birth rate of 68 percent. Women between ages forty and forty-two, also saw an increased success rate up until the ninth cycle.
Overall, researchers reported that patients had an increased chance of success up to the ninth …
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Guest: Patrice L Basanta-Henry, MD, MHSc, FACOG
Cesarean sections are among the most common surgical procedures performed in the U.S. Yet despite its commonality, patients undergoing cesarean deliveries are far more likely to have difficult and unsatisfatcory birth experiences, leading to higher incidence rates of postpartum depression, bonding difficulties, and unsuccessful breast feeding. A novel approach to address this issue is being called the Family-Centered cesarean delivery. How does it work, and what are the distinct differences from traditional protocols?
Host Dr. Renee Allen welcomes Dr. Patrice Basanta Henry, practicing Ob-Gyn & MFM at Atlanta Maternal Fetal Medicine, an affiliate of Mednax National Medical Group. Dr. Basanta-Henry’s clinical interests include intrauterine growth restriction and endocrine disorders in pregnancy.
Host: Thomas C. Wright, Jr., MD
Guest: David Gandell, MD
For women entering menopause, increased pain during intercourse is a common but little discussed problem which dramatically affects quality of life. While there are several treatment options available, many clinicians aren't up to date. Joining host Dr. Tom Wright to discuss current therapies for painful intercourse in this patient population is Dr. David Gandell, Clinical Professor of OB/GYN at the University of Rochester in Rochester, NY.
[Read the Article]
The most common operation done worldwide is the cesarean or C-section. Cesarean delivery is lifesaving for obstructed labor and other obstetrical emergencies; however, as with any surgical procedure, there are risks of complications and overuse can be harmful to both mothers and newborns. There were about 22.9 million cesarean deliveries worldwide in 2012. Based on older analyses from the mid-1980s, the World Health Organization (WHO) recommends that cesarean delivery rates should not exceed 10 to 15 per 100 live births.
In a study in the December 1 issue of JAMA, Harvard Researchers examine the relationship between cesarean delivery rates and maternal and infant death, and other adverse outcomes in children following planned cesarean delivery. The results indicate that the optimal cesarean delivery rate in relation to maternal and neonatal mortality is approximately 19 per 100 live births. Higher cesarean delivery rates were not associated with better outcomes in mothers and children.
[Watch more videos of The JAMA Report]
CDC's Dr. Phoebe Thorpe and Dr. David Lakey discuss the many costs of preterm birth, and how we can make prevention a priority in the United States. Tune in to find out how some states, like Texas, are educating the public and taking steps to reduce the rates of preterm birth and infant mortality.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Pregnancy loss can occur in any trimester of pregnancy and for several possible reasons. For clinicians who treat pregnant patients, delivering the bad news of pregnancy loss is an avoidable part of practice. How do health care professionals best counsel these patients and their loved ones through these difficult times? Host Dr. Renee Allen joins Dr. Jocelyn Slaughter-Moore, practicing OB/GYN at Heras Healthcare for Women and attending physician at Clearview Regional Medical Center in Monroe, GA, to discuss counseling and coping strategies for patients who have experienced pregnancy loss.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
In the US, more than one half of pregnant women are overweight or obese, and 8% of reproductive-aged women are extremely obese, putting them at a greater risk of pregnancy complications. In this episode, we review the magnitude of the problem, the anatomic and physiologic factors specific to the obese patient, and the maternal and fetal complications that can occur. Host Dr. Renee Allen welcomes Dr. Patrice Basanta Henry, an Ob-Gyn & MFM at Atlanta Maternal Fetal Medicine, an affiliate of Mednax National Medical Group. Dr. Basanta-Henry’s clinical interests include intrauterine growth restriction and endocrine disorders in pregnancy.
Host: Ana Maria Rosario
Guest: Anita L. Nelson, MD
Current clinical definitions and terminology for vaginal bleeding often fail to clarify frequency, duration, and volume. Moreover, standards of treatment sometimes differ between obstetric and gynecological points of view. Taken together, the risks for misclassifying and mistreating women with acute excessive vaginal bleeding are preventably high.
Joining host Ana Maria Rosario at Omnia Education's Women's Health Annual Visit in Pasadena, CA to discuss key considerations for acute excessive vaginal bleeding is Dr. Anita Nelson, Professor Emeritus at the David Geffen School of Medicine at UCLA.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Host Dr. Renee Allen welcomes Dr. Victoria Green, renowned breast cancer researcher and OB/GYN clinician. Dr. Green is an Associate Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. She will review USPSTF recommendations of biennial mammograms compared to ACOG's recommendations, as well as differences in how we define 'breast awareness' versus breast self-examination. Join the discussion!
[Read the Article]
In the United States, it is estimated that approximately 230,000 women will be diagnosed with breast cancer, and more than 40,000 will die from the disease this year alone. Early detection using mammography remains the best way to prevent premature death from breast cancer. A panel of experts examined decades of research to update the American Cancer Society's (ACS) recommendations for breast cancer screening. Based on this review, the 2015 recommendations for breast cancer screening for women at average risk of cancer include the following:
- Women should undergo regular screening mammography starting at age 45.
- Women 45 to 54 years of age should be screened annually.
- Women 55 years and older should transition to every other year screening or have the opportunity to continue annual screening.
- Women should have the opportunity to begin annual screening between the ages of 40 and 44 years.
- Women should continue screening mammography as long as their overall health is good and they have a life expectancy of 10 years or longer.
- Clinical breast examination is not recommended for breast cancer screening among average-risk women of any age.
[Watch more videos of …
Host: Kathy King, RDN
Guest: Angela Grassi
Polycystic Ovary Syndrome, or PCOS, is the top cause of female infertility in the United States. Patients with PCOS often ask whether nutritional choices can affect both their quality of life and even their fertility. How should the clinician respond?
Joining host Kathy King to investigate nutrition therapy for PCOS is dietitian Angela Grassi, author of PCOS: The Dietitian's Guide. Ms. Grassi is the founder of the PCOS Nutrition Center in Bryn Mawr, PA, dedicated to advocacy, education, and evidence-based research of this syndrome.
Host: Kathy King, RDN
Guest: Lily Nichols
Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rationales behind this nutritional guidance is dietitian and certified diabetes educator Lily Nichols, author of Real Food for Gestational Diabetes.
Host: Michael Krychman, MD
Guest: Sheryl A. Kingsberg, PhD
Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne in clinical trials have gone largely under the radar.
Joining Dr. Michael Krychman to discuss the rise of flibanserin and its key takeaways for clinicians is Dr. Sheryl Kingsberg, Chief of the Division of Behavioral Medicine in the Department of OB/GYN and Professor in the Departments of Reproductive Biology and Psychiatry at Case Medical Center University Hospitals in Cleveland, Ohio.
Host: Jennifer Caudle, DO
Guest: Renée Simone Yolanda Allen, MD, MHSc., FACOG
In the past 20 years, rates of bariatric surgery have risen more than 800%. Of the number of bariatric procedures performed every year, women of reproductive age account for the vast majority of patients. What are the obstetric and gynecological effects of these various surgical procedures on female patients, and how can potential complications be prevented? Host Dr. Jennifer Caudle welcomes Dr. Renee S. Allen, Board certified OB/GYN and hospitalist, Fellow of ACOG, and Masters of Health Sciences from Atlanta, Georgia, to discuss OB/GYN counseling strategies for women who have undergone or intend to undergo bariatric surgery.
Host: Jennifer Caudle, DO
Guest: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Host Dr. Jennifer Caudle welcomes Dr. Renee S. Allen, Board certified OB/GYN and hospitalist, Fellow of ACOG, and Masters of Health Sciences from Atlanta, Georgia. Dr. Allen shares her expertise as an OB/GYN hospitalist, the growing support from ACOG in this new arena, and the goals of an emerging subspecialty.
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough welcomes Dr. Gregory Weinstein, Professor and Vice Chair and the Director of the Division of Head and Neck Surgery. He is the Co-Director of The Center for Head and Neck Cancer in The Department of Otorhinolaryngology: Head and Neck Surgery at the Hospital of the University of Pennsylvania. The two discuss a dramatic rise in HPV-related cancers over the past decade, and what clinicians need to be aware of in assessing their patients for these indidious diseases.
[Read the Article]
An increasing number of pregnant women are undergoing noninvasive prenatal testing to help identify fetal genetic abnormalities. This is done using a blood test that looks at the DNA of both the mother and fetus. In a small percentage of these tests, the results appear abnormal, but the baby's genetics are later shown to be normal. A new study examined if the rare diagnosis of maternal cancer could be one cause of such discrepancies. The study is being released to coincide with its presentation at the 19th International Conference on Prenatal Diagnosis and Therapy in Washington, D.C.
Researchers at Tufts Medical Center in Boston examined more than 125,000 noninvasive prenatal test results over the course of a two year period. Approximately 3,800 women had abnormal test results, and ten of those women were subsequently diagnosed with cancer. Medical records and additional genetic information were examined in eight of those women to look for patterns suggestive of underlying cancer.
Based on the results of the study, researchers estimate there is between a twenty and forty-four percent risk of maternal cancer if an abnormal number of chromosomes are detected. Further studies are needed to fully understand …
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; Sucheta Bhatt, MD; Kathryn Murray, MS; Tracy L. Prosen, MD; Judy E. Garber, MD; Louise Wilkins-Haug, MD, PhD; Neeta L. Vora, MD; Stephen Warsof, MD; James Goldberg, MD; Tina Ziainia, MD; Meredith Halks-Miller, MD JAMA. 2015;314(2):162-169. doi:10.1001/jama.2015.7120 Importance: Understanding the relationship between aneuploidy detection on noninvasive prenatal testing (NIPT) and occult maternal malignancies may explain results that are discordant with the fetal karyotype and improve maternal clinical care.
Objective: To evaluate massively parallel sequencing data for patterns of copy-number variations that might prospectively identify occult maternal malignancies.
Design, Setting, and Participants: Case series identified from 125 426 samples submitted between February 15, 2012, and September 30, 2014, from asymptomatic pregnant women who underwent plasma cell-free DNA sequencing for clinical prenatal aneuploidy screening. Analyses were conducted in a clinical laboratory that performs DNA sequencing. Among the clinical samples, abnormal results were detected in 3757 (3%); these were reported to the ordering physician with recommendations for further evaluation.
Exposures: NIPT …
Host: Maurice Pickard, MD
Guest: Olufunmilayo (Funmi) Olopade, MD, FACP
Host Dr. Maurice Pickard welcomes Dr. Funmi Olopade, Walter L. Palmer Distinguished Service Professor in Medicine and Human Genetics, Director of the Hematology/Oncology Fellowship Program, and Director of the Center for Clinical Cancer Genetics at the University of Chicago. Dr. Olopade discusses disparities in health outcomes for black women with breast cancer. Dr. Olopade is an expert in cancer risk assessment and individualized treatment for the most aggressive forms of breast cancer, having developed novel management strategies based on an understanding of the altered genes in individual patients. She stresses comprehensive risk reduction and prevention strategies in high-risk populations, as well as earlier detection through advanced imaging technologies.
Host: Michael Krychman, MD
As many clinicians have become increasingly aware, the problem of obesity involves a complex interplay of habits and hormones, influenced by genetic predispositions and cultural practices alike. Whereas the supposed magic bullets of weight loss pills and fad diets are always in high demand, few to none have demonstrated consistent benefit for patients, and the struggle to avoid the "yo yo effect" of regained weight goes on.
Sexual health problems represent some of the most difficult issues reported by patients who are obese, but rarely are these complaints properly registered or addressed by clinicians. Joining Dr. Michael Krychman at ACOG’s annual scientific meeting to focus on this neglected aspect of obesity is Dr. Maida Taylor, Clinical Professor of OB/GYN and Reproductive Sciences of the University of California-San Francisco. They discuss counseling strategies and interventions for patients striving toward better sexual health as they pursue more healthy, stable weight.
Host: Matt Birnholz, MD
Most women will readily testify that pelvic examinations are unpleasant experiences; they can be physically painful and induce anxiety. But recent studies have also indicated that examinations of asymptomatic, average-risk woman may lead to unexpectedly high rates false positives and unnecessary followup tests. So the perennial question resurfaces: are routine pelvic examinations more trouble than they're worth?
Join Dr. Matt Birnholz and guest Dr. Hannah Bloomfield, Chief of Research at the Minneapolis VA Medical Center, speaking at ACOG’s annual scientific meeting. They focus on the latest research behind this question of whether routine pelvic examinations are really necessary for monitoring patient health, and the potential pros and cons of abandoning this practice in annual OB/GYN checkups.
Host: Michael Krychman, MD
Low libido, a condition affecting an estimated 10% of women, can develop at any age and be attributed to several factors in a woman’s life, from lifestyle changes to medication and procedural side effects.
Join host Dr. Michael Krychman and Dr. Leah Millheiser, Director of Female Sexual Medicine at Stanford University School of Medicine, on the floor of ACOG’s annual scientific meeting. They discuss current knowledge gaps in recognizing and treating low libido, and the importance of sexual health psychology within therapeutic approaches.
Host: Matt Birnholz, MD
Many people believe that exercise during pregnancy is detrimental to the health of the fetus. This belief seems to have come from an outdated study that the fetus’s heart rate drops if the mother exercises. More recent studies, however, have supported a counterposition that exercise during pregnancy is safe and can actually be beneficial for both the mother and fetus.
Join Dr. Matt Birnholz and Dr. Linda Szymanski, Medical Director of Labor and Delivery at Johns Hopkins Hospital at the Johns Hopkins School of Medicine. They discuss the latest research on exercise during pregnancy, from benefits to harms, and how clinicians can counsel patients on the "right" amount of exercise during this life period.
Host: Matt Birnholz, MD
Guest: Maureen Whelihan, MD
There is a stigma around sex in the United States. That stigma makes it difficult both for patients to disclose details about their sex lives in clinical settings and for physicians to ask patients about sex. Consequentially patients may have treatable but unaddressed sexual problems because their physicians don't know those problems exists.
Join Dr. Matt Birnholz and Dr. Maureen Whelihan, President of The Center for Sexual Health and Education in West Palm Beach, Florida, as they discuss case stories spanning the various ages and stages of sexual health, and their implications in helping physicians and patients talk about sex.
Host: Matt Birnholz, MD
Studies in the field of anthropology have shown that having a healthy grandmother plays a critically positive role in family cohesion. But the wholistic, personalized health needs of women in their elder years are not always recognized. This care disparity is all the more prominent in general OB/GYN practice, but thanks to the work of a select few, the trends may be about to change.
Dr. Matt Birnholz speaks with Dr. Sarah Berga, Professor and Chair of OB/GYN at Wake Forest School of Medicine at ACOG’s annual meeting in San Francisco. They discuss maintaining grandmothers' health across both physiological and psychological spectra, and how this attention in care fundamentally changes larger family units for the better.
Host: Michael Krychman, MD
For women in their 40's and 50's, approximately one in four will develop a pelvic floor disorder such as urinary incontinence. By the age of 80, that prevalence rises to more than 50 percent. The struggle with a pelvic floor disorder has lasting effects on a woman's sexual health, leading to numerous psychosocial and physical consequences in turn. But of equal concern to many patients dealing with the symptoms of their disorder is the potential aftermath of reconstructive surgical treatments, such as mesh slings, due to their troubling complication rates. Are these concerns justified, and if so, how can the risks be mitigated by both physicians and patients?
Joining Dr. Michael Krychman to discuss the misconceptions versus realities of pelvic floor disorder treatments is Dr. Cheryl Iglesia, Professor in the departments of OB/GYN and Urology at the Georgetown University School of Medicine, and Drector of the Female Pelvic Medicine and Reconstructive Surgery section of Medstar Washington Hospital Center in Washington, DC.
Host: Michael Krychman, MD
Many clinicians think that one of the most dangerous things a woman will ever do in her life is to carry and conceive a child. Stemming from this belief, several misconceptions have risen within the medical community, and by extension the general public, concerning risks of sexual activity during pregnancy. Joining host Dr. Michael Krychman at ACOG's annual scientific meeting to clarify the facts versus myths on sexuality during and after this important life event is Dr. Haywood Brown, Professor and Chair of the Department of Obstetrics and Gynecology at Duke University Medical Center.
Host: Maureen Whelihan, MD
The increasingly recognized concept of a clinician's "work-life balance" is critical to thriving and avoiding burnout, but the philosophy behind this balance remains poorly understood. Some argue that adequate time alottment to one's priorities is the key factor in sustaining a positive medical career trajectory, but a select few believe that time allocation alone is not enough. Dr. Michael Foley, Chairman of the Department of Obstetrics and Gynecology at Banner University Medical Center-Phoenix, argues in favor of what he calls work-life harmony, where aspects of meaningfulness, relationships, and wellbeing better guide one's life and career decisions. Joining host Dr. Maureen Whelihan at ACOG's Annual Scientific Meeting in San Francisco, Dr. Foley applies a martial arts-centered perspective on medical careers based on his extensive experience as a seventh-degree black belt and the founder of The Center for Humane Living.
Host: Matt Birnholz, MD
In the past several years, endometrial ablation has become an increasingly utilized method for minimalizing heavy menstrual bleeding. What's more, this procedure has since been brought into the outpatient setting. But what do clinicians who are considering bringing this procedural practice into their offices need to know before moving forward?
Joining Dr. Matt Birnholz to discuss the benefits and limitations of in-office endometrial ablation is Dr. Monte Swarup, Partner at New Horizons Women’s Care from the Arizona OB/GYN Affiliates, and Clinical Assistant Professor at Midwestern University in Phoenix, AZ.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Tom Gellhaus, President-Elect of The American College of Obstetricians and Gynecologists, to discuss his vision for ACOG's initiatives to come, inspired in part by both his unique clinical training background and his extensive legislative activity experience on behalf of OB/GYN specialists nationwide.
Dr Gellhaus is Clinical Associate Professor of OB/GYN and Director of General OB/GYN at the University of Iowa Hospitals and Clinics in Iowa. City.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Mark DeFrancesco, 66th President of The American College of Obstetricians and Gynecologists, to the program. Dr. DeFrancesco looks back at the accomplishments of his immediate predecessors, and reflects on the three-fold initiative to which he will dedicate his efforts on behalf of ACOG to advance the OB/GYN specialty for years to come.
Dr. DeFrancesco is managing partner at Westwood Women’s Health in Waterbury, Connecticut, a division of Women’s Health Connecticut. He is a founding member of this organization, and served as its chief medical officer for many years.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Jeanne Conry, 64th President of The American Congress of Obstetricians and Gynecologists,
Host: Michael Krychman, MD
The market for sexual health products and accessories, from moisturizers to lubricants to self-stimulators, is very large, and this creates confusion among patients and physicians alike as to which types of products are most helpful for specific sexual health problems. To address ways to gauge the safety and efficacy of sexual health products on the market, particularly for perimenopausal patients with special needs, Dr. Michael Krychman welcomes Dr. Barb Depree, gynecologist, menopause care specialist, and founder of MiddlesexMD, a website providing information and recommended products for women's sexual health.
Host: Michael Krychman, MD
For years, women's sexual health matters have been relatively ignored in both clinical practice and the public eye despite consistently heavy media attention drawn towards men's sexual issues and associated therapeutic products. But there is recent evidence that the tide of public awareness is beginning to change, and that's women's sexual health is becoming more openly discussed across medical, public, and corporate entities. Joining Dr. Michael Krychman to qualify this new trend and examine ways to open communication about sexual health with women in clinical practice is Dr. Alyssa Dweck, assistant clinical professor of OB/GYN at the Mount Sanai School of Medicine and expert in women's sexual health and dysfunction.
Host: Michael Krychman, MD
Bladder leakage is one of many health-related issues that our female patients deal with. There are newly available treatment options, including non-surgical options, to help remedy the problem. Host Dr. Michael Krychman welcomes Dr. Holly Thacker to decipher the pros and cons of the various options available. Dr. Holly L. Thacker, nationally known for her leadership in women’s health, is the founder of the Cleveland Clinic Women’s Health Fellowship and is currently Professor and Director of the Center for Specialized Women’s Health at Cleveland Clinic and Lerner College of Medicine at Case Western Reserve University. She is also author of two books: Women’s Health: Your Body, Your Hormones, Your Choices and Cleveland Clinic Guide to Menopause.
Most women in the United States will develop fibroids at some point in their lives. But the range of issues experienced is very wide, from asymptomatic disease to debilitating illness. Joining Dr. Renee Matthews to examine the mysterious etiology and pathogenesis, quality of life impacts, and modern medical and surgical approaches to fibroids is Dr. Jessica Shepherd, Assistant Professor of Clinical Obstetrics and Gynecology and the Director of Minimally Invasive Gynecology at the University of Illinois College of Medicine in Chicago. Dr. Shepherd is also founder of Her Viewpoint, an online community empowering women about their health.
Host: Matt Birnholz, MD
Placenta accreta, also known as invasive placentation, is on the rise in US labor and delivery wards. It’s also potentially deadly, and healthcare professionals need to know how to detect it quickly and manage it safely.
Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York to discuss the types, risks, and therapeutic approaches for placenta accreta is Dr. Jordan Perlow, Director of Maternal Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, and Associate Clinical Professor of OB/GYN at the University of Arizona School of Medicine.
Host: Prathima Setty, MD
Guest: Sheryl A. Kingsberg, PhD
Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder for women of all ages, but it is also one of the most difficult to address. Clinicians need to understand the implications and address the concerns of their patients. Host Dr. Prathima Setty discusses this topic with Sheryl A. Kingsberg, PhD, Chief, Division of Behavioral Medicine, Department of Obstetrics/Gynecology, University Hospitals Case Medical Center, and Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University, Cleveland, OH.
About NAMS
The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.
Host: Prathima Setty, MD
What is the practical approach in treating and counseling patients suffering from hot flashes? Dr. Susan Reed discusses the latest research on herbal supplements, such as black cohosh therapy; as well as, pharmacologic options: SSRIs, SNRIs and Gabapentin. Dr. Susan Reed is the Professor and Division Director of the Women's Health and Adjunct Appointment, Epidemiology, Clinical Services Director at the UW National Center of Excellence in Women's Health at the Univesity of Washington Schoolf of Medicine, Seattle, Washington.
About NAMS
The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.
Host: Matt Birnholz, MD
The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.
Host: Matt Birnholz, MD
Cord Blood Banking has become increasingly prominent in OB/GYN practice, which demands a myriad of skills such as counseling expectant parents and families on collections, procedure processes, and differences in public vs private banks. Is your state of knowledge up to date?
Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York is Dr. Jordan Perlow, Director of Maternal Fetal Medicine at Banner Good Samaritan Medical Center in Phoenix, AZ, and Associate Clinical Professor of OB/GYN at the University of Arizona School of Medicine.
Host: Brian P. McDonough, MD, FAAFP
Stress has long been associated with cardiovascular risk, but few studies have connected stress with worsened recovery rates after heart attacks. Moreover, the recently published discovery that women with mental stress may suffer worse outcomes recovering from heart attacks than men under similar conditions raises more questions than answers. What are the possible mechanisms by which this gender disparity in outcomes may occur, and how can clinicians help mitigate this risk? Dr. Brian McDonough welcomes Dr. Nieca Goldberg, cardiologist and director of the Joan H. Tisch Center for Women's Health at NYU Langone Medical Center.
Host: Howard Levy, MD, PhD
Guest: Cynthia Casson Morton, PhD
After many years of collaborative research spanning the globe, the genetic mechanisms of uterine fibroid development have become well understood. What are the clinical ramifications of this knowledge, and how can genetic testing further guide treatment decisions? Speaking with Dr. Howard Levy on the genetics of uterine fibroids is Dr. Cynthia Morthon, Past President of the American Society of Human Genetics, and Professor of OB/GYN and Pathology at the Brigham and Women's Hospital and Harvard Medical School.
Host: Matt Birnholz, MD
Hypnosis in Obstetrics. It’s something you probably just don’t hear about every day, but the practice has existed for more than a century and in that time collected a fair amount of evidence on its behalf. What are the benefits and risks of hypnotic practice, both in the obstetric domain and in the wider arena of medicine? Joining Dr. Matt Birnholz to separate fact from fiction about hypnosis in medicine at Omnia Education’s Women’s Health Annual Visit in New York is Dr. David Gandell, Clinical Professor of Obstetrics and Gynecology at Strong Memorial Hospital of the University of Rochester in Rochester, New York.
Host: Prathima Setty, MD
Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study.
Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues.
Supported by an Educational Grant from BD Diagnostics.
ReachMD retains full editorial control of the content for this program.
Host: Matt Birnholz, MD
There’s an estimated 450,000 people with multiple sclerosis in the United States, and of this staggering number, there are 2 to 3 times as many women as men, with a gender gap that is only widening. Since the majority of women with MS get diagnosed in their 20’s and 30’s, the need for understanding the reproductive impacts of MS becomes critical. How can clinicians address these challenges in practice?
Joining Dr. Matt Birnholz at Omnia Education’s Women’s Health Annual Visit in New York is Dr. Carolina Ionete, Associate Professor of Clinical Neurology at the University of Massachusetts, and Associate Director of the MS Center in Wooster, MA.
Host: Prathima Setty, MD
What are the benefits and harms of screening women for breast cancer? How often should we screen our patients? Are there technological advancements to help our patients live better and longer? Dr. Prathima Setty welcomes Dr. Russell P. Harris, Professor of Medicine and Adjunct Professor of Epidemiology at University of North Carolina, Chapel Hill, NC.
Supported by an Educational Grant from BD Diagnostics.
ReachMD retains full editorial control of the content for this program.
Host: Matt Birnholz, MD
Risk assessments for ovarian tumors are ever-evolving, as advances in diagnostic imaging and biomarker development pave the way. What are the current views on overian tumor risk assessment, and how should they be incorporated into clinical practice? Joining Dr. Matt Birnholz to address these questions is Dr. Fred Ueland, Professor of Obstetrics and Gynecology, and Director of Gynecologic Oncology at the University of Kentucky.
Host: Prathima Setty, MD
Host Dr. Prathima Setty is joined by Dr. Bethanee J Schlosser, Assistant Professor in Dermatology and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, Chicago, IL. Dr. Schlosser discusses hair concerns and changes in post menopausal patients. She also addresses the importance of identifying the major causes, treatment options, and goals for patients who are suffering from hair loss of the scalp, increased facial hair and other hair changes.
About NAMS
The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.
Host: Prathima Setty, MD
Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients.
About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive …
Host: Matt Birnholz, MD
Guest: Michael Krychman, MD
Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.
Host: Brian P. McDonough, MD, FAAFP
Herbal supplements have become increasingly popular in women's health circles, but there is a lot of misinformation about the relative benefits versus risks. How do clinicians wein their patients off harmful medications they are taking, and what health issues do women taking these medications encounter? Join Dr. McDonough and Pharmacist David Foreman to discuss the state of supplementation in and outside of health practices today.
Host: Brian P. McDonough, MD, FAAFP
The notorious "Freshman 15" equates to weight gain commonly experienced by college-age students living away from home for the first time. How does this problem in weight management and healthy nutrition surface in primary care practice, and how can college students be counseled to avoid gaining extra weight during their first year? Joining Dr. Brian McDonough to speak on this subject is Alice Holland, RNP, Director of Student Health Services at Quinnipiac University in Hamden, Connecticut.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
An old clinical dogma in OB/GYN was that dyslipidemia during pregnancy wouldn't have any long term implications on the developing fetus because of short exposures at 9 months. This has since been shown to be untrue. What health issues surface in children whose mothers experienced abnormally elevated lipid levels in pregnancy, and how can these problems be prevented at the peripartum stage? Host Dr. Alan Brown joins Dr. Robert Wild, Professor of Obstetrics and Gynecology at the University of Oklahoma College of Medicine, to discuss prevention and treatment strategies for dyslipidemia during pregnancy. Dr. Wild is past president of the American Society of Preventive Cardiology, the Society of Reproductive Endocrinologists, the Oklahoma City Obstetrical and Gynecological Society, and the Menopause Group for the American Society of Reproductive Medicine.
Host: Prathima Setty, MD
Host Dr. Prathima Setty welcomes Dr. Eve Espey, Associate Professor of Obstetrics and Gynecology and Associate Dean of Students at the University of New Mexico School of Medicine, to discuss the comparative efficacies, side effect profiles, costs, and procedural methods for the latest long-acting reversible contraceptives available. Dr. Espey serves on the undergraduate medical education committee of the Association of Professors of Gynecology and Obstetrics and on the Committee for Underserved Women of the American College of Obstetrics and Gynecology.
Host: Mimi Secor, DNP, FNP-BC, FAANP
There are approximately 55 million women of menopausal age in the US. In fact, about 6,000 women reach menopausal age every day. For many, the spectrum of physical changes and their associated impacts on daily life aren't always anticipated or well understood. Clinicians of all levels have unique opportunities to provide guidance and treatment options for patients experiencing more severe effects of menopause; however, they don't always know what to ask, or how to ask it. To address this knowledge gap, host Mimi Secor welcomes Barbara Dehn, popularly known as Nurse Barb, a practicing Women's Health Nurse Practitioner, award winning author, and a nationally recognized health expert, to discuss clinical approaches to helping patients through the more difficult symptoms of menopause.
The CDC released a report on the prevalence of sexual violence and intimate partner violence (IPV) that stated about 36% of women in the US are raped or sexually assaulted by an intimate partner during their lifetimes. About 6% experience this in any given year. The costs are burdensome to the health care system and society, estimated at 2.3 to 7 billion dollars in the first year after the assault. What can physicians do to address this public health issue? Host family practitioner Dr. Jennifer Caudle welcomes Dr. Jane Liebschutz to answer these questions and provide insight to the important roles of the physician. Dr. Liebschutz is an Associate Professor of Medicine and Community Health Science and the Director of the General Internal Medicine-Family Medicine-Pediatrics Academic Fellowship at Boston Medical Center.
Host: Brian P. McDonough, MD, FAAFP
The American College of Physicians (ACP) has issued new clinical guidelines recommending against screening pelvic examination in asymptomatic, nonpregnant adult women. The college describes the recommendation as strong, with moderate-quality evidence. What are the new guidelines? What does this mean for the general practitioner? Joining host Dr. Brian McDonough is Molly Cooke, MD. FACP, Professor of Medicine and inaugural Director of Education for Global Health Sciences at UCSF. Dr. Cooke serves on the ACP Clinical Guidelines Committee. She reviews the guidelines from the perspective as a general practitioner and the choices she must make during the time she has with patients. The guidelines were published online July 1 in the Annals of Internal Medicine.
Host Dr. Prathima Setty welcomes Dr. Kurian Thott, Chief of OB/GYN at Stafford Hospital, to discuss the best gynecologic minimally invasive surgery procedures in practice today. Dr. Thott has specialized advanced training in Urogynecology and pelvic reconstructive surgery, and he was awarded for outstanding laparoscopic skill in minimally invasive surgery by both the American Association of Gynecologic Laparoscopists (AAGL) and Society of Laparoendoscopic Surgeons (SLS).
Host: Prathima Setty, MD
Guest: Draion M. "Dr. Drai" Burch, DO
Female sexual dysfunction (FSD) occurs in about 20 - 60% of patients. FSD is common problem but how comfortable are clinicians in disussing this with their patients? Host Dr. Prathima Setty welcomes Dr. Draion "Dr. Drai" Burch, obstetrician-gynecologist and teaching faculty member at Magee-Womens Hospital of The University of Pittsburgh Medical Center. Dr. Drai reviews the symptoms and causes of FSD and how he counsels patients on FSD. Dr. Drai is also Clinical Assistant Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh School of Medicine.
Host: Matt Birnholz, MD
It is known from prior studies that healthcare professionals who wait for the subjects of sex and intimacy to be brought forth by their patients will typically not cover these important health topics at all. Nowhere is this more prominent than in elderly patient populations, particularly in women, where even the mere idea of continuing sexuality is so often ignored. Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health and Survivorship in Newport Beach, CA, joins host Dr. Matt Birnholz to discuss counseling strategies on sexual health that physicians must incorporate into their practices for optimal care of elder women.
Guest: David Stone, MD
Host: Ana Maria Rosario
It's been two years since ACOG released Practice Bulletin #130 regarding the Prediction and Prevention of Preterm Birth. Where are we today in identifying patients who are a great risk? How can clinicians put the information into clinical practice to provide significant outcomes? Senior reporter Ana Maria Rosario welcomes Dr. David Stone, Practicing Ob-Gyn in the metro Detroit area for over 20 years. Dr. Stone shares his clinical experience, perspective and passion regarding the every day practice of predicting and peventing preterm birth. Dr. Stone is a Fellow of the American College of Obstetrics and Gynecology and a member of several national organizations including the American Medical Association and the Society of Robotic Surgeons
Host: Ana Maria Rosario
Breast cancer screening is not the same as breast cancer risk assessment. What are the various screening procedures, what are their respective strengths and weaknesses, and how can clinicians best assess which tools to use for their patients? Senior correspondent Ana Maria Rosario welcomes Dr. William C. Dooley to provide an update on breast cancer screening. Dr. Dooley is the G. Rainey Williams Professor Chair in Surgical Breast Oncology at the University of Oklahoma Department of Surgery.
Host: Lee Philip Shulman, MD, FACOG, FACMG
Guest: David Gandell, MD
Guest: Bahaeddine M. Sibai, MD
What does the current evidence tell clinicians about the use of progestogens for prevention of preterm birth (PTB)? How should women with a previous spontaneous PTB be evaluated for risk of subsequent PTB? And what interventions have been shown to be beneficial for reducing the risk of PTB in women who do not have a history of PTB but who are found to have a short cervical length? Host Dr. Lee Shulman welcomes Dr. Baha Sibai to answer these questions and more. Dr. Sibai is Professor of the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Sciences Center in Houston, Texas.
Guest: Lee Philip Shulman, MD, FACOG, FACMG
Host: Thomas C. Wright, Jr., MD
Host Dr. Thomas Wright chats with Dr. Lee Shulman on new prenatal screening choices. Dr. Shulman reviews the differences between prenatal screening and diagnosis. They also discuss the improvements in screening tools in the last several years and the latest technologies available to clinicians.
Dr. Lee Shulman is the Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief of the Division of Reproductive at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Co-Director of the Northwestern Ovarian Cancer Early Detection and Prevention Program and is the Medical Director of the Graduate Program in Genetic Counseling at Northwestern University.
Guest: Andrea J. Singer, MD, FACP, CCD
Host: Ana Maria Rosario
Guest: Thomas C. Wright, Jr., MD
In this program, senior correspondent Ana Maria Rosario chats with Drs. Andrea Singer andThomas C. Wright Jr. to review medical breakthroughs over the past 10 years in the field of women's health. Their discussion specifically focuses on cardiovascular medicine; advances in HPV; updates on female sexual dysfunction; current issues in obesity; advances in breast cancer screening; and the shift of osteoporosis/fracture management.
This program was recorded live from the 10 year anniversary kick off of the Women's Health Annual Visit CME series. Celebrate a decade of Omnia Education's Women's Health Annual Visit by registering for an upcoming program in a city near you. Visit www.OmniaEducation.com
Dr. Andrea J. Singer is Associate Professor of Medicine and Obstetrics & Gynecology and the Director of Women's Primary Care at Medstar Georgetown University Hospital and Georgetown University Medical Center in Washington, DC. Dr. Thomas C. Wright specializes in Pathology and Cell Biology at the College of Physicians and Surgeons of Columbia University in New York, NY.
Sponsored by
Host: Matt Birnholz, MD
The Society for Maternal Fetal Medicine (SMFM) has long been dedicated to the optimization of pregnancy and perinatal outcomes; but according to Dr. Vincenzo Berghella, President of SMFM and Professor of OB/GYN at Thomas Jefferson University School of Medicine, this mission is continually challenged by ongoing issues such as maternal morbidity and mortality, preterm birth, lack of updated practice guidelines, and OB/GYN burnout. Dr. Berghella speaks with host Dr. Matt Birnholz about SMFM's response to these and other issues, and includes his recently published 6 keys to physician happiness on behalf of practicing OB/GYNs everywhere.
Host: Mimi Secor, DNP, FNP-BC, FAANP
Host Mimi Secor welcomes Women's Health Foundation founder and Executive Director, Missy Lavender, to talk about innovative ways to bring women into pelvic health programs across the U.S. Through her foundation, Ms. Lavender helps address issues of ignorance and intimidation that often pervade both patient and medical professional circles when it comes to gynecological and bladder health maintenence.
Host: Matt Birnholz, MD
Dr. Andrew Wagner, Associate Professor of Obstetrics and Gynecology at the University of Oklahoma Health Sciences Center, joins host Dr. Matt Birnholz to discuss the roles of the OB/GYN as both primary care providers and specialists in screening, diagnosing, and treating hereditary cancer syndromes in women. Their discussion covers cancers of the breast, ovaries, endometrium and cervix, as well as related heriditary conditions such as Lynch Syndrome.
Host: Matt Birnholz, MD
Despite numerous advances in maternal-fetal medicine over the past decades, maternal morbidity and mortality continues to plague labor and delivery wards across the U.S. What are the various clinical, social, and economic determinants of health for expectant mothers, and what partnerships exist to improve maternal care? Dr. Sarah Kilpatrick, Chair of the Department of Obstetrics and Gynecology and Associate Dean of Faculty Development at Ceders-Sinai Health Center, joins host Dr. Matt Birnholz to discuss ways in which healthcare professionals can take the lead on this pressing issue.
Host: Brian P. McDonough, MD, FAAFP
Natural family planning (NFP), also called fertility awareness, is a method of birth control that does not use any drugs or devices. Despite gaining traction of late, there are varying attitudes and sentiments from the medical community toward this practice. Dr. Robert Motley, President of Medical Staff at Lehigh Valley Health Network, joins host Dr. Brian McDonough to describe this alternative approach and its respective advantages and disadvantages for patients.
Download and listen today!
Host: Matt Birnholz, MD
"We are what our parents and grandparents ate, and how they lived," says Dr. Mark Hanson, Director of the Academic Unit of Human Development and Health at the University of Southhampton in the United Kingdom. This chilling but increasingly recognized prospect concerning intergenerational passsages of disease risk helped found the Developmental Origins of Health and Disease (DOHaD) study, a worldwide collaboration aimed at better understanding environmental to genetic determinants of health across multiple generations. In this discussion with host Dr. Matt Birnholz, Dr. Hanson highlights the science behind broadening our scope of individualized care to include both past and future generations of each patient.
Host: Matt Birnholz, MD
What can in-depth exploration of medical history topics teach and inform us about current trends in clinical practice? Dr. Peter Marcus, Associate Clinical Professor of OB/GYN at Yale University School of Medicine, joins Dr. Matt Birnholz to discuss various ways in which scholarship in medical history fosters greater aptitude for patient care.
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough welcomes Dr. Nancy Fan, practicing OB/GYN at Saint Francis Hospital in Wilmington, DE and current Chair of the School Health Committee for the Medical Society of Delaware, to discuss challenges and controversies surrounding breast feeding recommendations in maternity care practice.
Host: Brian P. McDonough, MD, FAAFP
Joining Dr. Brian McDonough to talk about the roles of obstetrics and gynecology in primary care and medical education is Dr. James Cosgrove, Chairman of OB/GYN at Saint Francis Hospital in Wilmington, DE. They will discuss the importance of OB/GYNs keeping their primary care colleagues informed of patient screenings, surgeries, and conditions in order to enhance the level of care. Dr. Cosgrove will also touch on admission to medical schools, the importance of understanding the business side of medicine, and future advances in OB/GYN care.
Host: Prathima Setty, MD
Host Dr. Prathima Setty welcomes Dr. Julia Schlam Edelman, author of two books, Menopause Matters and Successful Sleep Strategies for Women. Dr. Edelman will discuss how she conducted her research for these books and the importance for female patients to understand how menopause and sleep disorder affect their overall health. Dr. Edelman is a board-certified gynecologist, certified menopause clinician, a Clinical Instructor at Harvard Medical School, and an Adjunct Clinical Instructor at Brown Medical School.
Download the podcast and listen today!
Host: Prathima Setty, MD
Fertility preservation technologies have become more advanced and more accessible over the past several years. Joining host Dr. Prathima Setty to discuss current options for women to protect their fertility is Dr. Naveed Khan, Reproductive Endocrinology and Infertility Specialist in Leesburg, VA. Dr. Khan practices with Shady Grove Fertility, the nation's largest fertility center, and is also a member of the American College of Obstetrics and Gynecology and the American Society of Reproductive Medicine.
Host: Prathima Setty, MD
Hormone replacement therapy: it's a topic that comes up daily in many practices across the U.S, but what do we really know about personalized approaches to initiating HRT in menopausal women? Joining host Dr. Prathima Setty to shed new light on this important subject is Dr. Michelle Warren, founder and medical director of the Center for Menopause, Hormonal Disorders, and Women's Health in New York City. Dr. Warren is also a professor in the Department of Medicine and Obstetrics and Gynecology at Columbia Presbyterian Medical Center.
Host: Andrea J. Singer, MD, FACP, CCD
Featured from the Omnia Education live activity entitled "Women's Health Annual Visit" (WHAV) are Dr. Andrea Singer, Associate Professor of Medicine and Obsetrics and Gynecology at Georgetown University Medical Center, and Dr. Susan Kellogg-Spadt, Professor of Obstetrics and Gynecology at Drexler University College of Medicine. They will review the biopsychosocial management and treatment of sexual disorders in women, including recommendations for improving patient counseling and overcoming the barriers to managing a patient with sexual dysfunction.
Guest: Robert C. Young, MD
Host: Matt Birnholz, MD
The American Society of Clinical Oncology (ASCO) Conference brings over 30,000 people each year and has a membership of over 33,000, a third of which are international. Discussing important clinical research updates unveiled at this event by scientists from across the world is Dr. Robert C. Young, President of RCY Medicine in Philadelphia and past-President of ASCO. Dr. Young was also awarded ASCO's Distinguished Service Award for Scientific Leadership in 2004.
Host: Brian P. McDonough, MD, FAAFP
It is important for fertility nurses to ensure that the patient is well-informed of the probable cause(s) of infertility, the treatment options available, and the risks and benefits of those therapies. Program Director of the upcoming 1st Annual Fertility Nurses Forum, Monica Moore, MSN, RNC addresses some common questions and issues facing fertility nurses. Monica is a nurse practitioner and nurse manager at RMA of Connecticut in Nowalk, Connecticut.
This Clinician's Roundtable segment is sponsored by Omnia Education
Guest: Martin R. Chavez, MD, FACOG
Host: Brian P. McDonough, MD, FAAFP
Host Dr. Brian McDonough is joined by Dr. Martin Chavez, Chief of Maternal Fetal Medicine at Winthrop University Hospital, to highlight updates in Non-Invasive Prenatal Testing.
Host: Matt Birnholz, MD
This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.
This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.
This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.
This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Guest: Lee Philip Shulman, MD, FACOG, FACMG
Omnia Education's and Prova Education's combined Capstone Conference in New York took advantage of common interests across all learners, addressing clinical trends and future directions across a broad spectrum of primary care and women's health topics. Joining host Lawrence Sherman to reflect on highlights from the combined agenda of Omnia's Stages in Women's Health® and Prova's Evolving Practice of Primary CareTM is Dr. Lee Shulman, Professor of Obstetrics and Gynecology at Northwestern University's Feinberg School of Medicine and Chairman of the conference program.
Guest: Edward J. Mayeaux, Jr., MD, DABFP, FAAFP
Host: Brian P. McDonough, MD, FAAFP
Despite their growing prevalence in the US, eating disorders such as anorexia and bulimia are still often misrecognized or undermanaged at the primary care level. Host Dr. Brian McDonough is joined by Dr. Edward Mayeaux, Professor of Family Medicine and Professor of Obstetrics and Gynecology at the Louisiana State University Health Sciences Center, to discuss effective diagnostic and treatment strategies for eating disorders in general practice.
Guest: Linda D. Bradley, MD
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough is joined by Dr. Linda Bradley, Professor of Surgery and Vice Chair of the Department of Obstetrics and Gynecology at the Women's Health Institute of the Cleveland Clinic, for a discussion on abnormal uterine bleeding. Topics of note include evaluation and treatment strategies, alternatives to hysterectomy, and office-based procedures to aid in the pre-operative workup for patients with this condition.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Debra Friedrich, DNP, ARNP, FNP-C, CLS
Join host Dr. Alan Brown and guest Dr. Debra Friedrich on the most common endocrine disorder in women- Polycystic Ovarian Syndrome (PCOS). They will review the epidemiology, prevalance, diagnosis, long-term risks and treatment options.
Dr. Debra Friedrich, DNP, ARNP, is an Assistant Professor at the University of South Florida College of Nursing and Director of the Family Nurse Practitioner Concentration. She is a family nurse practitioner and Clinical Lipid Specialist in practice in Bradenton, Florida.
Guest: Mary Jane Minkin, MD
Host: Matt Birnholz, MD
Millions of insured women will have additional choices when it comes to their preferred method of birth control due to the Affordable Care Act for Women. But, what does that mean for health care providers and their patients?How does it change how patients are given treatment? Dr. Matt Birnholz welcomes Dr. Mary Jane Minkin. Dr. Minkin will address these questions and more. Dr. Minkin is a clinical professor of obstetrics and gynecology at Yale University School of Medicine and has a private practice in New Haven, Conn.
Host: Matt Birnholz, MD
This Prova Education program, presented by Deborah O'Connor PhD, RD, Professor of Pediatrics at the University of Toronto and Director of Clinical Dietetics at The Hospital for Sick Children, has been developed from the May 2011 live meeting in Denver, CO, A Month in the Life: Achieving Recommended Nutritional Status in Preterm, Low Birth Weight Infants Before, During and Beyond Hospital Discharge.
This program discusses preterm infant nutritional needs beginning at the NICU, the complexities of ensuring good nutritional status, and monitoring care through the transition to home and community settings. Through a review of new evidence-based information, physicians can apply practices that will support nutrition decisions for pre-term and low birth weight infants upon admittance to the NICU and continue through transitions.
Host: Matt Birnholz, MD
Guest: Michael Lewiecki, MD, FACP, FACE
Anyone in medicine will freely admit that osteoporosis is a major health threat in the United States, and yet the majority of patients with osteoporosis remain undiagnosed and untreated. In fact, fewer than one-third of cases have even been diagnosed, and only 14% of women with osteoporosis receive treatment. This comes in stark contrast to the fact that more than 50% of women over age 50 will encounter an osteoporosis-related fracture. So what can the healthcare community do in the face of those odds? Addressing this issue is Dr. Michael Lewiecki, Osteoporosis Director at the New Mexico Clinical Research and Osteoporosis Center. He's also Clinical Assistant Professor of Medicine at the University of New Mexico School of Medicine. Dr. Matt Birnholz hosts.
Host: Matt Birnholz, MD
This Prova Education program, presented by Jae H. Kim, MD, PhD, Assistant Professor of Pediatrics at University of California, San Diego, has been developed from the May 2011 live meeting in Denver, CO, A Month in the Life: Achieving Recommended Nutritional Status in Preterm, Low Birth Weight Infants Before, During and Beyond Hospital Discharge.
This program discusses preterm infant nutritional needs beginning at the NICU, the complexities of ensuring good nutritional status, and monitoring care through the transition to home and community settings. Through a review of new evidence-based information, physicians can apply practices that will support nutrition decisions for pre-term and low birth weight infants upon admittance to the NICU and continue through transitions.
Host: Matt Birnholz, MD
National organizations such as the American Cancer Society and the American College of Obstetricians and Gynecology have published updated guidelines for cervical cancer screening. Crucial variations in these guidelines make implementing a sound, effective clinical protocol for management of gynecologic screening and treatment a challenge; and it is imperative that women's healthcare providers have a thorough understanding of clinical implications.
This Omnia Education program is presented by Dr. Thomas C. Wright, Jr., MD, Professor of Pathology at Columbia University College of Physicians and Surgeons.
Host: Matt Birnholz, MD
This Prova Education program, presented by Eyla G. Boies, MD, FAAP, FABM, Clinical Professor of Pediatrics at University of California, San Diego, has been developed from the May 2011 live meeting in Denver, CO, A Month in the Life: Achieving Recommended Nutritional Status in Preterm, Low Birth Weight Infants Before, During and Beyond Hospital Discharge.
This program discusses preterm infant nutritional needs beginning at the NICU, the complexities of ensuring good nutritional status, and monitoring care through the transition to home and community settings. Through a review of new evidence-based information, physicians can apply practices that will support nutrition decisions for pre-term and low birth weight infants upon admittance to the NICU and continue through transitions.
Guest: Janet Maxson, PhD, FNP
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Dr. Janet Maxon and host Alan Brown discuss the latest thinking on hormone replacement therapy, heart disease and the menopausal woman. They discuss the results of recent clinical trials, as well as when to initiate therapy, and side effects.
Guest: Thomas Moore, MD
Host: Steven Edelman, MD
New screening standards for gestational diabetes could significantly increase the number of women and babies we identify as at-risk. Guest host Dr. Timothy Bailey talks with Dr. Thomas Moore, chairman of the department of reproductive medicine at the University of California, San Diego, about diabetes in pregnancy, and how gestational diabetes affects infant, childhood, and even adolescent obesity and overall health. They discusses screening methods for gestational diabetes, who is at risk, and the benefit from dietary interventions.
Host: Matt Birnholz, MD
This year's meeting in Washington, DC, highlighted recent advances in the prevention, detection, and treatment of conditions impacting women. Presentations focused on fibroids, pregnancy, pelvic pain, breast and ovarian cancers, hormone imbalance, psychological issues, and overall health and well-being.
Host: Mimi Secor, DNP, FNP-BC, FAANP
Guest: Terri Warren, NP
The CDC has recommendations when it comes to the treatment, testing and counseling of patients who may have sexually transmitted infections or at high risk of contracting an STI. There are a number of ways to test for diseases like gonnorhea, chlamidiya, and syphillis and that can be confusing for NPs and their patients. Nurse Practitioner Terri Warren with the Westover Clinic in Portland, Oregon explains to host Mimi Secor some of the most important changes recommended by the CDC to help reduce the number of sexually transmitted infections in the country especially among teens.
Guest: Allegra Broft, MD
Host: Mary Leuchars, MD
As eating disorders are generally on the rise in the United States, what are the personal and economic costs of anorexia and bulimia? Dr. Allegra Broft, assistant professor of clinical psychiatry at Columbia University and research psychiatrist at the Eating Disorders Research Unit of the New York State Psychiatric Institute, is alarmed that eating disorders are not only have a high cost financially, but cost lives as well, likely accounting for the highest mortality among psychiatric disorders. How expensive and effective are residential programs for treatment of eating disorders? What other programs might help patients and families meet the challenges of eating disorder treatments? Hosted by Dr. Mary Leuchars.
Guest: Dorothy Mitchell-Leef, MD
Host: Gary Epstein
Dr. Dorothy Mitchell-Leef tells host Gary Epstein why she decided to go into medicine, despite the lack at the time of female physician role models, details many of the changes she has seen in the evolution of the role of women in medical practice. She also discusses the changes in reproductive medicine she has seen and worked on. Her practice had the very first IVF baby born in Georgia, the first ICSI baby in the United States, as well as the first frozen egg pregnancy in the United States, the first gestational pregnancy in Georgia, and other firsts.
This week's guest was nominated by the
Host: Matt Birnholz, MD
Tune in for the highlights of findings presented at the 33rd Annual San Antonio Breast Cancer Symposium, held from December 8th through the 12th, 2010, covering recent advances in the diagnosis, treatment, and prevention of breast cancer, including the risk of breast cancer and hormone therapy, lack of mammogram screening, combination therapy for hormone receptor positive breast cancer, and predictors of breast cancer outcomes.
Guest: Lois Jovanovic, MD, MACE
Host: Steven Edelman, MD
Universal guidelines in screening, diagnosis and early treatment for diabetes and pregnancy are presenting opportunities for the physician and patient to better manage their diabetes and the health of the newborn babies. What are the standards and what is the clinical relevance? Join host Dr. Steven Edelman and his guest, chief scientific officer of the Sansum Diabetes Research Institute, Dr. Lois Jovanovic, as they discuss the need to screen all pregnant women for diabetes.
Guest: Constance Roche
Host: Mimi Secor, DNP, FNP-BC, FAANP
It's estimated that one in eight women will be diagnosed with breast cancer in their lifetime. 75% of women who are diagnosed have no known risk factors. But the incidence and mortality rate of breast cancer has declined over the last couple of decades. The government released controversial amendments to screening recommendations last year based on mortality outcomes from breast cancer. What are the implications for our patients, and what screening guidelines should advanced practice clinicians recommend to patients? Nurse practitioner Constance Roche, a clinical coordinator at the Avon Comprehensive Evaluation Center in Boston, Massachusetts, joins host Mimi Secor to discuss how to identify high risk patients, the best screening techniques and how primary care providers can find the best specialist for their patients.
Guest: Yvette Petti, PhD, APRN-BC
Host: Mimi Secor, DNP, FNP-BC, FAANP
In the next five years, women will account for more than 10 percent of the veterans in the United States. The growing population of female soldiers has raised new challenges for government. Not only are women facing some of the same health issues as men, like depression and post traumatic stress disorder, but they are dealing with issues like sexual trauma, and the need for services such as mammograms and fertility counseling. Dr. Yvette Petti, adult nurse practitioner for the Department of Primary Care and Women's Wellness Services at the VA Medical Center in Battle Creek, Michigan, joins host Mimi Secor to discuss what the Veterans Administration is doing, and how they are reaching outside the VA, to meet the health needs of women veterans.
Guest: Suleena Kalra, MD
Host: Lee Freedman, MD
Primary and secondary amenorrhea can have various underlying causes among adolescents, including polycystic ovarian syndrome (or PCOS), thyroid disease, and atypical body weight. What types of behavior and lifestyle modifications should be the first steps for adolescent patients with irregular menstruation? Dr. Suleena Kalra, assistant professor in the department of obstetrics and gynecology at Penn Medicine, discusses ways to regulate periods among adolescent patients and protect their future fertility. How significant a role might stress play in amenorrhea among these patients? Dr. Lee Freedman hosts.
Produced in Cooperation with
Guest: Evelyn Resh, CNM, MPH
Host: Mimi Secor, DNP, FNP-BC, FAANP
All parents want to make sure their teenage daughters are well-informed about issues related to sex, but how do advanced practice clinicians make sure teens are comfortable about their sexuality as they move into adulthood? Certified nurse midwife Evelyn Resh, director of women's health and sexuality counseling at Miraval Resorts, Tucson, Arizona, joins host Mimi Secor to talk about giving girls the knowledge and information they need to make healthy decisions about sex. They also discuss the impact that mothers have on their daughters' body image, and new sexual issues facing girls today.
Guest: Douglas Diekema, MD
Host: Maurice Pickard, MD
Although female genital mutilation and circumcision are banned in the US, these brutal procedures are still part of a ceremonial ritual for some cultures. This issue was brought to national attention in the US when a recent statement from the American Academy of Pediatrics suggested a pinprick or nicking procedure performed by pediatricians in this country might be an effective way to discourage families from traveling overseas for more disfiguring procedures. The statement was retracted soon after its release. Dr. Douglas Diekema, director of education for the Treuman Katz Center for Pediatric Bioethics, and professor in the division of bioethics, department of pediatrics at the University of Washington School of Medicine, discusses the original intent of this policy suggestion, and the greater issue of female genital mutilation and circumcision in the US and worldwide. How often do American pediatricians see girls who have had complications from these procedures? Dr. Maurice Pickard hosts.
Guest: Helen Carcio, NP
Host: Mimi Secor, DNP, FNP-BC, FAANP
More than 33 million people in the United States suffer from overactive bladder problems. Bladder health programs are being established in existing and new clinics to treat this issue that is rapidly growing, especially among the elderly. NP Helen Carcio began a certification program on the internet that teaches medical entrepreneurs how to establish these clinics. She joins host Mimi Secor to discuss start-up costs, the treatment process and the role of the NP and PA in this groundbreaking new expertise.
Guest: Lynne Mofenson, MD
Host: Maurice Pickard, MD
Although HIV transmission through breast milk is a significant global health issue, many mothers and their babies depend on breastfeeding for survival. About 90% of children who become infected with HIV each year are in sub-Saharan Africa. What therapeutic interventions are recommended for mothers with HIV in order to prevent transmission of the virus to their babies? Dr. Lynne Mofenson, chief of the pediatric, adolescent and maternal AIDS branch at the National Institute of Child Health and Human Development, at the National Institutes of Health in Rockville, Maryland, discusses two exciting new developments found to reduce the risk of HIV transmission from mothers to their babies in places where replacement feeding for infants isn't available. Hosted by Dr. Maurice Pickard.
Guest: Jonathan Fanaroff, MD, JD, FCLM, FAAP
Host: Maurice Pickard, MD
About 500,000 births in the US every year are pre-term, making premature delivery far from uncommon. And with the increasing survival of pre-term infants, parents and caretakers are having to make more difficult decisions then ever before. How are prenatal consultations beneficial, and when is the most appropriate time for physicians to have a prenatal discussion with parents? Dr. Jonathan Fanaroff, associate medical director of the Neonatal Intensive Care Unit at Rainbow Babies & Children's Hospital and director of the Rainbow Center for Pediatric Ethics in Cleveland, Ohio, suggests strategies for approaching this type of conversation with parents, and emphasizes the role of these discussions in strengthening the relationship and trust between physicians and parents. Dr. Maurice Pickard hosts.
Guest: Roger Green, DNP
Host: Mimi Secor, DNP, FNP-BC, FAANP
Healthcare practiced between the grocery store's pharmacy and produce section is becoming one of the largest sectors employing nurse practitioners in the United States. Since retail clinics see patients from the age of 1 to 100 most NPs are family nurse practitioners. Dr. Roger Green, division vice president of the western region of the Kroger grocery store system's Little Clinics, joins host Mimi Secor to talk about why such clinics are so popular among patients and NPs who work in this rapidly growing medical specialty.
Guest: Sheryl A. Kingsberg, PhD
Host: Maureen Whelihan, MD
Pain is one of the most significant barriers to pleasurable sex— and very common, affecting 15 to 25 percent of women at some point during their lifetime. Dyspareunia and vaginismus are two of the most common pain disorders. What are the signs and symptoms, and what are the questions you can ask your patients in order to assess whether they're having pain and what type? Dr. Sheryl Kingsberg, chief of the division of behavioral medicine in the department of OB/GYN at Case Medical Center University Hospitals in Cleveland, Ohio, joins host Dr. Maureen Whelihan to talk about treating dyspareunia and vaginismus through medication, behavioral therapy and pelvic floor physical therapy.
Host: Maureen Whelihan, MD
Guest: Michael Krychman, MD
When a woman is first diagnosed with breast cancer, a doctor's first concern is a treatment plan. But what happens after chemotherapy, radiation and surgery? Women must once again learn to reconnect with their bodies. Dr. Michael Krychman, executive director of the Southern California Center for Sexual Health and Survivorship Medicine, joins host Dr. Maureen Whelihan to discuss the treatment of low sexual desire in breast cancer survivors.
Guest: Isaac Schiff, MD
Host: Bruce Bloom, DDS, JD
In the 80-year history of hormone therapy, it has been alternately embraced and rejected. Case in point: the original term, hormone replacement therapy, came to be seen as highlighting a negative state, and was changed to simply hormone therapy. Why has the pendulum swung so frequently back and forth? What is the latest "timing hypothesis," and will it again change our evaluation of hormone therapy? Host Dr. Bruce Bloom explores the studies and new thinking, the benefit for bone density, the risk of breast cancer, and more, with Dr. Isaac Schiff, chief of the Vincent Obstetrics and Gynecology Service at Massachusetts General Hospital and the Joe Vincent Meigs Professor of Gynecology at Harvard Medical School.
Series Produced in Cooperation With
Guest: Michael Krychman, MD
Host: Maureen Whelihan, MD
More than 43 percent of women across the country, of all ages and races, have some type of sexual complaint or problem; but more often than not, they don't talk to their doctor about it. How can doctors bring up this issue without making their patients feel uncomfortable? Dr. Michael Krychman, executive director of the Southern California Center for Sexual Health and Survivorship Medicine, joins host Dr. Maureen Whelihan to discuss how to overcome the barriers when talking about sex with patients, as well as what causes low desire in women and how to treat it.
Guest: Michal Elovitz, MD
Host: Lee Freedman, MD
The preterm birth rate in the United States is increasing, despite efforts to expand research and studies in this area. What are some of the risk factors for preterm birth, and are there any ways we can prevent preterm birth? Dr. Michal Elovitz, associate professor of obstetrics and gynecology, and director of the Maternal and Child Health Research Program, in the department of obstetrics and gynecology, at Penn Medicine, examines results of completed and ongoing trials aimed at preventing premature delivery among high-risk women with a history of prior preterm birth. What are future directions for research in this area? Tune in to hear host Dr. Lee Freedman explore these questions and more about preterm birth.
Produced in Cooperation with
Host: Lee Freedman, MD
Guest: Anuja Dokras, MD, PhD
In what situations do couples consider preimplantation genetic diagnosis, or PGD, and should all of these couples undergo genetic counseling prior to PGD? What is the process for PGD? How accurate has PGD testing become, and what are its remaining limitations? How does preimplantation genetic screening differ from PGD? Host Dr. Lee Freedman addresses these questions and more with Dr. Anuja Dokras, medical director of the in vitro fertilization program at Penn Fertility Care and associate professor of obstetrics and gynecology at Penn Medicine.
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
Guest: Elisabeth Howard, PhD, CNM
Guest: Edie McConaughey, CNM, MS
What can a medical student or resident learn from a midwife about childbirth? Dr. Elisabeth Howard and Edie McConaughey, both certified nurse midwives at Women & Infants Hospital in Providence, Rhode Island, recently completed research on midwives as educators to medical students. They discuss with host Lisa Dandrea Lenell why it's important for these two professions to collaborate even though there may be a difference in philosophy and why midwives are good teachers for future doctors.
Host: Steven Edelman, MD
Guest: Irwin Goldstein, MD
The vascular, neurologic, hormonal and psychological issues associated with the diabetes and metabolic syndromes are commonly the cause of sexual problems. What benefit does a multidisciplinary approach to sexual medical issues bring to people living with diabetes? Join host Dr. Steven Edelman and his guest, director of San Diego Sexual Medicine at Alvarado Hospital in Southern California, Dr. Irwin Goldstein, as they discuss both male and female sexual dysfunction, treatments and a multidisciplinary approach to sexual medical issues.
Guest: Thomas Moore, MD
Host: Steven Edelman, MD
Characterized by high blood sugar levels first recognized during pregnancy, gestational diabetes affects about four percent of all pregnant women. Join host Dr. Steven Edelman and Dr. Thomas Moore, director of perinatal medicine at University of California, San Diego Medical Center, as they discuss the diagnosis and treatment for gestational diabetes.